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ABSTRACT 
Carboxyl-modified polystyrene nanoparticles (COO-PS-NPs) have many 
potential applications, for example drug-delivery systems, but their toxicity remains 
poorly assessed. In the current study, characterisation, uptake and toxicity of two sized 
COO-PS-NPs in cultured BEAS-2B lung epithelial cells were investigated. 
The 20nm sized COO-PS-NPs tended to aggregate heavily in the cell culture 
media yielding larger aggregates, in contrast the 100nm COO-PS-NPs were stable. 
Electron and confocal microscopy demonstrated that COO-PS-NPs rapidly accumulate in 
vesicle-like structures within cells and fluorescent organelle co-staining showed the 
presence of 20nm COO-PS-NPs in mitochondria and the 100nm COO-PS-NPs in Golgi 
apparatus. Cellular studies revealed that COO-PS-NPs cause GSH depletion and induce 
ROS generation resulting in oxidative stress. Studies in a cell-free system showed that 
COO-PS-NPs directly deplete levels of GSH in solution. Size- and concentration-
dependent DNA strand breaks (by comet assay) were also observed and both 20nm and 
100nm COO-PS-NPs induced caspases-3/7 activation in a Ca
2+
 independent manner, 
however a significant decrease in cell viability was observed only at high concentrations 
of 20nm COO-PS-NPs. 
In summary, this in vitro study demonstrated that toxicity of the 20nm COO-
PS-NPs is mediated by oxidative stress after co-localisation to the mitochondria and that 
further studies are needed to assess the safety of COO-PS-NPs. 
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1.1 Engineered nanoparticles 
Nanoparticles (NPs) including engineered nanoparticles (ENPs) are defined in 
a size-based way, although the precise definition varies. Revell, for instance,  has 
described ENPs as extremely small laboratory man-made materials with one or more 
dimensions of a diameter of 100 nanometres (nm) or less [Revell (2006)] while Varela 
and colleagues have defined them as ultrafine particles that have at least two dimensions 
with less than 100nm in length [varela et al (2012)]. On the other hand, Stone and 
colleagues identified ENPs as having three dimensions with length less than 100nm 
[Stone et al (2010)]. The European Commission has reported that “nanomaterial means a 
natural, incidental or manufactured material containing particles, in an unbound state or 
as an aggregate or as an agglomerate and where, for 50% or more of the particles in the 
number size distribution, one or more external dimensions is in the size range 1-100nm”. 
[Commission Recommendation on the Definition of Nanomaterial (Brussels, 2011, 
published online)]. Whatever the precise definition, ENPs are extremely small and they 
therefore can easily penetrate through to all cells and reach almost all the areas of the 
body. 
ENPs are known to demonstrate large surface area to volume ratio due to their 
small size. This means that a large number of total atoms are exposed on the outer surface 
of ENPs (compared to atoms engulfed inside) and this would enhance their energy and 
consequently increase their chemical functional reactivity compared to their counterparts 
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of the large scale particles towards biological systems [Oberdörster et al (2005b), Vippola 
et al (2009)]. In other words, ENPs have significant adsorption capacities (because of 
their large surface area) that would improve their biological activity as dynamic carrier 
systems for other probes (e.g. drugs) and bio-molecules (e.g. proteins) in biological 
systems [Fröhlich
b
 (2012)]. Subsequently, this would enhance the drug efficacy when 
physically adsorbed (or covalently bound) onto the surface of the ENPs because they 
would provide effective drug transportation to the target of interest with good protection 
against digestion and/or extracellular degradation upon metabolism [Mailänder and 
Landfester (2009)]. 
The surface of ENPs can be modified (with functional group) or coated (with 
other material) to change their physicochemical properties [De Jong et al (2008)]. These 
consist of the ENPs attributes (such as size, shape, surface charge, functional group, 
chemical composition and porosity) in addition to the surrounding media-dependent 
characteristics (including bio-degradation, solubility (hydrophobicity/hydrophilicity) and 
aggregation/dispersion status) [Nel et al (2009)]. The ENPs physicochemical 
characteristics play a major role in determining the uptake, bioactivity, translocation and 
biodegradability of ENPs in biological systems [Alvarez-Román et al (2004)] as well as 
determining the ENPs-drug binding, adsorption, trafficking and fate [Olivier et al (2004), 
Rejman et al (2004)]. 
Over the past couple of decades, ENPs have attracted the attention of scientists 
and people from different fields including industries because of the unique 
physicochemical properties (including electronic, magnetic and optical characteristics) of 
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ENPs compared with traditional materials of large-scale size. These properties make 
them scientifically and economically important with uses in electrical and medical 
products as well as in wider range of applications [Yang et al (2010)] showing a very 
promising future for ENPs. They have also been used in medical sciences and 
technologies [Murthy (2007), Yang et al (2007)] such as diagnostics (e.g. contrast agents 
in magnetic resonance imaging (MRI)) [Mailänder and Landfester (2009)], therapeutics 
(i.e. drug/gene delivery and cancer detection) [Panyam and Labhasetwar (2010)] and in 
materials used for bone and hip replacements [Yang et al (2010)]. In addition, they are 
used in several applications including cosmetics and daily personal care products (e.g. 
sun lotions, deodorants and toothpaste), dyes for the textile industry [Wong et al (2006)] 
and in criminal detection (such as latent fingerprints identification) [Sametband et al 
(2007), Amey et al (2009)]. Thus, ENPs can be exploited broadly in several applications 
depending on their increased surface area compared to their unit mass [Allaker et al 
(2008)]. As many as 1500 ENPs-based containing consumer products have been 
estimated to be recently in market [Marquis et al (2009), Zhu et al (2010), The 
Nanotechnology Consumer Products Inventory (published online)]. 
1.2 Carboxyl-modified polystyrene nanoparticles and their applications 
Polystyrene nanoparticles (PS-NPs) are polymers without transition metals or 
minerals [Brown et al (2001)]. They are monodisperse of variable size [Holzapel et al 
(2005)] with a minimal negative charge but are often considered neutral as they do not 
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have a specific functional group [Lundqvist et al (2008)]. The carboxyl-modified 
polystyrene nanoparticles (COO-PS-NPs) are polar negatively charged polymeric 
nanoparticles with several carboxyl groups attached covalently to their surfaces [Alvarez-
Román et al (2004), Mailänder and Landfester (2009)]. 
These polymeric nanoparticles have been widely used in a variety of fields 
such as biomedical applications (as carriers for several bio-molecules such as antibodies, 
peptides or proteins and drugs to different tissues and organs), electrical applications and 
catalysts [Liu and Liu (2009)]. In addition, PS-NPs can be used as a research model for 
long-term exposure studies since they are not significantly biodegradable and can be 
detected easily in cells [Mailänder and Landfester (2009)]. Fluorescent PS-NPs have been 
used for sensing trace amounts of infectious diseases such as malaria and a PS-NPs-based 
diagnosis test has been used to identify malaria in Thailand [Tallury et al (2010)]. PS-NPs 
are the most widely used polymeric nanoparticles as drug-carriers because they are 
commercially available at inexpensive cost with high stability in biological systems [Liu 
and Liu (2009)]. However, they have hydrophobic surfaces which would result in a non-
specific adsorption of bio-molecules and they hence need to be modified by adding 
certain functional (carboxylic or amino) groups to allow covalent binding of bio-
molecules onto their surfaces [Liu and Liu (2009), Hai et al (2009)]. 
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1.3 Routes of human exposure to ENPs 
The human body can come in contact with ENPs released into the environment 
from different sources including industrial plants, chemical storage, waste handling, 
transportation means and ENPs-based products as well as to ENPs that escape to the soil 
and groundwater through agricultural applications such as ENPS-containing pesticides. 
ENPs have been used in a wide range of application and consequently human exposure to 
ENPs are potential through various routes including inhalation (from air), digestion (or 
ingestion from food and water), dermal penetration (from clothes and skin products) and 
injection (Fig. 1.1). However, inhalation seems to be the foremost exposure route of 
ENPs targeting the nose, nasal cavity and alveolar cells in the lungs (passing through the 
respiratory tract) and travels to other organs via the circulation system. The large surface 
area of the lungs is a major reason that makes them the target for the inhaled NPs 
[Mühlfeld et al (2007)]. 
1.4 Possible adverse effects of exposure to ENPs and translocation to different 
organs 
The use of ENPs containing products and nanotechnology applications is 
growing fast. The profit of medical ENPs-based application industry for example, such as 
ENPs containing artificial hip replacements [De Jong and Borm (2008)], is expected to 
reach $1 trillion by 2015 [Nel et al (2006)]. As a result, it is inevitable to avoid the 
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exposure to ENPs that may result in harmful consequences to human and thus, the 
awareness about the possible toxic consequences of the ENPs in biological systems has 
recently increased [Agarwal et al (2013)]. Accordingly, the nanotoxicological studies 
have been focusing on understanding the cells-ENPs interactions, developing risk 
assessment of ENPs on human health and environment, determining the concentrations 
(doses) for ENPs cytotoxicity and assessing the potential associated adverse health 
consequences of exposure to ENPs at the molecular level [Agarwal et al (2013)]. This is 
essential to ensure that they are safe to be used for example in medical applications and 
products used on a daily basis. Although not all ENPs used in applications might be 
harmful, the internalisation of the ENPs into cells can possibly cause adverse health 
impacts (Fig. 1.2). The exposure rate of the human body to ENPs, concentration, 
metabolism, accumulation in organs and secretion of ENPs out of the body are vital 
factors in evaluating possible risks of ENPs. 
As previously mentioned, lungs (by inhalation), gastro-intestinal tract (by 
ingestion) and skin (by dermal contact) are the most likely portals of NPs entry into 
human body. Other possible routes (such as injections) are limited to deliberate exposure 
to ENPs. The internalised ENPs (through the entry points due to their small size) can gain 
access to the circulatory system where they can be translocated within the body to other 
organs and tissues.  
This ENPs translocation through systemic circulation (i.e. blood stream) and 
distribution to different organs might have adverse effects on the human health. 
Thrombus formation, for example, measured after 2 and 6h in blood of human subjects 
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was increased following short exposure (1-2h) to dilute diesel exhaust (350µg/m
3
) 
[Lucking et al (2008)]. Moreover, the effect of 60nm sized PS-NPs of three different 
surface modifications; neutral (unmodified) PS-NPs, negatively charged (carboxyl-
modified) COO-PS-NPs and positively charged (amine-modified) NH-PS-NPs on 
thrombosis (and hemostasis) has also been studied in vivo and the results showed that 
although neutral and negatively charged COO-PS-NPs had no or weak effect, the 
positively charged NH-PS-NPs (60nm size) enhanced thrombus formation significantly in 
hamster after intravenous injection (at 50 and 500µg/kg body weight) and intratracheal 
administration (at 5000µg/kg body weight) [Nemmar et al (2002)]. Similarly, other study 
has revealed that continuous intravenous administration of the positively charged NH-PS-
NPs (60nm size) in ear veins of rat model has increased the thrombus formation in a 
dose-dependent manner while the negatively charged COO-PS-NPs did not affect 
thrombosis [Silva et al (2005)]. 
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Fig 1.1 Routes of ENPs uptake and translocation into human body including inhalation, 
digestion, injection and skin (adopted from: "Oberdörster et al
b
 (2005)"). 
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Fig 1.2 diagram of diseases and possible effects of ENPs internalisation into different 
organs of the human health (adopted from a report by Institute of Science In Society 
(ISIS) released in March 2010). The potential effects include asthma, bronchitis, lung 
cancer, neurodegenerative diseases (such as Parkinson), colon cancer, arteriosclerosis, 
heart diseases and autoimmune diseases leading potentially at the end to death, however 
these effects will depend on the physicochemical properties of particular ENPs. 
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1.5 Cellular uptake of ENPs and co-localisation into different compartments 
Due to their large surface area-to-volume ratio, ENPs are suggested to behave 
in a different way to large-scaled particles of the same materials. However, relatively 
little is known about the cellular uptake and possible biological effects of ENPs on health 
and the environment are poorly understood. 
Proteins are known to compete to be adsorbed onto the surfaces of ENPs in 
biological environments forming a transient “corona” complex which is likely to enhance 
the physical adhesion (interaction) of ENPs on the cell surface (this may be through 
plasma membrane receptors) by biologically identifying the ENP before being ingested 
into the cell or organelle where they can dissociate again [Ehrenberg and McGrath 
(2005), Cedervall et al
b
 (2007), Lynch et al (2007)]. This ENPs-protein corona, in 
addition to the ENPs shape and size, has been therefore proposed to determine the ENPs 
interactions with cells and with other molecules in biological fluids as well as 
determining their cellular fate and sub-cellular co-localisation [Lundqvist et al (2008), 
Rocker et al (2009), Hellstrand et al (2009), Jiang et al
b
 (2010)]. Therefore, understanding 
the corona formation and ENPs binding properties to bio-molecules will be helpful to 
gain knowledge about the biological effects of ENPs mainly at the cellular level.  
Adsorption of protein on ENPs (i.e. ENP-protein corona 
association/dissociation) was reported to depend on the ENP size and chemical surface as 
well as on the protein identity and concentration in the surrounding environment 
[Cedervall et al (2007)]. Lundqvist and colleagues have studied the effect of the 60nm 
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sized PS-NPs of the three different surface modifications; neutral (unmodified) PS-NPs, 
negatively charged (carboxyl-modified) COO-PS-NPs and positively charged (amine-
modified) NH-PS-NPs on formation of human plasma protein-nanoparticles corona using 
two sizes of each (50 and 100nm). They have found that both size and surface properties 
play a key role in determining the compositions of the protein coronas formed from 
human plasma on the different particles of identical materials [Lundqvist et al (2008)]. 
However, it has been reported recently that proteins exist in biological systems that might 
decrease the targeted cellular uptake of ENPs, potentially by wrapping and shielding the 
ligands (e.g. proteins used for modification on ENPs) and hence preventing specific 
binding to receptors on the cell surface leading to decrease in the pool of ENPs available 
to interact with cells [Salvati et al (2013)]. 
It has been speculated that several physicochemical properties of the ENPs 
including their surface charge (that might be modified by functional group or protein), 
size and morphology as well as the cell line would play major role in the cellular uptake 
of the ENPs [Mailänder and Landfester (2009)]. It has been stated: "Since cell 
membranes are negatively charged, positively charged ENPs were expected to be taken 
up even more efficiently than negatively charged ENPs " [Mailänder and Landfester 
(2009)]. In agreement with this statement, Lorenz and colleagues reported that ENPs with 
positively charged surfaces (e.g. functionalized with cationic group) were efficiently 
internalised into mesenchymal stem (MSC) cells and cervical epithelial adenocarcinoma 
(HeLa) cells compared to uncharged (non-functionalized) ones [Lorenz et al (2006)]. 
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However, the negatively charged ENPs might gain access into the cell after attaching to a 
positively charged bio-molecule on the cell membrane. 
The uptake of different sizes (20 - 1010nm) of fluorescently labeled PS-NPs by 
several cell lines including ECV 304, Hepa 1–6, HepG2, HNX 14C, KLN 205 and 
HUVEC was studied and the results demonstrated that the uptake of the 20nm was 
detected in all cells, however the detection of large PS-NPs (≥ 93nm) was cell type-
dependent [(Zauner et al (2001)]. Moreover, the uptake of 200nm sized red fluorescent 
COO-PS-NPs was minimal in rat carcinoma hepatocytes (C3A), human carcinoma 
hepatocytes (HepG2) and isolated rat hepatocyte couplets (IRHCs) and happened after 
long period of exposure time (> 30 minutes) compared with their 20nm counterparts which 
were absorbed much earlier (~10 minutes) in all cell lines investigated particularly in the 
C3A cells [Johnston et al (2010)]. This would indicate the impact of size on the cellular 
uptake of ENPs. The results also showed that in contrast to the gradual increase in the 
uptake of the 20nm COO-PS-NPs over time in the serum containing medium, COO-PS-
NPs aggregated in the serum free medium (SFM) which reduced their uptake into cells 
[Johnston et al (2010)]. It has been observed that only albumin in the serum-containing 
media can significantly increase the size of the COO-PS-NPs due to aggregation, whereas 
most other serum proteins have a stabilizing effect on them [Fatisson et al (2012)]. 
The surface charge of the particles has been suggested to affect the attachment 
of particles to and interaction with the cell membrane and hence influence their cellular 
uptake [Mailänder and Landfester (2009)]. The previous study by Lorenz and colleagues 
has also reported that positively charged ENPs were co-localised in MSCs and HeLa cells 
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mainly in endosomes whereas they were found attached to the cell surface in Jurkat and 
KG1a cells [Lorenz et al (2006)]. In earlier study by Johnston and colleagues, the 20nm 
sized PS-NPs were co-localised in the tubulin cytoskeleton, in compartments between 
neighbouring cells and then in the mitochondria after 10, 30 and 60 minutes respectively 
but not in early endosomes, lysosomes, or nucleus. In contrast, the 200nm sized PS-NPs 
were found to be only bound the cell surface after 30 minutes of exposure and upwards 
[Johnston et al (2010)]. 
Taken together, these findings would suggest that the cellular uptake of ENPs, 
clearance, efficiency and subsequent toxicity are influenced by several factors including 
size, shape, functional group and surface charge of ENPs in addition to exposure time, 
cell line and serum content of the biological fluid (e.g. cell culture media) which all can 
affect the ENPs adherence and interaction with cells [He et al (2010), Tsuji et al (2006)]. 
It seems that cells might utilize different uptake mechanism for ENPs internalisation 
and/or that the charge located on the surface of ENPs could be influenced perhaps by the 
surroundings environment (such as the media) to undergo modification that may facilitate 
their uptake and translocation to various sites within the cell. 
1.6 Mechanism of cellular uptake of ENPs 
At the cellular level, it is important to understand the uptake pathway(s) of 
ENPs since this would possibly affect their co-localisation within cell compartments and 
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this would hence help in controlling the intracellular fate and target of drug by nano-
carriers [Palakurthi et al (2011)]. 
The permeable plasma membrane is composed of phospholipid bilayers with 
embedded proteins to function as a selective barrier that surrounds the cell to isolate its 
cytoplasm (protecting the intracellular components in the interior from the outside 
environment) and to regulate the biological communication as well as the selective 
exchange of substances and materials in and out of the cell [Zhao et al (2011)]. The 
interaction of ENPs with the plasma membrane of the cell is the first step towards the 
cellular internalisation of ENPs and the co-localisation in or near the intracellular 
organelles. However, the uptake mechanism(s), the cellular fate and the consequent 
toxicological effects of ENPs in biological systems are not fully understood because a 
variety of ENPs, various cell lines, several practical methods and different experimental 
conditions (e.g. time, concentration, size of ENPs) employed in different studies. This has 
resulted in different (and possibly controversial) results. 
Uptake of ENPs (or other materials and viruses) into cells is known as 
endocytosis [Palakurthi et al (2011)]. Endocytotic mechanism is an active (i.e. energy-
dependent) transport system in which ENPs gain entry to a cell without passing directly 
through the cell membrane in multiple stages as the cell encloses them when in contact 
with its exterior membrane in intracellular vesicles (pockets originate from its membrane) 
to bring them from outside into the cell [Sahay et al (2010), Zhao et al (2011)]. 
Endocytosis consists mainly of two categories, depending on the size and nature of the 
engulfed molecules, which are phagocytosis (i.e. cell eating or engulfment of large sized 
 
 
 
 
Chapter 1                                     General Introduction 
 
 
 
 
16 
insoluble objects > 750nm) and pinocytosis (i.e. cell drinking or engulfment of fluids, 
solutions and soft objects) [Conner and Schmid (2003)]. Pinocytosis itself can be 
categorized in four groups (with distinctive morphologies depending on the mechanism 
of the vesicle formation) including macro-pinocytosis, clathrin-mediated (or receptor-
mediated) endocytosis, caveolin-mediated endocytosis and clathrin- and caveolin-
independent [Conner and Schmid (2003), Geiser (2010), Dos Santos et al (2011)]. These 
different endocytotic mechanisms are illustrated diagrammatically (Fig. 1.3 A). It has 
been reported that phagocytosis is restricted to particular cell types including 
macrophages, monocytes, neutrophils and dendritic cells [Prokop and Dvidson (2008)] 
which form the mononuclear phagocyte immune system [Hume (2006)] whereas 
pinocytosis occurs in all types of cell [Palakurthi et al (2011)]. Some features of these 
different endocytotic mechanisms are summarized in brief in the next section. 
Phagocytosis is an endocytotic mechanism in which the attachment of a large 
size object to the cell membrane would trigger specific surface receptors to signal and 
initiate membrane-origin phagosome (large endosome vesicle) that encapsulates the 
foreign material and deliver the ingested cargo to lysosome where it can be destroyed by 
the lysosomal degradative enzymes [Samaj et al (2004)]. Macro-pinocytosis is a 
nonspecific mechanism in which large vesicle is generated by bending the cell membrane 
with the particles containing extracellular fluid inside the cell before the two ends get 
closer to each other and fuse together forming large vesicle (named macro-pinosome) 
[Conner and Schmid (2003)]. The clathrin- and caveolin-independent endocytosis is also 
a non-specific mechanism to engulf substances. It involve formation of lipid rafts that are 
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small size cholesterol-rich domains with diameter of 40-50nm which can be captured by 
endocytotic vesicle, followed by internalisation [Dos Santos et al (2011]. 
In the clathrin- (or receptor-) mediated endocytosis (Fig. 1.3  B), clathrin (large 
specific protein molecule) is concentrated along specific regions of the inner surface of 
the cell plasma membrane forming clathrin-coated pits. On the opposite outer side of 
these pits, receptors would specifically bind to ENPs (or other ligands) and clathrin is 
then linked to receptors by AP-2 adaptors (complex) stimulating this clathrin-coated pit 
to grow inside the cell to form a coated endocytotic vesicle in the cell cytoplasm bringing 
the enclosed substances into the cell. The vesicle is detached and fuses in the cytoplasm 
with lysosomes releasing the ligands from the receptors to digest the contents or 
discharge them while the receptors are sent back to the plasma membrane for recycling 
[Bauer et al (2008)]. Since the endocytotic clathrin-coated pit has about 120nm in 
diameter [Lunov et al
a
 (2011)], this clathrin-mediated endocytosis would internalise only 
small area of the cell surface with engulfed molecules and small volume of extracellular 
fluid. 
Regarding caveolin-mediated endocytosis (Fig. 1.3 C), it has been speculated 
that caveolin protein is produced in the endoplasmic reticulum (ER) and is transferred to 
the Golgi apparatus to be organized with phospholipid rafts into higher-order oligomers. 
Cholesterol is then added upon exiting the Golgi apparatus forming a caveolae-lipids 
associated structures that fuse into the plasma membrane forming caveolae pits (of 60-
80nm diameter) that have hairpin-like shapes [Parton et al (2007)]. Caveolae pit stays 
stable at the plasma membrane until it is induced by ENP (probably due to increase in 
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their sizes) for internalisation into the cell and this pit with the content is released to fuse 
either with the early endosomes or cavesomes [Parton et al (2007)]. 
It has also been suggested that ENPs are able to enter cells through non-
endocytotic mechanisms including passive transport (e.g. diffusion and permeation 
(trans-cellular pathway) through holes in the plasma membrane) or even through 
promoting cell membrane rupture and other unclear mechanism(s) before accumulating 
near plasma membrane and/or gaining access to different organelles (such as 
mitochondria, nucleus, etc) [Li et al (2003), Geiser et al (2005), Tsoli et al (2005), Porter 
et al (2006), Rothen-Rutishauser et al (2006), Johnston et al (2010), Yacobi et al (2010)]. 
In contrast, other studies have demonstrated that ENPs uptake may be achieved via 
endocytotic mediated mechanisms [Stearns et al (2001), Chithrani et al (2006)]. 
Receptor- (clathrin-) mediated endocytosis was speculated to be the most 
effective uptake mechanism for ENPs [Decuzzi et al (2008)]. Nonetheless, it seems that 
determining the mechanism(s) responsible for the internalisation of ENPS into cells is 
complicated and several factors might be involved in the ENPs interactions with and 
uptake into cells and intracellular organelles such as size of ENPs [Rejman et al (2004)], 
shape [Geng et al (2007)] and surface charge [Dausend et al (2008), Mailänder and 
Landfester (2009)]. One study has suggested that ENPs with a size ≤ 200nm diameter are 
internalised via clathrin-mediated endocytosis while these ENPs that have a size > 200nm 
diameter are ingested via caveolin-dependent endocytosis [Rejman et al (2004)]. In 
addition, a stronger driving force and additional energy have been hypothesized to be 
essential for the uptake of large sized ENPs [Gao et al (2005)]. Another study has 
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proposed macro-pinocytosis to be the uptake mechanism of positively charged PS-NPs 
into the cytoplasm of the human epithelial cervical cancer (HeLa) cells whereas 
negatively charged PS-NPs were hypothesized to be cellularly internalised by unknown 
dynamin-  and clathrin-independent pathway [Dausend et al (2008)]. Moreover, it has 
been reported that ENPs with positive charge are generally internalised into cells in much 
high rate when compared with these that carry negative charge [Höcherl et al (2012)]. 
In addition to the size and surface charge of ENPs, it has been anticipated that 
other physicochemical characteristics (including the chemical composition, shape and 
structure of NPs) and the formation of ENP-protein corona [Höcherl et al (2012)] as well 
as the cell line (due to distinct cell properties) [Zauner et al (2001), Cortez et al (2007)] 
are overall most likely to contribute to the uptake phenomenon. Consequently, different 
ENPs might possibly have more than one intracellular fate and uptake mechanism into 
different cell lines. Moreover, the increase in size of ENPs after agglomeration has to be 
taken into account when analyzing the internalisation mechanism. Moreover, electrostatic 
attractive forces between charged ENPs and oppositely charged molecules embedded or 
attached to the cell membrane have been suggested to cause the cell membrane to wrap 
around the ENP and promote endocytosis [Li et al (2010)]. 
Confocal microscopy was used to investigate and compare routes of uptake and 
fate of fluorescent cationic amino-modified polystyrene nanoparticles (NH-PS-NPs) of 
60nm diameter in five different cell lines including macrophages (RAW 264.7), human 
bronchial epithelial cells (BEAS-2B), human microvascular endothelial cells (HMEC), 
hepatoma cells (HEPA-1) and pheochromocytoma cells (PC-12) as ports of entry or 
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systemic targets for ENPs [Xia et al (2008)]. The experimental data proposed that the 
uptake pathway and toxicity mechanism of NH-PS-NPs are cell line-specific with 
different toxic impact on these cells showing that the HMEC, HEPA-1 and PC-12 cells 
were relatively resistant to these NH-PS-NPs compared to highly toxic effect observed in 
the other two cell lines after 16h. NH-PS-NPs were found in lysosomes (lysosomal 
membrane glycoprotein-1 compartment; LAMP-1) in RAW 264.7 cells leading to 
mitochondrial damage and caspases-activated apoptosis initiated by intracellular Ca
2+
 
release after lysosomal permeabilization into the cytosol. In BEAS-2B cells, NH-PS-NPs 
have been suggested to be taken up by caveolae causing necrotic cell death associated 
with induction of mitochondrial clustering and ATP depletion [Xia et al (2008)]. In both 
cell lines, however no mitochondrial co-localisation with NH-PS-NPs has been observed 
which would suggest that this damage of mitochondria is not a result of a direct 
interaction between NH-PS-NPs and mitochondria. 
In summary, several endocytotic mechanisms may contribute to the cellular 
internalisation (uptake) of ENPs depending on their size, chemical composition and 
surface charge. However, the uptake mechanism of ENPs is still not well in-depth known 
and seems to be more complicated than the simple vesicle formation. It may include 
different stages where a portion of the plasma membrane is invaginated in the first stage 
of this pathway and pinched off to create membrane-bound vesicles (known as 
endosomes) which encompass the particles and import them into the cell. Secondly, these 
endosomes carry the engulfed particles to specialized vesicular structures. Finally, the 
content is transported across the cell to different intracellular compartments. 
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Fig. 1.3 (A) Different types of endocytosis that involves creating endosomes to engulf and deliver 
ENPs to different cell compartments (adopted from: "Conner and Schmid (2011)"). (B) 
Mechanism of clathrin-mediated endocytosis in which the clathrin are linked to receptors by AP-2 
complexes forming clathrin-coated vesicles that are detached from plasma membrane and 
delivered to early endosomes (adopted from: "Grant et al (2006)") while in caveolae-mediated 
endocytosis (C), caveolae pits with hairpin-like shapes are induced by ligands on membrane 
before internalised into cell (adopted from: "Parton et al (2007)"). 
A 
B 
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1.7 Toxicity of ENPs and possible mechanism of cellular death 
Following body exposure to ENPs, they can be distributed to various organs 
where they can interact with cells and might cause cyto- and geno-toxicity, if they are not 
cleared out (excreted or digested). These ENPs toxicity can be shown as inflammation, 
generation of reactive oxygen species (ROS), GSH depletion, DNA damage and injury of 
cells and tissues [Nel et al (2006)]. Moreover, retention of ENPs in the body for a long 
time after uptake (mainly via inhalation) and translocation (within the blood stream) to 
different organs has been reported to cause their potential toxicological effects to increase 
[Seaton et al (2010)]. 
The cellular defensive antioxidant system is composed of enzymatic molecules 
(such as catalase, superoxide dismutase, glutathione peroxidase and glutathione 
reductase) in addition to non-enzymatic antioxidants (such as copper and iron chelators, 
flavonoids as well as vitamins A, E and C) [Mohora et al (2009)]. Glutathione (γ-L-
Glutamyl-L-CysteinylGlycine), in its reduced form (GSH), is one of the critical cellular 
defensive non-enzymatic antioxidant (reducing) agents that can modulate the ROS level 
[Green et al (2006)]. It is a very small molecule (having low molecular weight) composed 
of three amino acids that are γ-glutamic acid, cysteine, and glycine with a sulfhydryl 
(thiol) unit [Jefferies et al (2003)]. This tripeptide is produced in high concentration (~ 15 
mM) due to its significant importance [Deponte (2012)] in the cytosol of almost all 
mammalian cells through the γ-glutamyl cycle [Pastore et al (2003)]. GSH synthesis is an 
ATP-dependent process in which γ-glutamic acid is conjugated through its γ-carboxyl 
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group with cysteine by the action of γ-glutamylcysteine ligase forming γ-
GlutamylCysteinyl to which glycine is then added by a GSH synthetase enzyme to 
produce GSH (Fig. 1.7 A) [Meister (1988), Bains et al (1997), Green et al (2006)]. It is 
the fundamental non-protein thiol source and the total cellular GSH is found mainly in 
the cytosol (80-85%) and mitochondria (10-15%) while small amounts were found in the 
nucleus and endoplasmic reticulum [Lu (2013), Green et al (2006)]. Although this 
ubiquitous tri-peptide plays a major role in many cellular biological processes and 
mechanisms (such as regulating gene expression, apoptosis, DNA synthesis and repair, 
protein synthesis, proliferation, apoptosis and serving as a form of cysteine moiety 
storage), it functions foremost as an antioxidant system to protect cells by detoxifying 
chemical xenobiotics and neutralizing toxins including pollutants and ROS which can 
build up in cells and cause damage by oxidative stress [Meister (1988),  Stephen et al 
(1996), Grant et al (1996), Baudouin-Cornu et al (2012), Lu (2013)]. Table 1.1 
summarizes the defensive role of GSH against some of the toxic molecules in the cell 
[Jefferies et al (2003)]. 
The sulfur (thiol, -SH) group of cysteine is responsible for the biological 
reactivity of GSH by allowing it to donate an electron to other unstable ROS molecules 
that are highly reactive due to a lack of balanced electron pairs [Bains et al (1997)]. By 
donating an electron, the GSH molecule itself becomes unstable and so it seeks stability 
via binding other GSH molecules through the glutathione peroxidase enzyme which 
forms a di-sulphur bond between the two GSH molecules (Fig. 1.7 B) creating one 
molecule of glutathione disulfide (GSSG); the oxidized form of glutathione (M.W. of 612 
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g/mol) [Kulinskii et al (2009), Marquis et al (2009)]. GSSG can be reduced afterward 
most efficiently by glutathione reductase using nicotinamide adenine dinucleotide 
phosphate (NADPH) to yield the GSH molecule (M.W. of 307 g/mol). GSH represents > 
90% of the total non-protein sulfur in cells while GSSG (named glutathione disulfide) 
represents < 10% of the total glutathione concentration [Meister (1988), Bains et al 
(1997), Bass et al (2004)]. The cellular redox homeostasis (i.e. the oxidation/reduction 
balance) of GSH is important in the regulation of many cellular metabolic processes since 
it maintains cell viability. It has been speculated that a minor level of GSH depletion and 
GSSG accumulation (by ROS) has protective effects. This low level depletion can act as 
a sensor to trigger the activation of a group of antioxidant and detoxification enzymes, 
known as phase II enzymes (including NADPH quinone oxidoreductase (NQO1), 
catalase, superoxide dismutase, glutathione-S-transferase (GST) isoenzymes, glutathione 
peroxidase (GPx) and glutathione reductase) to produce more GSH and other protective 
antioxidant molecules [Nel et al (2006)]. On the other hand, higher levels of cytotoxic 
oxidative stress due to failure to provide sufficient protection and ROS overproduction 
may cause adverse damaging effects [Xia et al (2006)]. Therefore, the measurement and 
monitoring of changes in intracellular GSH level and ROS production can give an 
indication about the cellular ENPs-induced oxidative stress state and the toxicological 
effects of ENPs. 
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Biological molecule Toxic effect GSH protective role 
Oxidizing agents 
ROS generation that can 
cause oxidative damage to 
lipids, DNA and proteins 
ROS and RNS are reduced and 
inactivated by interacting with 
GSH to generate the oxidized 
form of glutathione molecule 
(GSSG) that has a disulphide 
bond. 
RNS 
Inactivation of respiratory 
chain complexes that 
would lead to inhibition of 
protein and DNA synthesis 
Chemical 
carcinogens 
Cancer induction 
GSH participates in phase II 
detoxification by conjugating 
xenobiotics to produce inactive 
hydrophobic less toxic 
compounds (mercapturic acids) 
that can be effectively transported 
and excreted. 
Table 1.1 A summary of GSH protective role against some biological molecules that 
can have harmful effects on the cell. Modified from Jefferies et al (2003). 
Few studies hypothesize that ENPs may be useful as they can act as oxygen 
radical scavengers [Kajita et al (2007), Tsai et al (2007)]. However, ENPs-derived 
oxidative stress caused by inducing the generation of ROS has been postulated to play a 
major role in the toxicological cellular response. ROS may either directly affect the 
integrity and functionality of proteins, membrane lipids and DNA by oxidation [Unfried 
et al (2008)] or may indirectly induce cellular responses by affecting the calcium (Ca
2+
) 
sensitive signaling pathways [Ermak and Davis (2002)]. ENPs-stimulated oxidative stress 
can cause the release of Ca
2+
 from their major stores, in endoplasmic reticulum (ER) or 
sarcoplasmic reticulum (SR), through calcium channel leading to Ca
2+
 level elevation in 
the cell cytoplasm [Donaldson et al (2003)]. 
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ROS are very transient free radicals that are chemically highly reactive 
molecules containing oxygen. They include superoxide anions (O2•‾), hydroxyl radical 
(HO•), peroxy radical (ROO•), and hydrogen peroxide (H2O2) [Waris et al (2006), 
Genestra et al (2007), Rigas et al (2008)]. They are produced at low concentrations as 
natural byproducts of many aerobic cellular metabolism processes (e.g. oxygen 
metabolism and inflammation) to play a role in gene regulation and intracellular signal 
transduction process in the cell by acting as secondary messengers and inducing cellular 
apoptosis [Valko et al (2006)]. Under normal circumstances, ROS can be detoxified 
within cells to regulate their concentrations and preserve the ROS 
formation/detoxification balance through the cellular defense anti-oxidant system. H2O2, 
for example, is detoxified to H2O and O2 either by glutathione peroxidase in 
mitochondria or by catalases in peroxisomes (in cytosol) [Mohora et al (2009)]. However, 
failure to maintain and stabilize the balanced level of ROS by defensive anti-oxidant 
mechanisms would disrupt the redox status resulting in abnormal ROS accumulation 
caused by uncontrolled formation (overproduction) of these oxidants within the cell or 
tissue in a way that exceeds the cellular defense anti-oxidant capacity [Stone and 
Donaldson (2006)]. As a result, the cellular redox homeostasis would be shifted toward 
more oxidized conditions that represent an oxidative stress status [Ermak and Davis 
(2001)]. ROS accumulation may cause toxic effects leading to cell death owing to 
damage and oxidation of wide range of cellular bio-molecules such as DNA, protein and 
lipids [Stone and Donaldson (2006), Magder (2006), Marquis et al (2009)]. Thus, ROS 
need to be continuously detoxified by antioxidants including enzymes (e.g. catalase, 
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superoxide dismutase, glutathione peroxidase and glutathione reductase) and other non-
enzymatic molecules (e.g. glutathione (GSH), copper and iron chelators, flavonoids as 
well as vitamins A, E and C) [Mohora et al (2009)]. 
2',7'-dichlorodihydrofluorescein diacetate (H2DCF-DA); a non-fluorescent dye 
that is able to cross the cell membrane, is one of the most widely used probes to evaluate 
intracellular oxidative stress. Within cells, H2DCF-DA is hydrolyzed by esterases 
yielding a fluorescent 2′,7′-dichlorofluorescein product (λex 512nm / λem 530nm) that can 
be measured as an indicator for NP-induced ROS formation as it reacts with ROS in the 
presence of cellular peroxidises [Bass et al (1983), Hanley et al (2008)]. However, 
cytochrome c that is released from the mitochondria during apoptosis has been reported 
to be a strong oxidative catalyst for H2DCF-DA and may result in the overestimation of 
oxidative stress, therefore H2DCF-DA should be used carefully for oxidative stress 
measurements when apoptosis occurs as a result of nanoparticle exposure [Lawrence et al 
(2003)]. MitoSOX Red (λex 510nm/λem 580nm), a selective non-fluorescent probe, can 
also be used to identify superoxides within the mitochondria and locate ROS produced as 
a result of NP-mediated toxicity [Robinson et al (2006)]. 
Under normal conditions, the intracellular Ca
2+
 plays a vital role in several 
biological processes of cell life and death via a signaling mechanism that can regulate 
several cellular events. These events include cytokine gene expression, redox-sensitive 
mitogen activated protein kinase (MAPK) family activation as well as the activation of a 
number of redox-sensitive transcription factors such as activator protein 1 (AP-1), nuclear 
factor-kappa B  (NFκB) and nuclear factor of activated T-cells (NFAT) [Dolmetsch et al 
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(1997), Donaldson et al (2003)].  This would consequently induce the expression and 
release of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and 
interleukins (ILs). 
In abnormal conditions including ROS overproduction and/or ROS elimination 
deficiency, Ca
2+
 level would be increased in the cytoplasm (in cellular response to 
oxidative stress) by activating inositol 1,4,5-triphosphate (IP3), a signaling molecule for 
IP3-sensitive calcium channels to release Ca
2+
 from ER and/or by inhibiting the Ca
2+
 
adenosine triphosphatase (ATPase), a calcium pump that eleminates Ca
2+
 from cytoplasm 
into ER/SR stores [Donaldson et al (2003)]. It has been proposed that ROS overload can 
also alter calcium pumps on the cell plasma membrane allowing the Ca
2+
 to enter the cell 
from the outside space [Roveri et al (1992), Fusi et al (2001)]. This at the end would 
result in excessive accumulation of massive amounts of Ca
2+
 in the cytosol which may 
cause cytotoxicity and lead to cell death [Zhivotovsky and Orrenius (2011)]. 
Alternatively, elevated Ca
2+
 in cytosol can induce Ca
2+
 uptake into the mitochondria 
through the Ca
2+
 uniporter-mediated pathway to reach high levels (of hundred µM) [Roy 
and Hajnoczky (2008)]. This would disrupt the function of mitochondria (due to swelling 
of mitochondria and alteration of its outer membrane permeability) and provoke the 
release of cytochrome c and other mitochondrial apoptosis-stimulating factors into the 
cytoplasm which would end up hence with apoptosis induction [Roy and Hajnoczky 
(2008)]. Therefore, the Ca
2+
 level in cells following exposure to chemicals can be studied 
to explore the mechanism through which they can exert their deleterious effect on cells. 
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DNA is an important target for ROS generated either naturally during various 
endogenous metabolical processes or by exogenous chemical oxidants (such as toxic 
substances) and is vulnerable daily to thousands of oxidative damages [Ames et al 
(1993)]. Overwhelming the cellular antioxidant defense system capacity by ROS 
generation would disrupt the cellular redox homeostasis leading to toxic oxidative stress 
due to ROS accumulation and hence to adverse biological consequences. Unneutralized 
ROS induced by ultrafine particles (UFPs, which are NPs with size < 100nm and referred 
to as NPs hereafter) have been revealed to be able to react with several bio-molecules in 
the cell (mostly DNA) causing DNA damage (by guanine oxidation that generates 8-oxo-
7,8-dihydro-2′-deoxyguanosine (8-oxodG) product) and lipid peroxidation and resulting 
therefore in cell destruction [(Brown et al (2004), Risom et al (2005)]. Several NPs (such 
as carbon black and welding fume) have showed genotoxic effects [Donaldson et al 
(2005)]. 
Apoptosis is an energy-dependent programmed (carefully regulated) cell death 
mechanism that involves several cellular morphological changes including membrane 
blebbing, chromatin condensation, fragmentation of nucleus and DNA, loss of 
mitochondrial membrane potential and cell shrinkage [Porter (1999)]. It is a complicated, 
crucial and essential cell self-destruction process for the development and homeostasis of 
multicellular organisms [Hengartner (2000), Elmore (2007)]. Two major apoptotic 
pathways were identified, that are the intrinsic mitochondrial-mediated apoptosis (fig. 
1.4) and the extrinsic plasma membrane death receptor-mediated apoptosis (fig. 1.5), 
however, the endpoints of both apoptotic pathways involve the release of several death-
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inducing molecules and caspases activation [Hengartner (2000)] and evidences shows 
that there is signiﬁcant cross-link between the two apoptotic mechanisms [Elmore 
(2007)]. 
In the intrinsic pathway (fig. 1.4), death signal induction (due to oxidative 
stress, unrepaired DNA damage or others) would trigger the activation of some pro-
apoptotic proteins (such as Bax) and the translocation of them to the mitochondria 
leading to the deactivation of the anti-apoptotic proteins (such as bcl-2 and Bcl-xL) and 
causing mitochondrial swelling and disruption of the outer membrane [Hengartner 
(2000)]]. The intermembrane proteins including the pro-apoptotic cytochrome c (cyt C) 
would be released upon this disruption through the transition pore to the cytosol where it 
combinds the apoptosome protein complex to activate the apoptotic protease activating 
factor-1 (Apaf-1) and pro-caspase-9 in the presence of dATP leading to further caspase 
cascade activation and cell death initiation [Beurel and Jope (2006)]. 
In contrast, the extrinsic pathway (fig.1.5) activation involves the binding of 
the ligands to cell-membrane death receptors (such as the tumor necrosis factor (TNF) 
family) and the recruitment of cytoplasmic adaptor proteins (such as Fas-Associated 
protein with Death Domain (FADD)) which would trigger the formation of death-
inducing signaling complex (DISC), stimulate the caspase cascade and initiate apoptosis 
[Beurel and Jope (2006)]. 
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Fig. 1.4 This diagram shows the intrinsic pathway of apoptosis that is triggered by 
internal cell signalling (such as DNA damage and oxidative stress) which would lead to 
mitochondria disruption, release of cytochrome c and caspase cascade activation 
resulting in the cell-self destruction. (Adopted from: "Beurel and Jope (2006)") 
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Fig. 1.5 This diagram shows the extrinsic signalling pathway of apoptosis that is 
stimulated when the ligands (such as Fas) bind to the apoptosis-inducing receptors on 
the cell plasma membrane. This would activate a caspase cascade resulting in 
apoptosis. (Adopted from: "Beurel and Jope (2006)") 
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Apoptosis has been reported in several studies using various material- and 
inorganic-based ENPs in different cell lines such as TiO2 in BEAS-2B cells [Park et al 
(2008), Shi et al (2010)], Cu-NPs in PC12 cells [Xu et al (2012)] as well as COO-PS-NPs 
and NH-PS-NPs in Caco-2 cells [Thubagere and Reinhard (2010)]. The ENPs-induced 
apoptotic pathway was proposed to depend on the composition, concentration, size and 
charge of ENPs in addition to the type of the exposed cells [De Stefano et al (2012)]. 
Apoptosis is a well-controlled and regulated cellular process of programmed cell death 
that is involved in various normal physiological and abnormal pathological events [Riedl 
and Shi (2004)]. 
Caspases play a fundamental role in apoptosis and in inflammation as well 
[Boatright and Salvesen (2003)]. They are conserved intracellular cysteine protease 
enzymes that are classified, depending on their role in the apoptotic cascade, into the 
initiator caspases with long pro-domain (including caspase-2, -8, -9, and -10) and the 
effector caspases with short pro-domain (that consist of caspase-3, -6, and -7) 
[Zhivotovsky and Orrenius (2011), Riedl and Shi (2004), Shi (2002)]. Caspases are 
synthesized and stored within cells in inactive forms (known as pro-enzymes or 
zymogens) that need to undergo activation to stimulate apoptosis that is triggered either 
by extrinsic (receptor-mediated) pathway at the plasma cell membrane that includes cell 
surface death ligand-receptors binding (such as tumor necrosis factor (TNF) family; e.g. 
FAS) or by intrinsic pathway which is mediated by the mitochondria-stress response that 
is mediated by numerous intracellular death stimulus [Parrish et al (2013), Cullen and 
Martin (2009), Riedl and Shi (2004)]. These caspases can cleave after the aspartate 
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residues with Asp-Glu-Val-Asp (DEVD) sequence of amino acids in key intracellular 
substrates [Elmore (2007)]. Caspase-3 and -7 are central components in executing the 
apoptotic pathway and need to be activated by other activators (of catalysis or another 
initiator caspases) in a downstream cascade that result at the end into apoptosis (a 
commitment of cell death) [Cullen and Martin (2009)]. Therefore, the assessment of 
caspase-3/7 activation can give a clear indication about the mechanism through which the 
ENPs-stimulated cell death takes place. 
A reliable assay to investigate the caspase-3 and -7 activities was consequently 
used in this study to monitor the apoptosis in BEAS-2B cells treated with different 
concentrations of the 20nm or 100nm sized COO-PS-NPs. In the enzymatic caspase-3/7 
assay, a specific pro-luminescent DEVD-containing lysis buffer reagent is typically used 
as a substrate that is cleaved by the activated caspase-3/7 in the apoptotic cell lysate to 
release the aminoluciferin which becomes luminescent only in the presence of luciferase 
enzyme [Wesierska-Gadek et al (2005)]. The luminescence can be measured (at λex 
360nm and λem 460nm) using a plate-reading luminometer and the signal is directly 
proportional to the amount of caspase-3/7 activity [Carrasco et al (2003)]. 
Autophagy (i.e. self-eating) is a regulated intracellular pro-survival mechanism 
that is activated in response to different intra- and extracellular stress including oxygen 
and nutrition deficiency (starvation), endoplasmic reticulum stress, oxidative stress and 
infection [Zhong et al (2013), De Stefano et al (2012), Glick et al (2010), He and 
klionsky (2009)]. It is a cell survival machinery that serves to maintain the homeostasis 
(the balance required between synthesis and catabolism) in cells and hence play 
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important roles in several cellular processes such as metabolism and cell growth by 
controlling the intracellular degradation and removal of damaged cellular components (of 
aged organelles, dysfunctional aggregated bio-molecules and/or unwanted pathogens) 
[Zhong et al (2013), De Stefano et al (2012), Glick et al (2010), He and klionsky (2009)]. 
In this catabolic multi-steps mechanism, a phagophore (which is a cell membrane-
originated sac) segregates and surrounds damaged proteins, aged organelles and 
contagious pathogens in the cytosol forming autophagosome that is double-membrane 
structure vesicle (Fig. 1.6). The cargo containing autophagosome is transferred and fused 
with lysosome forming autolysosomes where the content of materials is digested and 
degraded by hydrolytic enzymes (hydrolases) to its basic main components which are 
then released into the cytoplasm for reuse in cell growth and other synthesis processes 
[Xie and Klionsky (2007), Stern et al (2012), Zhong et al (2013)]. 
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Fig. 1.6 In this diagram, a membrane sac (phagophore) is expanded to separate the 
cytosolic material (a, b); forming an autophagosome (that is a double-membrane 
vesicle) containing damaged proteins, aged organelles and/or contagious pathogens (c); 
which fuses in turn with a lysosome in the cytoplasm to form an autolysosome (d); 
where the content is lysed and degraded by the lysosomal hydrolases (e). (Adopted 
from: "Xie and Klionsky (2007)"). 
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Some literatures indicated that nanoparticles engulfed in lysosomes can have 
cellular toxicological effects by causing lysosomal dysfunctions and inducing autophagy 
[Stern et al (2012)]. Autophagy, in turn, has been also suggested to potentially cause cell 
damage and to involve in some diseases (such as cancer and muscular disorder) [Shintani 
and Klionsky (2004)]. 
The toxicological effects of ENPs on cells have been recently suggested to be 
mediated via autophagy which might be induced (due to oxidative stress) or interrupted 
(due to mitochondrial damage or lysosomal enzymes inhibition) leading to accumulation 
of autophagosomes in both cases [Zhong et al (2013), De Stefano et al (2012), Stern et al 
(2012)]. TiO2-NPs, Si-NPs and AU-NPs, for example, have been reported to activate 
autophagy [De Stefano et al (2012), Stern et al (2012)] whereas drug delivery-polymeric 
NPs were reported to co-localise in the mitochondria of rat macrophages causing 
mitochondrial decay and leading to toxicity by disrupting autophagy [Eidi et al (2012)]. 
Lysosomal rupture induced by positively charged NH-PS-NPs (~100nm size), but not by 
negatively charged COO-PS-NPs, was also reported in human macrophages associated 
with ROS generation and mitochondrial membrane damage [Lunov et al
b
 (2011)] and 
such damage can block the autophagosome-lysosome fusion (i. e. prevention of 
autolysosome formation that is an essential step in autophagy) causing autophagy 
dysfunction [Stern et al (2012)]. Nevertheless, the autophagic pathway (that involves 
regulated lysosomal degradation) has been speculated to be the most effective process for 
self-destruction in cells that cannot undergo apoptosis [Levine and Yuan (2005)] and in 
cells exposed to non bio-degraded ENPs [Zabirnyk et al (2007)]. 
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LC3-II (microtubule-associated protein 1 light chain 3) is an ubiquitin-like 
protein that is converted from cytoplasmic LC3-I upon autophagic pathway activation 
and hence can be investigated on the autophagosome membrane (by western blot or 
TEM) as an autophagy biomarker for autophagosome formation to identify the 
autophagy-mediated cytoxicity in ENPs-treated cells [Wu et al (2014), Zhong et al 
(2013), Barth et al (2010)]. However, since accumulation of autophagosomes can indicate 
either autophagy induction or a disruption, other assays should be conducted to clarify the 
two options [Zhong et al (2013)]. 
It has been shown that NPs can generate more ROS than its larger-sized 
counterpart after incubation with H2DCF-DA (ROS-sensitive probe) either in cells (such 
as Mono Mac 6 macrophages) or cell-free system [Wilson et al (2002)] and this is most 
likely due to their larger surface area that allow active interactions with cellular 
components. In addition to ROS generation, NPs have been suggested to cause 
intracellular Ca
2+
 alteration, activation of transcription factors (such as NF-κB) and 
induction of production of cytokines (such as TNF-α) [Brown et al (2004)]. The co-
localisation of NPs [Li et al (2003), Xia et al (2006)] and cationic PS-NPs [Xia et al 
(2006)] in the mitochondria has been reported to cause mitochondrial injury and 
dysfunction due to membrane damage leading hence to toxic oxidative stress. Another 
study has investigated the intracellular co-localisation and the potential cellular effects of 
the negatively charged COO-PS-NPs and the results showed size-dependent 
internalisation into cells with no considerable difference in ROS generation between the 
20nm COO-PS-NPs and their 200nm counterparts although the 20nm COO-PS-NPs were 
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toxic while 200nm ones were not [Fröhlich et al (2009)]. The 20nm COO-PS-NPs were 
co-localised into endosomes and lysosomes (and rarely in the nucleus) but not into the 
mitochondria or endoplasmic reticulum resulting in cellular damage and death that can be 
linked to induction of apoptosis or necrosis [Fröhlich et al (2009)]. Furthermore, 
Bhattachajee et al have also illustrated that the production of intracellular ROS in 
mitochondria is an important mechanism for cytotoxicity [Bhattacharjee et al (2010)]. 
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B 
 
Fig. 1.7 (A) GSH synthesis in cells by condensing glutamate with cysteine via γ -
glutamylcysteine synthetase enzyme to produce γ-GlutamylCysteinyl and glycine is then 
added by GSH synthetase enzyme (published online, adopted from: 
"http://www.gsh.com.tw/images/glutathione_synthesis.gif"). (B) ROS (e.g. H2O2) scavenging 
by intracellular GSH that is oxidized to produce GSSG while the harmful H2O2 is converted 
to water releasing oxygen molecule (published online, adopted from: "http://david-
bender.co.uk/metonline/CHO/favism/images/GSH.png"). 
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1.8 Influence of the ENPs physicochemical properties on uptake, co-
localisation and toxicity 
Several physicochemical properties of ENPs are important from toxicological 
perspective as they are associated with the ENPs-mediated adverse health effects and thus 
alterations in these characteristics were thought to affect the biological and environmental 
toxicity of ENPs. It has been reported that even slight changes or adjustment in the 
essential physicochemical properties of ENPs can have significant impacts on their 
functions, cellular uptake, bio-distribution, fate, clearance, efficiency and toxicity in any 
biological application [He et al (2010), Yang et al (2010)]. Thus, investigating the 
physicochemical properties that might control the cell-ENPs interactions would help in 
understanding the behavior of ENPs, the cellular responses towards them and the adverse 
health risk which would return back with benefit on the design of  ENPs to be safely used 
(or at least with less harmful side-effects) in numerous applications. 
Size (that is inversely correlated with the surface area) and surface charge of 
the ENPs seem to be the most significant parameters that play important role in 
controlling their cytotoxicity, metabolism, distribution and uptake [Panyam and 
Labhasetwar (2010), Bhattacharjee et al (2010)]. The small-sized NPs would have larger 
surface area with higher number of particles per unit mass and increased reactivity (due 
to larger absorption capacity and higher binding energy per atom) [Roduner (2006)] 
increasing hence their biological effect compared to their larger-sized counterparts. It has 
been reported that the small size of ENPs may cause them to be more toxic [Lam et al 
 
 
 
 
Chapter 1                                     General Introduction 
 
 
 
 
42 
(2004)] and have relatively higher intracellular uptake (2.5 ~ 6 fold) in general [Desai et 
al (1997)] due to their easier penetration into cells compared to macroparticles of the 
same substance. Confocal microscopy results for the uptake of different sizes (20 and 
200nm) of fluorescently labeled COO-PS-NPs by rat hepatocytes (C3A) and human 
hepatocytes (HepG2) revealed that the internalisation occurred in a size-dependent 
manner [Johnston et al (2004)]. Moreover, the uptake of different sizes (20, 40 and 
100nm) of fluorescently labeled COO-PS-NPs into human astrocytoma (1321N1) and 
human lung carcinoma (A549) was investigated and results showed faster uptake of the 
40nm (compared to the 20nm or 100nm particles) in both cell lines which suggest 
different mechanisms of internalisation for the different sized COO-PS-NP [Varela et al 
(2012)]. 
Several studies have revealed that the charge of the ENPs significantly affects 
their ability to be internalised (by determining the cellular endocytosis mechanism) and 
cytotoxicity. Harush-Frenkel and colleagues have showed that positively charged (i.e. 
cationic) ENPs have accumulated at the plasma membrane in cells when clathrin- and 
caveolin-dependent endocytosis is strictly inhibited however the amount of negatively 
charged (i.e. anionic) ENPs being taken up into human cervical epithelial carcinoma 
(HeLa) cells is not affected [Harush-Frenkel et al (2007)]. These outcomes indicate that 
cationic ENPs have more potential to be internalised via clathrin-mediated pathways 
when compared to anionic ENPs that use other pathways. In agreement with that, it has 
pointed out that charging ENPs positively may improve their capability as drug delivery 
system due to the strong attraction of cationic ENPs by the negatively charged plasma 
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membrane of cells and weak ENPs-cell membrane electrostatic repulsion forces [He et al 
(2010)]. Moreover, Harush-Frenkel and colleagues have showed in another study that 
some anionic but not cationic ENPs were accumulated in the lysosomes where they 
undergo a degradative pathway (Fig. 1.8) after being taken up into polarized epithelial 
Madin-Darby canine kidney (MDCK) cells by different endocytotic pathways [Harush-
Frenkel et al (2008)]. 
A relationship between surface charge and cellular uptake was clearly observed 
when polymeric carboxyl- (COO-) or amino- (NH-) modified ENPs have been used 
[Lorenz et al (2006), Mailänder et al (2009)]. Using confocal fluorescence microscopy 
and fluorescence-activated cell sorting (FACS) technique, a study has revealed that NH-
PS-NPs have utilized the clathrin-mediated pathway to gain entry into mesenchymal stem 
cells (MSC) due to the positive charge of amino groups whereas their unmodified 
counterparts (with no functional groups) were internalised via a clathrin-independent 
endocytosis [Jiang et al
a
 (2010)]. In further study by Jiang and colleagues as well, the 
negatively charged COO-PS-NPs were quickly and effectively taken up into the MSCs 
cell line by clathrin-mediated endocytosis compared to the negatively charged non-
functionalized PS-NPs that were internalised via macro-pinocytosis [Jiang et al (2011)]. 
In both cases, the accumulation rate of plain non-functionalized PS-NPs in MSCs is much 
lower than their modified counterparts (that have functional group of either NH- or COO- 
on their surfaces) showing the role of the functional groups in the cell-ENPs interactions. 
Likewise, positively charged gold nanoparticles (AU-NPs) were found to be more rapidly 
uptaken than the neutral or negatively charged ones [Zhu et al (2010)]. The uptake of PS-
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NPs into rat alveolar epithelial cell monolayers (RAECM) assessed by confocal 
microscopy was increased (20–40 times) as the charge became less negative/more 
positive at equivalent size [Yacobi et al (2008)]. In contrast, another study by 
Bhattacharjee and colleagues revealed that positively charged amino-modified silica 
nanoparticles (NH-Si-NP) were more cytotoxic than their negatively charged carboxyl-
modified (COO-SiNP) and neutral unmodified (SiNP) counterparts. They have shown 
that treatment with NH-Si-NP led to more reduction in the mitochondrial metabolic 
activity of macrophage (NR8383) cells and generation of intracellular ROS at the highest 
level with protective effect of vitamins (E and C) against the cytotoxicity of the NH2-
SiNP suggesting a role of oxidative stress in the mechanism of cytotoxicity 
[Bhattacharjee et al (2010)]. 
It is important to bear in mind that ENPs might tend to aggregate in biological 
systems and this would reflect the size of the aggregates more than the size of the 
nanoparticles themselves. Therefore, investigating the ENPs physicochemical 
characteristics in biological environments or systems is essential for in vitro studies. The 
dynamic light scattering (DLS) system, also named photon correlation spectroscopy, is 
the most-used method for ENPs size characterisation in solution however, it is preferable 
to use other different techniques such as electron microscopy methods (e.g. Transmission 
Electron Microscopy (TEM)) for size characterisation. The same DLS technique can be 
used for zeta-potential measurement as an estimation of surface charge. 
Moreover, the experimental conditions (including the agglomeration tendency 
of ENPs) and the characteristics of the target cells in addition to the ENPs 
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physicochemical properties, are important parameters that have been suggested to 
influence the toxicity, translocation along with intracellular trafficking and uptake of the 
ENPs into cells [Oberdörster et al (2005a), Patil et al (2007), Qiao et al (2007), Rothen-
Rutishauser et al (2007), Unfried et al (2008), Yacobi et al (2007)]. 
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Fig. 1.8 Surface charge of ENPs determines their intracellular pathways in polarized epithelial MDCK cells. Cationic and anionic ENPs are 
internalised differently. (adopted from "Harush-Frenkel et al (2008)"). 
 
 
 
Chapter 1                                                                                                        General Introduction 
 
 
 
 
47 
1.9 Aims of the current study 
Nanoparticles (NPs) including COO-PS-NPs have many potential applications, 
as drug delivery system for example, however their toxicity remains poorly assessed. The 
current thesis undertook an in vitro study to evaluate the potential toxicological effects of 
COO-PS-NPs on the cellular activities of cultured BEAS-2B lung epithelial cells. Since 
the toxicity of other ENPs has been shown to be concentration- and size-dependent 
[Fröhlich et al
b
 (2012)], several concentrations of two different sizes (20nm and 100nm 
diameter) of the same red fluorescent negatively charged COO-PS-NPs were used for 
investigation of toxicity at different time points to evaluate the possible impacts of these 
important parameters. The cellular uptake and co-localisation of COO-PS-NPs within 
specific organelles was also studied as NPs need to gain access to inside the cell to exert 
their effect [Lovric et al (2005)].  
Furthermore, the aggregation of COO-PS-NPs was characterised in the culture 
media as well as in the stock solution for comparison to relate their physical behavior to 
effects in biological systems. Although the surface charge of the COO-PS-NPs was also 
characterised, its role in toxicity was not investigated herein, but may be need to be taken 
in consideration in further projects. 
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2.1 Chemical reagents and cell culture labware products 
All chemicals were used without additional purification and were obtained 
mainly from Sigma Aldrich (Dorset, UK) or Fisher Scientific (Loughborough, UK) 
unless otherwise stated. The LHC-9 serum-free medium (SFM) and commercial red 
fluorescent (λex @ 580nm/ λem @ 605nm) carboxyl-modified polystyrene nanoparticles 
(COO-PS-NPs), with 20nm (F-8786) and 100nm (F-8801) average nominal diameter 
sizes, were purchased from Invitrogen (Paisley, UK). Phosphate buffer saline (PBS) 
tablets were from Oxoid Ltd (Basingstoke, UK) and trypsin-ethylenediaminetetraacetic 
acid (trypsin-EDTA, 1X, 0.05% – 0.02% in D-PBS) was from PAA Laboratories GmbH 
(Cölbe, Germany), Bradford reagent was from Bio-Rad Laboratories GmbH (München, 
Germany) and hydrogen peroxide (H2O2, 30%) was from BDH Laboratory Supplies 
(Poole, UK). Cell culture plastic and glass labware products (including multi-well plates, 
flasks, micro-tips, disposable polystyrene serological pipettes, conical and micro-
centrifuge tubes, cryo-vials, cell scrapers, reservoirs, cuvettes and microscope slides) 
were purchased primarily from Corning Incorporated Life Sciences (NY, USA) however 
some labwares were also obtained from SPL Life Sciences (Pocheon-city, South Korea), 
VWR International (Lutterworth, UK), Greiner Bio-One (Stonehouse, UK) or Fisher 
Scientific. 
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2.2 BEAS-2B Cell culture 
In vitro models seem to be more attractive for preliminary assessment of the 
potential toxicological effects of ENPs due to several reasons including the high expense 
of in vivo experiments, ethical concerns raised as a result of the increased number of 
animals required for laboratory testing as well as governmental and public urging to 
develop alternatives to animal testing. Furthermore, in vitro studies are faster with vast 
control of the experimental conditions compared with in vivo ones and the quantity of 
ENPs used for in vitro experiments will be minimal which would make these models of 
low cost. Nevertheless, selecting the most appropriate representative cell line as a 
realistic in vitro model that resembles (and specifically relevant to) the target organ of 
interest in vivo is crucial in investigating the potential toxicological effects of ENPs. 
Lungs are the main target for ENPs following exposure by inhalation and human 
epithelial cells (BEAS-2B) were therefore used in this study as they were found to be 
relevant representatives to the lung. 
The BEAS-2B cells used in this in vitro study are immortalized normal human 
bronchial epithelial cell line derived from non-cancerous person [ATCC (published 
online)]. The growth properties of these cells were transformed to expand their 
capabilities to divide and replicate continuously without altering their phenotype and 
genotype. This would avoid the replicative senescence status that primary cells are 
normally arrested in after a fixed number of replications and hence enable researchers to 
maintain consistency during in vitro experiments. 
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The use of serum-free medium (SFM) to culture cells in vitro has many 
advantages since it increases the cell culture productivity by eliminating the cytotoxicity 
due to serum cytotoxins and cutting down the risk of possible contamination that may 
come from serum microbiological contaminants [Newman (2003), Van der Valk et al 
(2004), Brunner et al (2010)]. SFM has an improved consistency as a result of reducing 
substantial quantitative and qualitative batch-to-batch variation, hence enhance the 
control of cell culture conditions of sterilization and safety [Newman (2003), Van der 
Valk et al (2004), Brunner et al (2010)]. Thus SFM used in cell culture tends to improve 
the consistency of experimental results. SFM is also preferred since serum production is 
complicated and costly in addition to avoiding the controversial ethical issue of using 
animal-derived components in media [Newman (2003), Van der Valk et al (2004)]. 
Furthermore, SFM is used for in vitro studies of nanoparticles since serum containing 
media may affect the ENPs internalisation into cells due to serum proteins adsorption 
onto the ENPs surface which might increase or decrease their uptake in vitro [Chithrani et 
al (2006)]. It has been stated that cells react in response to substances that are in contact 
with their membranes or already taken inside, but not to the floating ones in the media 
[Teeguarden et al (2007)]. Thus, cells need to be washed several times (with PBS) at the 
end of the treatment to eliminate the unbound and non-internalised COO-PS-NPs and 
cells will be re-incubated with fresh SFM. 
All cell culture work was conducted aseptically using a class II tissue culture 
cabinet and all solutions, supplies, reagents and materials were autoclaved and sterilized 
by wiping with 70% ethanol as necessary before being used to avoid contamination that 
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may interfere with conducted assays as well as alter cell morphology, growth, viability 
and production. Materials in contact with the cells were tested on a regular basis to 
prevent contamination and recognize any of its potential sources in early stages. All 
labwares used for cell cultures were coated with type-I rat tail collagen (6.66 µg 
collagen/cm
2
 for 2h) before being used and all solutions used in cell culture were pre-
warmed to 37ºC in a water bath (SUB14, Grant Instruments (Cambridge) Ltd, Shepreth, 
UK).  
2.2.1 Maintenance 
BEAS-2B cell line was obtained from the Health Protection Agency (Cat no. 
95102433). These adherent cells were routinely cultured in a suitable Lechner and 
LaVeck serum-free cell-culture medium (LHC-9 SFM), maintained at 37ºC and 5% CO2 
in a humidified incubator (MCO-15AC, Sanyo Electric Co. Ltd, Osaka, Japan) and fresh 
media was supplied every 2-3 days after cell washing with PBS. Flasks were checked 
microscopically for confluence. When cells were about 90% confluent (every 3–4 days), 
they were washed with PBS to remove dead cells and trypsinised with trypsin-EDTA 
(37ºC for 5-7 min) to detach them from surfaces. The flasks were tapped firmly to certain 
detachment of cells and fresh media (5 ml) were then added to neutralize the enzymatic 
activity of trypsin. Cells were mono-dispersed by pipetting before centrifuging the cell 
suspension at 1200 rpm (MSE Falcon 6/300, MSE Ltd., London, UK) for 5 min and the 
resulted cell pellet was re-suspended in 1 ml media. 
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2.2.2 Passage 
For cell sub-cultures, cells were passaged into new T75 and T25 flasks (at 1:3 
and 1:6 split ratio respectively). Each batch of BEAS-2B cells were used for 10 passages 
or fewer. For experiments, cell number was counted using a Neubauer haemocytometer 
(Weber International Ltd, Teddington Middlx, UK) and cells were reseeded into 
appropriate multi-well plates using fresh LHC-9 SFM. Cells were seeded at 2×10
4
 
cells/100µl LHC-9 SFM/well in 96-well plates, at 2×10
5
 cells/2ml LHC-9 SFM/well in 
12-well plates and at 5×10
5
 cells/5ml LHC-9 SFM/well in 6-well plates. The multi-well 
plates were maintained at 37ºC in 5% CO2 humidified incubator for 24h to allow cells to 
adhere and grow to be approximately 85% confluent. For the cell treatment with 
nanoparticles, cells were washed next day with PBS to remove suspended dead cells and 
incubated in fresh LHC-9 SFM for 10min at 37
º
C in a 5% CO2 humidified incubator 
before being treated individually with single definite dose of various concentrations of 
nanoparticles. However, information about the chemical composition and ingredients of 
LHC-9 SFM were considered proprietary for the manufacturer and undivulgable. 
2.3 Treatment with COO-PS-NPs 
In this study, red fluorescently-labelled, negatively charged, carboxyl-modified 
polystyrene nanoparticles (COO-PS-NPs) were used because they are pure (with high 
quality and no contamination as manufacturer claimed) and are abundantly available at 
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quite low cost. The 20nm and 100nm COO-PS-NPs were selected for the current study 
since these sizes are relevant to the NPs-based applications. 
According to the manufacturer, the red fluorescent carboxyl-modified 
polystyrene nanoparticles (commercially named latex beads or FluoSpheres) are spherical 
beads with red dyes integrated in the core (λex @ 580nm/ λem @ 605nm) which means 
that the fluorescent nanoparticles have the same surface properties and composition of 
non-fluorescent particles. This would allow evaluation of toxicity, assessment of uptake 
and easy detection of localisation of the COO-PS-NPs of similar composition under 
identical conditions in the living cells without help of other substances that might change 
their size or composition. Moreover, these nanoparticles have attached carboxylic acids 
on their surface which make them negatively charged and were supplied as suspensions 
(2% solids) in 2mM sodium azide containing water. These COO-PS-NPs are stable for at 
least one year (as stated by the supplier) when recommended storage conditions are 
strictly fulfilled (2-6º C, protected from light). More information about the chemical 
composition of COO-PS-NPs, their structure and configuration were considered 
proprietary for the manufacturer and undivulgable. 
2.3.1 Dosage of COO-PS-NPs 
Although freshly prepared solution of ENPs using the powder form was argued 
to be the most suitable [Stone et al (2010)], the suspension form of COO-PS-NPs (i.e. 
dispersed in a solution) was chosen in this study to avoid problems of reproducibility of 
dispersion. A freshly-prepared diluted solution of fluorescent 20nm COO-PS-NPs (1:10) 
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in LHC-9 SFM was used as well as a stock solution of 100nm COO-PS-NPs (without 
dilution) for the treatment of cells in multi-well plates. 
It has been shown that the response of cells is proportional to surface area of 
ENPs (cm
2
) in media volume (ml) [Oberdörster et al
a
 (2005)]. In agreement with that, 
Sager and Castranova concluded that using surface area as a dose unit in the toxicity 
assessment studies is more reliable than the mass-based dose [Sager and Castranova 
(2009)]. Moreover, there will be a huge variation in the number of the particles of the 
different size nanoparticles exposed to the living system if weight (i.e. mass) per volume 
was the approach used to express concentration (mg/ml or µg/ml) and this might affect 
the results [Varela et al (2012)]. Therefore, the surface area (cm
2
) of ENPs per volume 
unit (ml) of media is used in this study as a concentration of COO-PS-NPs for cell 
treatment. Using the surface area of ENPs per volume (cm
2
/ml) will allow discriminate 
between the size effect and concentration effect when studying the internalisation, 
toxicity, characterisation and mechanism of action. The surface area for the COO-PS-NPs 
was calculated according to this equation: 
   
x = particle weight (g) per ml y = density (g/ml) z = diameter (nm) 
The concentrations used for treatments were in range to 25–300 cm2/ml. 
Triplicate (or at least duplicate) wells were conducted in every experiment for each 
treatment and each experiment was repeated independently at least three separate times 
unless mentioned. 
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2.3.2 Dispersion of COO-PS-NPs  
In aqueous systems, ENPs form aggregates (i.e. tightly associated particles) 
and/or agglomerates (i.e. loosely associated particles) and in both cases the nanoparticles 
are held together by relatively weak attractive forces including Van der Waals forces, 
electrostatic forces as well as surface tension in the absence of the repulsion interactions 
[Revell (2006)]. This presence of aggregation (due to high surface energy) can alter the 
physicochemical characteristics of the ENPs including their size from the initial state 
[Donaldson et al (2001)] and they hence need to be dispersed by external forces (e.g. 
extensive sonication or strong agitating) to deagglomerate them before being added to the 
biological system. This is essential in order to simulate real exposure conditions and to 
avoid the inaccurate evaluation of the ENPs toxicity and co-localisation [Magdolenova et 
al (2012)]. Nevertheless, avoiding sonication was recommended as sonication might 
cause alteration in the ENPs characteristics [Teeguarden et al (2007)]. 
The samples of COO-PS-NPs were hence dispersed to minimise aggregation 
by vortexing at maximum speed for 2minutes in order to reduce particle interactions 
(avoiding heating of the nanoparticles that may alter their characteristics in suspension) 
[Oberdörster et al
a
 (2005)]. The prepared COO-PS-NPs solutions were immediately used 
for cell treatment and added to cell cultures (80–90% confluence) at various 
concentrations and cells were incubated for different time points at 37ºC in a 5% CO2 
humidified incubator. Samples were also retained for nanoparticle characterisation (See 
section 2.4). 
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In some experiments, chemicals of buthionine sulfoximine (BSO), hydrogen 
peroxide (H2O2, 30%) or etoposide were used as positive controls whereas cells in the 
absence of nanoparticles (non- treated cells in medium only) were used as negative 
controls. 
2.4 Characterisation of COO-PS-NPs 
Characterisation of COO-PS-NPs (including size, surface charge, elements 
contamination and shape) is performed in the stock solutions and in the cell culture media 
using different techniques. This is required for monitoring and understanding the changes 
of the physicochemical properties in the biological solutions. 
2.4.1 Determination of the COO-PS-NPs size and surface charge 
Dynamic Light Scattering (DLS) technique was applied for COO-PS-NPs 
characterisation to evaluate the hydrodynamic diameter and surface charge using Nano-
ZS Zetasizer Instrument (Malvern Instruments Ltd., Worcestershire, UK). At incubation 
temperature (37
°
C), samples of stock solution and various dilutions of COO-PS-NPs in 
LHC-9 SFM (2.5–300 cm2/ml) were vortexed for 2 min and transferred to 1ml clear 
cuvettes. At a scattering angle of 90
°
, the average size of nanoparticles was measured in 
triplicate (with 20 single measurements per sample) and calculated to assess the 
aggregation state of the nanoparticles. The zeta potential (ζ-potential) is the electric 
potential difference between the surface of the particle and the suspension medium in the 
colloidal system where one state of matter (gas, liquid or gas) is dispersed very well in 
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another [McFadyen and Fairhurst (1993)]. ζ-potential is not the surface charge itself but it 
is proportional to the surface charge of ENPs [Fubini et al (2010)]. The ζ-potential was 
determined in the stock and diluted samples of COO-PS-NPs in triplicate with 10 single 
measurements per sample. The average size and ζ-potential were assessed using COO-
PS-NPs diluted in ultrapure de-ionized water (Milli-Q dH2O) (300 cm
2
/ml) in order to 
find out how size and surface charge may change in relation to the media compositions 
and to determine whether particles aggregate or not under experimental conditions. 
Furthermore, characterisation was also carried out at room temperature (25
°
C) to observe 
the effect of temperature on the physicochemical characteristics of COO-PS-NPs. 
2.4.2 Composition quantification of COO-PS-NPs by ICP-MS 
Inductively coupled plasma mass spectrometry (ICP-MS) is a sensitive 
analytical technique used for detecting many of the elements (metals and non-metals) in 
the periodic table at concentrations as low as parts per million [Scheffer et al (2008)]. 
This analysis is based on ionizing the samples yielding a plasma from which the ions are 
then separated and quantified. Each element is identified as a signal pulse depending on 
its unique mass spectrum and quantities of elements are proportional to their signal 
intensities (received on a detector) [Laborda et al (2011)]. 
For sample preparation, 100µl of COO-PS-NPs (20nm or 100nm) were 
separately aliquoted and centrifuged for 5min at 5000rpm using a benchtop 
microcentrifuge (5415D, Eppendorf AG, Hamburg, Germany) and the supernatants were 
carefully aspirated. Nitric acid (HNO3, 70% analytical grade) (Fisher Scientific Ltd, 
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Loughborough, UK) was used for nanoparticle digestion due to its oxidizing ability, 
chemical compatibility, purity, low cost and availability. Each delicate pellet of 
nanoparticles was acidified in tightly capped glass vial in 57µl of HNO3 and the samples 
were then incubated for 24h at 37
°
C. Next day, the samples were diluted to 2ml with MQ 
dH2O (approximately 2% final concentration of HNO3) and filtered through a 32mm 
acrodisc syringe filters with a sterile 0.2μm supor membrane (Pall Life Sciences, 
Portsmouth, UK). A blank sample (57μl HNO3) was prepared and diluted in the same 
way as the other samples and all samples were then subjected to analysis by ICP-MS. 
2.4.3 Determination of COO-PS-NPs size and morphology (shape) by TEM 
Transmission electron microscopy (TEM) is an ideal analytical tool for NPs 
characterisation to study their structural appearance (shape and size) [Mühlfeld et al 
(2007)] using high magnification at very short wavelengths to get high resolution 
imaging capacity. Fig. 2.1 illustrates the main steps for cell sample preparation for 
examination by TEM including fixation, post-fixation, dehydration, embedding, 
sectioning and staining [Bozzola (2007), Schrand et al (2010)] following the treatment 
with the ENPs of interest. 
Samples of the 20nm and 100nm sized COO-PS-NPs in stock solution were 
analyzed individually by TEM to investigate their actual size and the probable 
aggregation. Sample preparation was carried out by directly placing 10μl (tiny drop) of 
the sample of interest upon the grid allowing the sample to settle. The residuals were then 
removed with filter paper, the drop was left to dry on grids for about 2 minutes and was 
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negatively stained by adding 10μl (tiny drop) of 1% Uranyl acetate for about 1 minute 
before washing it off. The TEM grids were then mounted individually on sample 
receiver, inserted into the vacuum chamber and imaged by TEM (JEOL, model 1200EX) 
instrument (JEOL, Tokyo, Japan) operating at accelerating voltage of 80 kV. 
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Fig. 2.1 The major steps in cell sample preparation for TEM imaging following the treatment. (adopted from "Nagashima (2011)"). 
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2.5 Measurement of the mitochondrial activity by MTT assay 
Only in viable cells, the active mitochondrial reductase (dehydrogenase) 
enzyme can reduce the yellow MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) salt into water-insoluble purple formazan crystals [slater et 
al 1963)] (Fig. 2.2). The purple formazan salts can be dissolved by DMSO and the optical 
density of the formazan concentration can be quantified spectrophotometerically to 
indicate the metabolic activity of cells which is directly proportional to the growth and 
number of viable cells [Mosmann (1983), Lanone et al (2009)]. 
 
Fig. 2.2 Reduction of yellow tetrazolium salt (MTT) to water-insoluble purple formazan 
crystals by the active mitochondrial reductase enzyme of the viable cells as an indication 
of viability. [adapted from “Assay Guidance Manual by Sittampalam et al (2004)”] 
The rapid colorimetric MTT assay is broadly used nowadays to quantitatively 
assess the potential toxicological effect of materials on the cell mitochondria activity and 
that directly proportional to the number of living cells in treated samples [Van Meerloo et 
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al (2011)]. This convenient cytotoxicity assay was applied in this study to evaluate the 
BEAS-2B cell viability (since cytotoxicity results in loss of mitochondrial activity) after 
24h incubation with different single concentrations of 20nm and 100nm of COO-PS-NPs. 
BEAS-2B cells seeded in 96-well plastic tissue culture plates were incubated 
with various concentrations of COO-EPSNP at 37ºC in a 5% CO2 humidified incubator 
for 1, 4, 6, 12, 18 and 24h. Following treatment, old media was discarded, cells were 
washed with 100μl PBS and 100µl fresh LHC-9 SFM was added. 25µl of MTT solution 
(of 5mg/ml PBS) was then added to each well and cells incubated for 3h at 37ºC. Media 
containing MTT solution were then aspirated and 200µl of dimethylsulfoxide 
(DMSO)/well were added before covering the plates with foil and agitating gently on 
rocker for 1h at RT to dissolve the purple formazan crystals. Absorbance was read at a 
wavelength of 590nm using a micro-well plate reader (FL 600, Bio-Tek Instruments Inc., 
Winooski, USA) against DMSO as a blank. The mean of mitochondrial metabolic 
activity that represent the cellular viability at different concentrations was expressed as a 
percentage of non-treated cells (negative control). 
 
 
 
x = treated sample absorbance y = control (non-treated) sample absorbance 
The above formula was applied in this cytotoxicity experiment for calculating 
the living cells which have active mitochondrial function that enable them to reduce MTT 
salts into water-insoluble purple formazan crystals via mitochondrial dehydrogenases. 
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2.6 Measurement of ROS generation by H2DCF-DA assay 
In this study, the formation of ROS (mainly H2O2) was examined by a 
fluorometric assay using 2',7'-dichlorodihydrofluorescein diacetate (H2DCF-DA) to 
detect cellular oxidative stress induction caused by reactive oxygen species in BEAS-2B 
cells after treatment with different concentrations of COO-PS-NPs. 
H2DCF-DA is a hydrophobic membrane-permeable non-polar non-fluorescent 
dye that is able to freely enter across the cell membrane [LeBel et al (1992)]. It is one of 
the most widely used probes to detect oxidative stress by measuring the intracellular ROS 
production (mainly H2O2) using flow cytometry [LeBel et al (1992)]. Within cells, 
H2DCF-DA is hydrolyzed by intracellular esterases so the diacetate groups are cleaved 
and removed yielding a polar non-fluorescent 2',7'-dichlorodihydrofluorescein (H2DCF) 
derivative that is trapped in the cell. This H2DCF derivative is then oxidized in the 
presence of intracellular ROS (chiefly peroxides such as H2O2) and transformed by 
peroxidases into green fluorescent 2′,7′-dichlorofluorescein (DCF) product which can be 
quantified by flow cytometer (λex 512nm / λem 530nm) [Bass et al (1983), LeBel et al 
(1992), Wang and Joseph (1999), Müller et al (2008), Hanley et al (2008)]. The 
produced fluorescence would be directly proportional to the overall intracellular ROS 
concentration and can used as an indicator for ENPs-induced ROS formation. 
BEAS-2B cells cultured in 12-well plastic tissue culture plates were treated 
with various concentrations of COO-PS-NPs and cells were incubated at 37ºC for 24h. 
This assay was also conducted on BEAS-2B cells after incubation with a range of COO-
PS-NPs concentrations (25-300 cm
2
/ml) for different time points (1, 4, 6, 12 and 18h). At 
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the end of treatments, cells were washed with 1ml PBS and incubated in media 
containing 200µl H2DCF-DA (10μM final concentration) at 37ºC for 45min. In the main 
lab, cells were washed with PBS, trypsinised (500µl/well, 5-7 min at 37ºC), neutralized 
with media (500µl/well), centrifuged at 4000 rpm for 4 min and each pellet was then re-
suspended in 400µl PBS before being transferred to a FACS tube. The analysis was run 
to measure the COO-PS-NPs induced ROS generation by a Becton Dickinson FACS 
Calibur flow cytometer instrument (BD Science, San Jose, USA) using 488nm laser for 
excitation to count ten thousand cells (events) from each sample and detect them in 
channel FL-1. 
CellQuest software program (Pro-V 5.2.1, BD Science) was used for data 
acquisition while the Weasel software program (V 3.1, Walter and Eliza Hall Institute 
(WEHI), Melbourne, Australia) was used for data display, gating and analysis. The 
cellular debris was gated out from the analysis and the median of fluorescence was 
calculated. H2DCF-DA was also incubated with the COO-PS-NPs in the absence of cells 
to check the possibility of nanoparticles interference with the assay. The results were 
expressed after being calibrated with the blank (i.e. the blank was subtracted from each 
sample). 
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2.7 Determination of the total reduced glutathione (GSH) level 
2.7.1 GSH assay 
Briefly, BEAS-2B cells cultured in 6-well plastic tissue culture plates were 
treated with different concentrations of COO-PS-NPs and cells were incubated at 37ºC 
for 24h. At the end of incubation, a modified protocol based on the fluorometric method 
described initially by Hissin and Hilf (1976) was used for the measurement of the 
intracellular GSH content. Media containing the PS-NPs were aspirated and cells in each 
well were washed twice with 1ml of warm PBS after which cells in each well were 
scraped into 450µl of ice-cold cell lysis buffer [0.1% Triton X100 in PO4-EDTA buffer 
(100 mM NaH2PO4 and 5 mM Na2-EDTA, adjusted to pH 8.0)]. Lysates were transferred 
to eppendorf tubes on ice and 10–15µl of each sample was retained in a separate tube for 
protein estimation. Next, 50µl of ice-cold protein precipitation buffer (50% w/v 
trichloroacetic acid (TCA) in PO4-EDTA buffer) was added to the lysates and samples 
were centrifuged at 13000rpm for 5min. The resulting supernatants (containing the GSH) 
were then transferred to new eppendorf tubes. 1.8ml of PO4-EDTA buffer, 100µl of GSH 
sample solution and 100µl of freshly made O-Phthalaldehyde (OPT, 1mg/ml 100% 
methanol) (Fisher Scientific Ltd, Loughborough, UK) were mixed in individual 3ml 
polystyrene fluorescence cuvettes (Sarstedt Ltd, Leicester, UK) and placed in a covered 
box which was incubated at RT with rocking for 15min. A GSH standard curve was 
prepared using a freshly made GSH stock solution (0.325 mM, 0.1 mg/ml in PO4-EDTA 
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buffer) and different concentrations (0-2µg) were treated in the same way as test samples 
except 5% w/v trichloroacetic acid (TCA) in PO4-EDTA buffer was used. The 
fluorescence was subsequently read (PerkinElmer LS50B luminescence spectrometer, 
PerkinElmer, Cambridge, UK) with λexcitation @ 340nm (slit width 2.5nm) and λemission @ 
420nm (slit width 4.0nm). 
2.7.2 Bradford assay 
This assay was first described by Bradford for protein estimation [Bradford 
(1976)] and is based on the shift in Coomassie blue G-250 absorbance when binding 
protein under acidic conditions [Reisner et al (1975)]. The Coomassie dye has a red, 
green or blue color in the basic (cationic), neutral or acidic (anionic) pH respectively with 
different absorbance wavelengths and the pH equilibrium is shifted to the anionic status 
upon the protein binding that occurs mainly through electrostatic (Van der Waals and/or 
hydrophobic) interactions between the arginine and aromatic (i.e. Try, Tyr and Phe) 
amino acid residues with the sulfonic group of the dye [Compton and Jones (1985)]. 
In this assay, the Bradford reagent was diluted (1:5 in dH2O) and filtered into a 
glass tube. 1ml of this diluted reagent solution was placed separately in 1ml cuvettes 
(Sarstedt Ltd, Leicester, UK), 2µl of test sample was added and stirred with a plastic rod. 
A stock solution of BSA (1 mg/ml dH2O) was freshly prepared and different volumes (0, 
1, 2, 4, 6, 8 and 10 µg) were treated in the same way as test samples. The cuvettes were 
placed in a covered box for 10min and the absorbance readings were then taken at 595nm 
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(UVIKON 922 spectrophotometer, Kontron Instruments, Bletchley, UK) against 1ml 
diluted Bradford reagent as a blank. 
The protein standard curve was plotted using Beer Lambert law, the test 
sample values were calibrated against the standard curve of GSH and expressed per 
milligram of cellular protein. The total intracellular GSH concentrations in samples 
(treated cells and controls) were calculated using the standard curve, normalized to mass 
of total protein in cells and expressed as nmol/mg of proteins contained in the sample. 
2.8 Evaluation of the DNA strand breaks by comet assay 
The comet assay (known also as single cell gel electrophoresis) is a simple, 
sensitive and reliable practical method that is widely used for investigating the DNA 
damage [(Szeto et al (2005)]. The concept behind this assay is to insert the cell in agar 
(after the treatment is accomplished), unwind the DNA by immersing in highly salted 
solution (pH>13) before running the electrophoresis to pull the damaged DNA to the 
anode (the positive pole). The DNA containing strand breaks would migrate more rapidly 
in agarose gel than intact DNA upon application of an electric field forming a comet tail 
that can be stained by a DNA fluorescent dye and viewed microscopically. The extent of 
the stimulus induced DNA damage can be directly related to the amount of DNA strand 
breaks in the stained comet tail and to the tail length [Singh et al (1988), Collins (2004)]. 
The assay involves several steps including cell collection and lysis, DNA unwinding, 
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electrophoresis, staining, cell counting (of at least 100 cells per sample) under the 
microscope and comet analysis by computer program (Fig. 2.3). 
2.8.1 Evaluation of the DNA strand breaks in BEAS-2B cells 
BEAS-2B cells in 6-well plastic tissue culture plates were treated with different 
concentrations of PS-NPs and plates were incubated at 37ºC in a 5% CO2 humidified 
incubator for 24h. At the end of treatment, media containing the PS-NPs were aspirated 
and cells in each well were washed twice with 2ml PBS before scraping cells into 300µl 
of PBS. Cell suspensions were centrifuged at 8000rpm for 5min and the supernatants 
were carefully aspirated and each cell pellet was re-suspended in 150µl of PBS. 30µl of 
the re-suspended cells was transferred into a clean tube containing 300µl molten 2% low 
melting point agarose (LMPA, Bioline ltd., London, UK) and mixed well. 150µl of each 
cell suspension was spread onto a well-labeled glass microscope slide (26x76mm, VWR 
International BVBA, Leuven, Belgium) pre-coated with normal melting point agarose 
(NMPA, 0.5% w/v, 48h to dry, Bioline ltd.) and a duplicate slide was prepared the same 
way. Each of the two slides were covered with a glass cover slip  (22x64mm, VWR) 
avoiding bubbles formation, placed on a metallic tray over ice and left in the cold room 
(at 4
º
 C) for approximately 20min to allow the agarose to set. When solid, the cover slips 
were removed and the slides were incubated for 1h at 4
º
 C in foil-wrapped Coplin jars 
filled with cold lysis buffer (2.5M NaCl, 0.1M Na2-EDTA, 10mM Tris base, 1% sodium 
N-lauryl sarcosinate, 10% DMSO and 1% Triton X-100). Later, the slides were incubated 
horizontally in large electrophoresis tank containing cold electrophoresis buffer (300mM 
NaOH and 1mM Na2-EDTA, pH≥13) for 20min to unwind the DNA and were then 
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electrophoresed for 20min (32V, 300mA) using a Bio-Rad power pack 200 power supply 
(Bio-Rad Laboratories, Hercules, USA). Slides were washed (3 x 5 min) with cold 
neutralization buffer (400mM Tris base, pH 7.5) on paper tissues before staining each 
slide with 50µl DNA-specific SYBR gold (1:1000 in dH2O, Invitrogen, Paisley, UK), 
placing new glass cover slips and storing slides in the cold room in a foil-wrapped moist 
box for analysis (within 24h). 
The comets (on slides) were viewed using Axiovert 10 inverted fluorescence 
microscope (Zeiss Ltd, Göttingen, Germany) using a 20X objective lens. Computerized 
image analysis was performed using the Comet 4.0 (Comet assay IV) software program 
(Perceptive Instruments Ltd., Haverhill, UK) and 100 cells per slide were randomly 
selected and analyzed. The median of tail intensity percentage (i.e. the DNA content 
percentage in the comet tail) was used to represent the DNA damage level since it is 
linearly related to the numbers of DNA breaks following treatment [Collins (2004)] and it 
is not influenced by the time and voltage used for running the electrophoresis showing a 
robust indicator of DNA damage [Olive and Durand (2005)]. 25cm
2
 and 150cm
2
 were 
used as dose concentrations of both 20nm and 100nm COO-PS-NPs compared to BSO 
and untreated cells as positive and negative controls respectively. 
2.8.2 Estimation of the DNA damage in COO-PS-NPs treated cell lysate and cell 
suspension 
BEAS-2B cells were seeded without treatment in 6-well plastic tissue culture 
plates at 37ºC in a 5% CO2 humidified incubator for 24h. The media were aspirated 
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before washing cells twice with 1ml of warm PBS and cells in each well were then 
scraped into 300µl warm PBS and the cell suspensions were centrifuged at 8000rpm for 
5min. The supernatants were then carefully aspirated and each cell pellet was re-
suspended in 150µl of PBS. The cell suspensions were categorized in two groups as 
follows; 1
st
 group samples were treated with different concentrations (25 and 150 cm
2
/ml) 
of the 20nm or 100nm COO-PS-NPs for 1h while the 2
nd
 group samples were left 
untreated. 30µl of the re-suspended cells of each of the two groups was transferred into a 
clean tube containing 300µl molten 2% low melting point agarose (LMPA, Bioline ltd., 
London, UK) and mixed well. 150µl of each cell suspension was spread onto a labeled 
glass microscope slide (26x76mm, VWR International BVBA, Leuven, Belgium) pre-
coated with normal melting point agarose (NMPA, 0.5% w/v, 48h to dry, Bioline ltd.). 
The slides were covered with a glass cover slip  (22x64mm, VWR) avoiding bubbles 
formation, placed on a metallic tray over ice and left in the cold room (at 4
º
 C) for 
approximately 20min to allow the agarose to set. When solid, the cover slips were 
removed and the slides were incubated for 1h at 4
º
 C in foil-wrapped Coplin jars filled 
with cold lysis buffer (2.5M NaCl, 0.1M Na2-EDTA, 10mM Tris base, 1% sodium N-
lauryl sarcosinate, 10% DMSO and 1% Triton X-100). Later on, the slides were washed 
(3 x 5 min) using cold neutralization buffer (400mM Tris base, pH 7.5) on paper tissues. 
The 2
nd
 group samples were exposed to different concentrations (25 and 150 cm
2
/ml) of 
the 20nm or 100nm COO-PS-NPs for 1h before incubating all the slides horizontally in 
large electrophoresis tank containing cold electrophoresis buffer (300mM NaOH and 
1mM Na2-EDTA, pH≥13) for 20min to unwind the DNA. The electrophoresis was run 
for 20min (32V, 300mA) using a Bio-Rad power pack 200 power supply (Bio-Rad 
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Laboratories, Hercules, USA) and the other steps were then applied as performed earlier 
(section 2.9.) to assess the COO-PS-NPs induced DNA damage. 
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Fig. 2.3 The different steps of the alkaline comet assay including cell collection, lysis, DNA unwinding, electrophoresis and staining before 
running the comet analysis by computer program under the microscope. (adopted and modified from "Karlsson (2010)"). 
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2.9 Observation of COO-PS-NPs cellular uptake and co-localisation 
The uptake and co-localisation of ENPs to different organelles were studied in 
fixed and living BEAS-2B cells using confocal laser scanning microscopy (CLSM) 
technique. 
2.9.1 Laser Scanning Confocal Microscopy (LSCM) 
LSCM from Nikon (A1R-A1, Nikon Instruments, Surrey, UK) was used to 
visualize BEAS-2B cells exposed to a range of fluorescence COO-PS-NPs concentrations 
in order to investigate their internalisation inside these cells. 
2.9.1.1 Live cell preparation 
BEAS-2B cells were cultured in a T-25 flask at 37ºC in a 5% CO2 humidified 
incubator and split (when 70% confluent, at 1:25) in a glass bottom MatTek culture dish 
(35mm, MatTek Corporation, Ashland, USA) allowing cells to adhere and grow 
overnight at 37ºC in a 5% CO2 humidified incubator. Next day, the media were replaced 
and cells were incubated with 20nm or 100nm COO-PS-NPs (25 and 150cm
2
/ml for 
uptake investigation and 50cm
2
/ml for Rhodamine staining) at 37ºC in a 5% CO2 
humidified incubator for various times (45min, 1h, 5h and 24h for uptake investigation 
and 24h for Rhodamine staining). After treatment, cells in each dish were washed with 
2ml cell imaging media (CIM, Hank’s balanced salt solution (HBSS), 10 µM, pH 7.4 and 
filtered) and another fresh 2ml CIM was added to the cells. Cells were imaged at 37
º
C by 
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LSCM using a 60 x oil lens against untreated cells as negative control and images were 
analyzed using NIS-Elements software. 
2.9.1.1.1 Mitochondria staining with rhodamine 123 in live cell 
In some experiments, live cells were prepared (section 2.9.1.1) and incubated 
with 20μl rhodamine 123 (10μM final concentration) for about 30 minutes to stain the 
mitochondria. Cells were then washed twice in PBS (2 ml/well) and 2ml LHC-9 SFM 
were placed before imaging by LSCM. The emission signals were collected 
independently using a serial mode technique to avoid crosstalk between the channels and 
image was then processed using ImageJ software (1.47V, downloaded from the Research 
Services Branch, National Institute of Mental Health, Maryland, USA). 
2.9.1.2 Fixed cells preparation 
BEAS-2B cells were cultured overnight on glass cover slips (22x22mm, VWR) 
in a 6-well plastic tissue culture plate (until 70% confluent). They were then incubated 
with the 20nm or 100nm COO-PS-NPs (50cm
2
/ml) for various time points (1, 6 and 24h 
for WGA-Lectin staining and 24h for DAPI staining) at 37ºC in a 5% CO2 humidified 
incubator. Following treatment, media containing nanoparticles were discarded and cells 
were washed with 2ml PBS. Cells were fixed using 2ml neutral buffered formalin (NBF) 
solution (4% formaldehyde) per well and incubated at 4
º
C for 10min. NBF was then 
removed and cells were washed twice with 2ml PBS. 
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On a glass microscope slide (26x76mm, VWR), a drop of hydramount was put 
and the cover slip (with the treated cells) was smoothly placed upside down on that drop 
allowing the hydramount to disperse over the entire section and the cover slip edges were 
then sealed with nail polish to prevent the sample from drying out. Slides were imaged 
immediately by confocal microscopy or stored at 4
º
C in foil (protected from light) for up 
to two weeks. 
2.9.1.2.1 Nucleus staining with DAPI in fixed cells 
Following cell fixation with formaldehyde (section 2.10.1.2), a drop of blue-
fluorescent DAPI (4',6-diamidino-2-phenylindole) nucleic acid stain (Vector Laboratories 
Ltd., Peterborough, UK) in Vectashield mounting medium was put on a glass microscope 
slide (26x76mm, VWR). The cover slip (with the treated cells) was smoothly placed 
upside down on that drop to stain the nucleus allowing DAPI to disperse over the entire 
section. The cover slip edges were then sealed with nail polish to prevent the sample from 
drying out and slides were imaged immediately by confocal microscopy or stored at 4
º
C 
in foil (protected from light) for up to two weeks. 
2.9.1.2.2 Golgi apparatus staining with WGA-Lectin in fixed cells 
Following cell fixation with formaldehyde (section 2.10.1.2), cells were stained 
for about 45 minutes with WGA-Lectin FITC (2µg/ml in PBS) and washed twice with 
PBS (2ml/well). A drop of either hydramount or Vectashield with DAPI was put on a 
glass microscope slide (26x76mm, VWR). The cover slip (with the treated cells) was 
smoothly mounted upside down on that drop allowing it to disperse over the entire 
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section. The cover slip edges were then sealed with nail polish to avoid sample drought 
and samples were imaged immediately by confocal microscopy (Leica) or stored at 4
º
C in 
foil (protected from light) up to two weeks. 
2.9.2 Transmission Electron Microscopy (TEM) 
Transmission Electron Microscopy (TEM) can be employed to observe 
localisation of ENPs within cellular compartments [Mühlfeld et al (2007)] using high 
magnification at very short wavelengths to get high resolution imaging capacity. 
2.9.2.1 Investigation of cellular uptake of suspended COO-PS-NPs by TEM 
In details, BEAS-2B cells were cultured at a density of 5×10
5
 in 5ml of LHC-9 
SFM/well on type I rat tail collagen-coated glass cover slip in 6-well plate which was 
incubated overnight in a 5% CO2 humidified incubator at 37
º
C. Cells at 85% confluence 
were then incubated with COO-PS-NPs (1:100 dilutions) for 24h at 37
º
C. At the end of 
treatment, media containing nanoparticles were discarded, cells were washed with warm 
PBS (2ml/well), primarily fixed (to preserve the cell structure) using 3ml of 2.5% 
glutaraldehyde (GA, glutaric acid dialdehyde) in 0.1M phosphate buffer solution (pH 7.4) 
for 24h in the fridge at 4
º
C to reduce autolysis (cell components self-destruction). Cells 
were then post-fixed for more preservation of the lipids and proteins using 1% osmium 
tetraoxide (OsO4) in 0.1M phosphate buffer for 1h. Samples were dehydrated (2 x 15 
minutes) in a graded ethanol series (50%, 70%, 90% and 100%) and then in propylene 
oxide (1-2 Epoxypropane, C3H6O). Samples were then put on a rotator in fume hood in 
propylene oxide/resin mixture (1:1) for 45 minutes to ensure thorough mixing followed 
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by full resin for about 1h to aid good infiltration. Resin was polymerized at 60
°
C 
overnight (for ~16h) and semi-thin sections (1µm) were cut with an ultra-microtome. 
Ultra-thin (approximately 80nm) sections, which can endure vacuum (in vacuum 
chamber) and heat (from electron beam) while imaging with TEM, were obtained 
afterward using a diamond knife. The sections were mounted independently onto a 200-
mesh single slot supporting carbon-coated copper grids, stained with uranyl acetate (2%) 
and lead citrate before being visualized by TEM (JEOL 1200EX) operating at 80 kV to 
investigate intracellular localisation of these COO-PS-NPs within BEAS-2B cells. 
2.10 Investigation of the role of calcium in COO-PS-NPs cytotoxicity 
The 1,2-bis-(O-Aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid 
tetraacetoxymethyl ester, abbreviated BAPTA-AM, is a derivative of the non-fluorescent 
membrane-permeable Ca
2+
-specific chelator (as a selective sponge of Ca
2+
) where the 
ester moiety is cleaved in the cell by esterase enzyme (Fig. 2.4) to release the BAPTA 
that can bind the Ca
2+
 molecules in the cytoplasm [Collatz et al (1997)]. BAPTA-AM 
was employed in this study to treat the BEAS-2B cells before exposure to COO-PS-NPs 
in order to investigate the potential role of free cytosolic Ca
2+
 in the mechanism of COO-
PS-NPs cytotoxicity using the MTT assay (section 2.5) and in the ROS production using 
H2DCF-DA assay (section 2.6). 
 
 
 
Chapter 2                  General Materials and Methods 
 
 
 
 
79 
 
Fig. 2.4 Cleavage of ester moiety of BAPTA-AM by esterase enzyme releasing the 
BAPTA that selectively bind cytosolic Ca
2+
 molecules forming BAPTA-Ca
2+
 complex. 
(published online, adopted from: "website of Dojindo Molecular Technologies Inc.") 
To evaluate the ability of BAPTA to protect cells against COO-PS-NPs and 
investigate the cellular death mechanism of these nanoparticles, BEAS-2B cells in 96-
well plastic tissue culture were incubated with 5µM BAPTA-AM (Enzo Life sciences 
Ltd., Exeter, UK) for 1h before washing with 100µl PBS and re-incubation for 24h with 
concentrations (ranging 25 - 300 cm
2
/ml) of the 20nm and 100nm COO-PS-NPs at 37ºC. 
Previously described MTT assay protocol (section 2.5) was applied and the absorbance 
was read against DMSO as blank and compared to cells exposed to COO-EPSNP but not 
treated with BAPTA-AM. The same BAPTA-AM treatment was also employed before 
treating BEAS-2B cell with 20nm and 100nm COO-PS-NPs (at  concentrations of 75 and 
300 cm
2
/ml) and the earlier described H2DCF-DA assay protocol (section 2.6) was then 
used for evaluating ROS generation. 
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2.11 Measurement of caspase-3/7 activity 
These caspases can cleave after the aspartate residues with Asp-Glu-Val-Asp 
(DEVD) sequence of amino acids in intracellular substrates [Elmore (2007)] and many 
kits that use this pro-luminescent DEVD-based substrate are commercially available to 
assess the caspases activation following cell treatment with the apoptosis-inducing 
compound of interest. 
BEAS-2B cells seeded in a white-walled 96-well plastic tissue culture plates 
were incubated individually with various concentrations (25, 50, 75, 150 and 300 cm
2
/ml) 
of the 20nm and 100nm COO-EPSNP at 37ºC for 24h. After treatment, old media were 
aspirated, cells were washed in 100μl PBS, 50μl fresh LHC-9 SFM was added and the 
plate was left to equilibrate to RT. 50μl of the well-mixed Caspase-Glo 3/7 reagent 
(G8091, Promega UK Ltd, Southampton, UK) was added and the plate was wrapped in a 
foil. The foil-wrapped plate was gently agitated for 30sec on a plate shaker to mix the 
contents, incubated at RT for 1h and the luminescence readings were measured using a 
Bio-Tek FL 600 micro-well plate reader (Bio-Tek Instruments Inc, Winooski, USA) to 
monitor the activation of caspase-3/7 in these COO-PS-NPs treated BEAS-2B. Wells 
containing media alone were used as a blank. 
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2.12 Investigation of the mechanism of the COO-PS-NPs action 
2.12.1 Measurement of the GSH level in cell-free system 
Several eppendorf tubes containing 10µl GSH solution (0.1mg in 1ml PO4-
EDTA) were incubated on ice for 1hr with different concentrations (25 and 150 cm
2
/ml) 
of the 20nm and 100nm COO-PS-NPs. Next, 50µl of ice-cold protein precipitation buffer 
(50% w/v trichloroacetic acid (TCA) in PO4-EDTA buffer) was added to each sample 
before centrifugation at 13000rpm for 5min and the solutions were then transferred 
individually to new eppendorf tubes. 50µl of that solution were mixed individually in 3ml 
polystyrene fluorescence cuvettes (Sarstedt Ltd, Leicester, UK) with 0.9ml PO4-EDTA 
buffer and 50µl freshly made O-Phthalaldehyde (OPT, 1mg/ml 100% methanol) (Fisher 
Scientific Ltd, Loughborough, UK). The samples were incubated at RT in a covered box 
with rocking for 15min and the fluorescence was then read (PerkinElmer LS50B 
luminescence spectrometer, PerkinElmer, Cambridge, UK) with λexcitation @ 340nm (slit 
width 2.5nm) and λemission @ 420nm (slit width 4.0nm).  
2.12.2 Evaluation of the GSH level in COO-PS-NPs treated cell lysate 
To measure the GSH level in BEAS-2B cells, cells were seeded without 
treatment in 6-well plastic tissue culture plates at 37ºC in a 5% CO2 humidified incubator 
for 24h. The media were aspirated before washing cells twice with 1ml of warm PBS and 
cells in each well were then scraped into 450µl ice-cold cell lysis buffer [0.1% Triton 
X100 in PO4-EDTA buffer (100 mM NaH2PO4 and 5 mM Na2-EDTA, adjusted to pH 
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8.0)]. About 10–15µl of each sample were retained in a separate tube for protein 
estimation and the remainder lysates were incubated independently in new eppendorf 
tubes with different concentrations (25 and 300 cm
2
/ml) of the 20nm or 100nm COO-PS-
NPs for 1h on ice. Then, 50µl ice-cold protein precipitation buffer (50% w/v 
trichloroacetic acid (TCA) in PO4-EDTA buffer) was added to the lysates and the other 
steps of the GSH assay (section 2.7.1) in addition to Bradford assay procedures (section 
2.7.2) were then applied as performed earlier. 
2.13 Statistical Analysis 
As mentioned before, all experiments were repeated at least three times unless 
mentioned. SPSS software (Stat Soft Inc., Tulsa, USA) was applied in performing the 
entire statistical analysis and p ≤0.05 values were considered statistically significant. The 
multi-regression and factorial two--way ANOVA was performed for evaluating the 
significant differences between groups preceded by testing data for the presence of 
outliers, normal distribution (Kolmogorov–Smirnov’s test) and homogeneity of variances 
(Levene’s test). Results were presented graphically by Microsoft Excel and expressed as 
mean ± SEM that is represented by error bars. 
 
 
 
 
 
 
CHAPTER THREE: 
COO-PS-NPs PHYSICOCHEMICAL 
CHARACTERISATION 
 
 
 
 
Chapter 3                                         COO-PS-NPs Physicochemical Characterization 
 
 
 
 
84 
3.1 Introduction 
The physicochemical properties of engineered nanoparticles (ENPs) determine 
their behavior in the biological test media and affect their uptake, clearance, sub-cellular 
internalisation, biological interactions, fate and the toxicity towards living cells [Nel et al 
(2009)]. Among the physicochemical properties of ENPs of importance are chemical 
composition, size (hydrodynamic diameter), shape, surface area, surface charge (zeta-
potential) and tendency to form agglomerates in biological systems [Stone et al (2010)]. 
The physicochemical properties of ENPs should be investigated in stock solutions and in 
biological systems in order to (i) inform on how they would change in cell culture media 
and other systems and (ii) to understand the role and effects of these characteristics on 
cellular uptake and toxicity of ENPs [Poda et al (2011)]. Such information about the 
ENPs characteristics in stock solution and test media will facilitate our understanding of 
ENP behavior upon contact with cells and their fate in cell culture systems and help in 
interpreting the results from the cell culture studies. 
The Scientific Committee on Emerging and Newly Identified Health Risks 
(SCENIHR) has declared that characterisation measurements of studied ENPs should be 
carried out in both the stock solution and after addition to biological system of interest 
[SCENIHR
a
 (2007), SCENIHR
b
 (2007)]. The committee also recommended that such 
measurements should be made in environments similar to and comparable with the real 
surrounding circumstances of exposure. Shape, size and surface charge of ENPs are 
among the most important properties that have been suggested to be characterised as they 
are of high importance in understanding of biological findings. Thus, characteristics of 
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COO-PS-NPs were studied in the experimental culture media and in cell (in some cases) 
in addition to the chemical composition of these COO-PS-NPs themselves and different 
techniques for characterisation were exploited such as DLS, ICP-MS and TEM. Below is 
a brief description of the basic principles of these techniques before indulging into the 
key findings. 
Dynamic light scattering (DLS) is a fast and accurate scattered laser light 
intensity detection-based method for measuring the size of NPs in suspensions [Braun et 
al (2011)]. It has been mentioned that size measurement in biological media by DLS is 
likely to be inaccurate due to the influence of these media on the NPs sedimentation 
(agglomeration), however, DLS is widely used solution-based method for NPs 
characterisations [Baalousha et al
a
 (2012)]. DLS measures the ﬂuctuations of the 
scattered laser intensity over time, which occurs as a result of the Brownian motion (e.g. 
diffusion) of NPs in suspension. The measured fluctuations are then used to determine the 
diffusion coefficient of the particles which can be converted to a hydrodynamic diameter 
of spherical-shape NPs that represents the size of NPs in suspensions [Wang et al (2009), 
Brar and Verma (2011)]. 
The surface charge of NPs is another important physicochemical parameter, 
which determines the behavior of NPs in the test media and their interaction (i.e. uptake, 
translocation, etc.) with the organism. The surface charge is usually reported as Zeta (ζ-) 
potential of the NP and is widely used to experimentally characterise NPs [Mohanraj and 
Chen (2006)]. The ζ-potential is the electrical potential at the shear (slipping) plane of a 
nanoparticle and is proportional to (but not the same as) the surface potential [McFadyen 
and Fairhurst (1993)]. One of the commonly available analytical techniques to measure ζ-
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potential is DLS using the laser Doppler electrophoresis, which enables measuring the 
speed of NPs under electric field effect, known as electrophoretic mobility. The ζ-
potential can then be calculated from the measured electrophoretic mobility based on the 
difference (shift) in the frequency between the incident laser beam and the scattered light 
resulted from hitting the moving NPs in solution [Baalousha et al
b
 (2012)]. The ζ-
potential depends on the characteristics of both the surrounding media and the surface of 
the nanoparticle itself. Understanding and controlling the ζ-potential parameter (by 
changing the environment or altering the surface features) is crucial because it is very 
strongly correlated with particle aggregations (i.e. stability in dispersion) [Win and Feng 
(2005)]. Previous studies have shown that ζ-potential is strongly influenced by the 
properties of the cell culture media or the surrounding environment including pH (activity 
of hydrogen ions), ionic strength (concentration of free ions) and content of protein such 
as serum [Sabuncu et al (2012), Pavlin and Bregar (2012)]. 
The surface charge (represented by ζ-potential) and size (hydrodynamic 
diameter) of the 20nm and 100nm sized red fluorescently-labeled COO-PS-NPs were 
measured with a Malvern Nano-ZS Zetasizer instrument as described in the General 
Materials and Method (section 2.4.1). 
Redox cycling metals, such as copper, iron and zinc are important transition 
metals that contribute in controlling different signaling and metabolic pathways, yet (if 
they escape the control mechanism) they bind to and interact with particular cell 
components (such as proteins and DNA molecules) leading to structure deformation, 
inactivation, dysfunction, DNA damage and cell toxicity [Flora et al (2008)]. These 
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metals were proposed to cause a ROS-induced oxidative stress in aerobic biological 
systems resulting in cell death if it exceeds the capacity of cell intrinsic antioxidant 
defense mechanism [Ercal et al (2001)]. Therefore, the chemical composition and 
impurities of ENPs needs to be well characterised and quantified to ensure that their 
toxicity is not related to metals impurities. Thus, the inductively coupled plasma mass 
spectrometry (ICP-MS) analysis of the inorganic COO-PS-NPs was performed on the 
stock suspension to characterise their chemical composition and obtain the elemental 
concentrations of specific metals (e.g. Fe, Zn and Cu). ICP-MS technique is a standard, 
highly sensitive (with low detection limits), precise and powerful analytical system that 
can be used for assessment of impurities and metal contaminants in a sample of ENPs 
[Scheffer et al (2008)]. Furthermore, transmission electron microscopy (TEM) with high 
spatial resolution is a useful well-established tool for the structural characterisation of 
ENPs mostly of sizes ≤ 100nm [Schrand et al (2010)]. Jones and Grainger cited several 
studies that have used this robust technique for characterising the particle size, shape and 
aggregation/dispersion state in solutions [Jones and Grainger (2009)]. TEM was applied 
in this study to verify the shape, size and dispersion status of COO-PS-NPs (20nm and 
100nm) in stock solution. 
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3.2 Results 
3.2.1 Hydrodynamic diameter and surface charge 
The solutions used for the characterisation by Nano-ZS Zetasizer were 
prepared using 20nm and 100nm sized COO-EPSNs in a total volume of 1 ml including 
COO-PS-NPs in undiluted stock solution (SS), COO-PS-NPs (300 cm
2
/ml) in MQ-dH2O 
as well as different concentrations of COO-PS-NPs (25, 50, 75, 150 and 300 cm
2
/ml) in 
LHC-9 serum-free media (SFM). Characterisations of COO-PS-NPs solutions were 
carried out at various temperatures (37
°
, 20
°
 and 4
°
 C) to investigate the impact of 
temperature on the ζ-potential and the hydrodynamic diameter of these COO-PS-NPs. 
COO-PS-NPs characterisation was performed since size in addition to the surface charge 
and the surface chemistry are important parameters for predicting the aggregation, the 
interaction with cells and the potential adverse toxicological impact that they can cause. 
The ζ-potential measurements demonstrated that all COO-PS-NPs were 
negatively charged in the prepared solutions and at different temperatures, with various 
concentrations and in distinct media. In addition, apart from solutions prepared by the 
20nm and 100nm sized COO-PS-NPs in dH2O, results (table 3.1) showed that the 
negative charges at 20
°
 C measured in SS and in serum-free media (SFM) were lower in 
general than that at 37° C and at 4
°
 C. In other words, the ζ-potential measured at 20° C 
declined compared with that at 37° C before it increase when recorded at 4
°
 C reaching a 
higher level - to some extent - than that at 37° C (Fig. 3.1 and Fig. 3.3). For instance, the 
ζ-potential of 20nm and 100nm sized COO-PS-NPs in SS were -57.68 mV and -53.19 
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mV successively at 37° C (incubation temperature in cell culture) compared with -54.75 
and -46.70 successively at 20
°
C (room temperature) and -63.90 and -55.89 successively at 
4
°
C (storage condition temperature). 
Moreover, with regard to the 20nm and 100nm sized COO-PS-NPs re-
suspended in MQ-dH2O the negative charge increased as the temperature decreased, yet 
this increase was larger and more obvious in the 100nm sized COO-PS-NPs (mainly 
between 37° and 20
°
 C). Furthermore, with increasing the concentration of 20nm and 
100nm sized COO-PS-NPs in SFM - despite the 50 and 75 cm
2
/ml - we can clearly notice 
an increase in the negative surface charge at constant temperature. Additionally, the 
negative charges of different concentrations of the 20nm sized COO-PS-NPs were 
decreased by 3-4 folds in SFM and the 20nm sized COO-PS-NPs were likewise 
decreased by 2-4 folds in SFM at various temperatures compared to the same sized COO-
PS-NPs in SS or in MQ-dH2O. 
Concerning the hydrodynamic diameter (size) of both sized COOH-PS-NPs in 
SS, the outputs of the DLS instrument (Table 3.2) showed that their sizes are larger than 
the primary nominal sizes quoted by the supplier at all the three temperatures (i.e. 37°, 
20° and at 4° C) investigated. The size of the 100nm COO-PS-NPs was increased by 
more than 12% whereas the size of the 20nm COO-PS-NPs was amplified by more than 
300% at all the three temperatures. Moreover, the hydrodynamic diameters of both sized 
COO-PS-NPs measured in MQ-dH2O and LHC-9 SFM were also altered from that 
measured in SS which clearly indicates the effective role of the suspension media on the 
size of the ENPs. This alteration was detected at all various temperatures investigated. 
This increase in hydrodynamic diameter is in line with the decrease in the ζ-potential. 
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In addition, temperature can affect the size of ENPs as there were significant 
differences in the hydrodynamic diameters of both sized COO-PS-NPs measured at 
various temperatures. The results (Fig. 3.5 and Fig. 3.7) showed significant differences in 
the hydrodynamic diameters of the 100nm sized COO-PS-NPs measured at 37°, 20° and 
4° C in MQ-dH2O and LHC-9 SFM, however, a significant difference in the 20nm sized 
COO-PS-NPs in LHC-9 SFM was only found between sizes measured at 37° and at 4° C. 
The highest hydrodynamic diameters of the 20nm sized COO-PS-NPs in LHC-9 SFM 
measured at 20° and at 4° C were recorded at the concentration of 300 cm
2
/ml while the 
highest measured at 37° C was at the concentration of 75 cm
2
/ml. On the other hand, the 
highest hydrodynamic diameters of the 100nm sized COO-PS-NPs in LHC-9 SFM 
measured at 20° C and at 4° C were recorded at the concentration of 25 cm
2
/ml while the 
highest measured at 37° C was at the concentration of 75 cm
2
/ml. 
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 The measured surface charge of the 20nm COO-PS-NPs (mV) 
°
C in SS 
300 cm
2
/ml 
in dH2O 
25 cm
2
/ml 
in LHC-9 SFM 
50 cm
2
/ml 
in LHC-9 SFM 
75 cm
2
/ml 
in LHC-9 SFM 
150 cm
2
/ml 
in LHC-9 SFM 
300 cm
2
/ml 
in LHC-9 SFM 
37 -57.68 ± 3.05 -51.91 ± 4.30 -13.57 ± 1.16 -13.67 ± 1.24 -16.05 ± 1.70 -15.09 ± 1.20 -17.31 ± 1.88 
20 -54.75 ± 2.24 -58.73 ± 1.58 -12.53 ± 0.79 -12.43 ± 0.57 -13.19 ± 0.87 -14.05 ± 1.16 -14.97 ± 1.07 
4 -63.90 ± 2.62 -66.36 ± 2.20 -15.74 ± 0.82 -15.28 ± 0.64 -15.82 ± 0.72 -16.58 ± 1.12 -18.63 ± 1.04 
 
 The measured surface charge of the 100nm COO-PS-NPs (mV) 
°
C in SS 
300 cm
2
/ml 
in dH2O 
25 cm
2
/ml 
in LHC-9 SFM 
50 cm
2
/ml 
in LHC-9 SFM 
75 cm
2
/ml 
in LHC-9 SFM 
150 cm
2
/ml 
in LHC-9 SFM 
300 cm
2
/ml 
in LHC-9 SFM 
37 -53.19 ± 1.21 -35.33 ± 4.37 -15.24 ± 1.17 -14.51 ± 1.38 -17.08 ± 2.07 -18.27 ± 2.02 -21.44 ± 2.55 
20 -46.70 ± 1.50 -62.88 ± 1.18 -14.09 ± 0.50 -14.16 ± 0.86 -16.24 ± 0.95 -16.29 ± 0.86 -19.21 ± 1.30 
4 -55.89 ± 1.14 -69.75 ± 1.06 -17.04 ± 1.00 -18.11 ± 1.00 -18.47 ± 1.62 -19.96 ± 0.88 -23.02 ± 1.34 
Table 3.1 The measurements of COO-PS-NPs surface charge at 37°C (incubation temperature), 20
°
C (room temperature) and 4
°
C (storage 
temperature). ζ-potential was measured in duplicate with total of ten samples (n=10) and was carried out in stock solution (SS), MQ-dH2O 
and serum free cell culture media (LHC-9 SFM). Different concentrations of the 20nm and 100nm nominal sized COO-PS-NPs were 
investigated in LHC-9 SFM because these concentrations were used for the cell treatment. Data of the surface charge values in this table 
represent the mean ± SD. 
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 The measured size of the 20nm COO-PS-NPs (nm) 
°
C in SS 
300 cm
2
/ml 
in dH2O 
25 cm
2
/ml 
in LHC-9 SFM 
50 cm
2
/ml 
in LHC-9 SFM 
75 cm
2
/ml 
in LHC-9 SFM 
150 cm
2
/ml 
in LHC-9 SFM 
300 cm
2
/ml 
in LHC-9 SFM 
37 
61.760 ± 0.74 
(PDI=0.383) 
58.914 ± 1.00 
2083.60 ± 
130.57 
1979.20 ± 
500.44 
2635.20 ± 
289.60 
1715.20 ± 
178.77 
1912.20 ± 268.04 
20 60.740 ± 0.44 55.000 ± 0.70 
1312.60 ± 
204.82 
1547.16 ± 
424.38 
1154.42 ± 
148.13 
1657.40 ± 
189.54 
2016.60 ± 577.63 
4 61.414 ± 1.10 52.426 ± 2.67 
1069.22 ± 
235.62 
1711.40 ± 
345.74 
1280.80 ± 
214.47 
1117.36 ± 
378.94 
1839.80 ± 106.62 
 
 The measured size of the 100nm COO-PS-NPs (nm) 
°
C in SS 
300 cm
2
/ml 
in dH2O 
25 cm
2
/ml 
in LHC-9 SFM 
50 cm
2
/ml 
in LHC-9 SFM 
75 cm
2
/ml 
in LHC-9 SFM 
150 cm
2
/ml 
in LHC-9 SFM 
300 cm
2
/ml 
in LHC-9 SFM 
37 
115.960 ± 2.08 
(PDI=0.06) 
135.920 ± 2.58 154.94 ± 5.20 164.64 ± 5.32 176.64 ± 9.21 172.08 ± 4.30 167.94 ± 2.52 
20 113.880 ± 1.21 129.120 ± 1.10 264.52 ± 4.67 230.70 ± 2.90 245.34 ± 5.37 228.26 ± 2.37 203.94 ± 2.36 
4 112.880 ± 3.71 107.218 ± 5.50 251.24 ± 8.94 220.88 ± 7.82 224.22 ± 7.84 235.92 ± 11 198.36 ± 8.06 
Table 3.2 Summary of the measurements of COO-PS-NPs size at 37°C (incubation temperature), 20°C (room temperature) and 4°C 
(storage temperature). This hydrodynamic diameter was measured in duplicate with total of five samples (n=5) and was carried out in stock 
solution (SS), MQ-dH2O and LHC-9 SFM. Different concentrations of the 20nm and 100nm nominal sized COO-PS-NPs were investigated 
in LHC-9 SFM because these concentrations were used for the cell treatment. Data of the hydrodynamic diameter values in this table 
represent the mean ± SD. PDI refers to the polydispersity index. 
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Fig. 3.1 The ζ-potential (surface charge) of 20nm COO-EPSNs in SS, in MQ-dH2O as well as in LHC-9 SFM revealed significant 
difference (*) between measurements recorded at 37° (dark red), 20° (orange) and 4° C (yellow). The ζ-potential was measured in 
duplicate with total of about ten samples (n=10). The error bars illustrated on the graph represent the standard error of the mean (± SEM). 
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Fig. 3.2 This graph shows a 3-D plot of the ζ-potential (surface charge) against the different concentrations of 20nm COO-EPSNs in 
LHC-9 SFM, in SS as well as in MQ-dH2O and the temperature (at 37°, 20° and 4° C). This is to reveal the different parameters on one 
graph. 
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Fig. 3.3 The ζ-potential (surface charge) of 100nm COO-EPSNs in SS, in MQ-dH2O as well as in LHC-9 SFM revealed significant 
difference (*) between measurements recorded at 37
°
 (navy blue), 20
°
 (blue) and 4
°
 C (turquoise). The ζ-potential was measured in 
duplicate with total of ten samples (n=10).The error bars illustrated on the graph represent the standard error of the mean (± SEM). 
 
 
 
 
 
Chapter 3                                                                              COO-PS-NPs Physicochemical Characterization 
 
 
96 
 
37 (°C)
-80
-60
-40
-20
0 37 (°C)
20 (°C)
4 (°C)
 
Fig. 3.4 This graph shows a 3-D plot of the ζ-potential (surface charge) against the different concentrations of 100nm COO-EPSNs in LHC-
9 SFM, in SS as well as in MQ-dH2O and the temperature (at 37°, 20° and 4° C). This is to display the different parameters on one graph. 
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Fig. 3.5 The hydrodynamic diameter values of 20nm COO-EPSNs in SS, in MQ-dH2O and in LHC-9 SFM were measured at 37
° (dark red) as 
well as at  20° (orange) and 4° C (yellow). The size of 20nm COO-EPSNs measured in LHC-9 SFM revealed significant difference (*) between 4° 
and 37° C. Significant difference in sizes of the COO-EPSNs were also observed in MQ-dH2O between all temperatures. Generally, the 20nm 
COOH-PS-NPs tend to aggregate heavily in the LHC-9 SFM. The hydrodynamic diameter was measured in duplicate with total of five samples 
(n=5). The error bars illustrated on the graph represent the standard error of the mean (± SEM). 
 
 
 
 
 
Chapter 3                                                                              COO-PS-NPs Physicochemical Characterization 
 
 
98 
 
37 (°C)
20 (°C)
4 (°C)
0
500
1000
1500
2000
2500
3000
2
5
cm
²
5
0
cm
²
7
5
cm
²
1
5
0
cm
²
3
00
cm
²
SS
d
H
₂O
 (
3
0
0
cm
²)
 
37 (°C)
20 (°C)
4 (°C)
 
Fig. 3.6 This graph shows a 3-D plot of the hydrodynamic diameter against the different concentrations of 20nm COO-EPSNs in LHC-9 
SFM, in SS as well as in MQ-dH2O and the temperature (at 37°, 20° and 4° C). This is to display the different parameters on one graph. 
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Fig. 3.7 The hydrodynamic diameter values of 100nm COO-EPSNs in SS, in MQ-dH2O as well as in LHC-9 SFM were reported at 37
°
 
(navy blue), 20
°
 (blue) and 4
°
 C (turquoise). No significant differences in size were monitored in high concentrations of the 100nm COO-
EPSNs in LHC-9 SFM between 20
°
 and 4
°
 C. Significant difference in sizes of the 100nm COO-EPSNs in MQ-dH2O were observed 
between all temperatures but not in the 100nm COO-PS-NPs in SS. It seems that the 100nm COOH-PS-NPs tend to be more stable than 
their 20nm counterparts in all media. The hydrodynamic diameter was measured in duplicate with total of five samples (n=5). The error 
bars illustrated on the graph represent the standard error of the mean (± SEM). 
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Fig. 3.8 This graph shows a 3-D plot of the hydrodynamic diameter against the different concentrations of 20nm COO-EPSNs in MQ-dH2O, 
in SS as well as in LHC-9 SFM and the temperature (at 37°, 20° and 4° C). This is to display the different parameters on one graph. 
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3.2.2 Core size and morphology 
The specifications of the 20nm and 100nm sized COO-PS-NPs regarding their 
shape and size were studied by TEM with a voltage of 80 kV (as described earlier in 
section 2.4.2). The images were taken in SS before running the other experimental studies 
to monitor their shape, compare their sizes with measurements taken by DLS method and 
correlate the results with the possible toxicological effects in BEAS-2B cells. 
TEM images of these COO-PS-NPs (Fig. 3.9 and Fig. 3.10) revealed that both 
of the 20nm and 100nm sized COO-PS-NPs have spherical shapes. The ImageJ (which is 
an image processing) software was used to investigate the size distribution (i.e. frequency 
of number) of the 20nm and 100nm sized COO-PS-NPs and the results of analysis of 
TEM images of these nanospheres (Fig. 3.11) demonstrated that the average of size 
number of the 20nm COO-PS-NPs was around 27.4 ± 4.8nm while the number average 
of the 100nm COO-PS-NPs was about 86.0 ± 6.2nm. This indicates that their primary 
individual sizes did not appear to differ much from what was declared in the 
manufacturer bulletin. Both the 20nm and the 100nm sized COO-PS-NPs show 
aggregations that may be occurred during sample preparations, however the 
agglomeration level of the 20nm COO-PS-NPs was much higher than their 100nm 
counterparts. 
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Fig. 3.9 TEM images of the 20nm COO-PS-NPs showing dispersed (A), slightly 
aggregated (B) and more aggregated (C) nanoparticles. However, agglomeration in image 
(c) might be due to the drying effect of the sample preparation  The scale bar is 0.1 µm. 
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Fig. 3.10 TEM images of the 100nm COO-PS-NPs showing dispersed (A), slightly 
aggregated (B) and a bit more aggregated (C) nanoparticles. The scale bar is 0.1 µm. 
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Fig. 3.11 Analyses of TEM images of the 20nm (A) and 100nm (B) sized COO-PS-NPs 
were conducted using ImageJ software to investigate the number of size distribution of 
these nanospheres. The results showed that the number average of the 20nm COO-PS-
NPs was around 27.4 ± 4.8nm while the number average of the 100nm COO-PS-NPs 
was 86.0 ± 6.2nm 
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3.2.3 Chemical composition and impurities 
The chemical composition of COO-PS-NPs stock solution was investigated for 
metal contamination using ICP-MS. Copper (Cu), iron (Fe) and zinc (Zn) were the three 
main chemical elements quantitatively determined in stock solution samples. In this ICP-
MS method, the solution sample is vaporized and transported to inductively coupled 
plasma where it is ionized and the resulted cloud of ions is then analyzed by mass 
spectrometer to determine the elemental composition as the signal intensity is specifically 
and directly correlated to the observed content of chemical elements [Scheffer et al 
(2008)]. The results of the COO-PS-NPs samples analyzed by ICP-MS method illustrated 
that Cu was the lowest element and Zn was the highest element present in both samples. 
Nevertheless, these metals were significantly very low since there were only trace 
amounts of Cu (3.64, 3.17 ppb), Fe (61.95, 40.12 ppb) and Zn (93.2, 91.25 ppb) in the 
stock solution samples of the 20nm and 100nm COO-PS-NPs respectively (Fig. 3.12). 
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Fig. 3.12 Aanalysis of the chemical composition carried out two times (n=2) on stock 
solutions of COO-EPSNs shows only trace amounts (ppb) of Cu (3.64, 3.17), Fe (61.95, 
40.12) and Zn (93.2, 91.25) in the 20nm and 100nm sized respectively. The results were 
plotted in this figure as concentration versus metal content (above) and as concentration 
versus sample (below). 
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3.3 Discussion 
In the current study, COO-EPSNPs were physicochemically characterized 
using various techniques. Hydrodynamic diameter of COO-EPSNP was evaluated by 
DLS technique in solutions of different concentrations of the 20nm and 100nm sized 
COO-EPSNPs in LHC-9 serum free media to investigate NP aggregation status (i.e. 
dispersed particles unite together forming clusters) in cell culture media. Size 
measurements were also performed in the stock solution and in distilled water. The DLS 
method was applied as well for the surface charge measurements in the same aqueous 
solutions. The readings at low temperatures (4
°
C and 20
°
C) were recorded as well to 
explore the impact of the temperature change on the nanoparticle size and surface charge. 
The chemical purity of these nanoparticles was investigated to identify and quantify trace 
elemental composition while their shape and size were also assessed with the TEM. 
The shape, size and dispersion of the 20 and 100nm sized COO-PS-NPs in 
stock solution were studied by TEM (see section 2.4.2) before running the other 
experimental studies. The TEM images (Fig 3.5 and 3.6) revealed that these COO-PS-
NPs have spherical shapes and that their size is slightly changed. The diameter of these 
nanospheres measured with TEM was smaller than the hydrodynamic diameter obtained 
by DLS technique. This can be clearly seen when TEM images were analyzed using 
ImageJ software that measured the size distribution since the number average of the 
20nm COO-PS-NPs was about 27.4 ± 4.8 nm while the number average of the 100nm 
COO-PS-NPs was 86.0 ± 6.2 nm. DLS technique is based on measuring the scattered 
light intensity of NPs and thus it calculates the z-average of the size of NPs (i.e. the 
diameter of core and surrounding shell) whereas the TEM is a number counting-based 
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system that measures the number average of diameter of only the core of NPs [Hassellov 
et al (2008)]. This would explain the difference in the measurement of the size of NPs 
resulted from the two techniques as the measurement of the nominated COO-PS-NPs (in 
particular the 20nm) by the DLS was higher than the size values of the same COO-PS-
NPs measured by TEM. This difference could also be as a result of the bias caused by 
DLS instrument in consequence of the presence of small aggregates (even if they are 
small) formed in the solution that would affect the high sensitivity of DLS instrument 
[Farkas et al (2011)]. In general, characterization of NPs using several techniques might 
lead to inconsistent results that may vary significantly due to several reasons including (i) 
the difficulties and limitations of individual analytical method, (ii) the sample preparation 
difficulties that can end up with imprecise characterizations [Poda et al (2011)] or (iii) 
simply the fact that different techniques measure different aspects of the NPs [Shang et al 
(2014), Hassellov et al (2008)]. 
The size characterization results of the COO-PS-NPs at 37
°
C by DLS 
demonstrated aggregations of the 20nm COO-PS-NPs in the LHC-9 SFM (appeared as 
increase of hydrodynamic diameter of NPs) compared to these in the SS and in the MQ- 
dH2O (Fig. 3.5). In contrast, the 100nm COO-PS-NPs appeared to stay mono-dispersed 
(i.e. single particles or as loose agglomerates) in the stock solution at the room 
temperature (20
°
C) and limited accumulation was observed in SFM (Fig. 3.7). NPs 
adsorb surrounding proteins on their surfaces which would change the NPs size by 
forming a protein-NPs corona and this adsorption can mediate the toxicity of NPs and 
influence the human health [Kendall et al (2004), Cedervall et al
b
 (2007]. The state of 
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NPs aggregation was reported to decrease inversely with increasing the particle size 
[Gharagozloo and Goodson (2011)] 
The classical DLVO theory, (identified after independent work by the Russian 
scientists Derjaguin B. and Landau L., and Dutch scientists Verwey E. and Overbeek J. 
[Froberg et al (1999)]), suggests that the balance between the electrostatic repulsive 
forces (between the NPs that carry the same surface electric charge) and the Van der 
Waals attractive forces (between the electrons of one NP and the nuclei of another) would 
create an effective steady energy barrier that can preserve the dispersion condition of the 
NPs (i.e. prevent aggregation) in a colloidal system [Fubini et al (2010)]. The 
electrostatic repulsive forces are dominant and strong while the Van der Waals attractive 
forces are weak and are affected by distance between NPs [Fubini et al (2010)]. It is 
known that NPs dispersed in aqueous solution are subjected to Brownian motion (that is a 
randomly and continuously movement of particles in a suspension) [Shang et al (2014)] 
and would result in collision (hitting) of the suspended NPs with each other and with the 
surrounding fluid molecules.  
The NPs dispersed in aqueous solution are in stable condition and would need 
the kinetic energy (generated by NPs collisions) to be high enough to overcome the total 
energy barrier and to disrupt the electrostatic boundary (between the nanoparticle outer 
surface and the medium layer surface) causing a drop in the ζ-potential [Freitas and 
Müller (1998)]. When the balanced energy barrier is disturbed, NPs get closer to each 
other and thus, the Van der Waals attractive forces would strive to pull them together into 
contact and cause them to agglomerate. High temperature has been proposed to increase 
kinetic energy since it can affect the Brownian motion of NPs in solutions [Freitas and 
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Müller (1998), Zhang et al (2012); Attachment Efficiency of Nanoparticle Aggregation in 
Aqueous Dispersions: Modeling and Experimental Validation]. This would reduce the 
energy barrier [Chen et al (2012)] stimulating consequently the NPs aggregation. In 
addition, Both the NP’s size and concentration can also affect the aggregation kinetics 
[Metin et al (2014); Aggregation kinetics and shear rheology of aqueous silica 
suspensions]. This means that high temperature, high NP’s concentration and small NP’s 
size would all increase the aggregation kinetics, reduce the NPs dispersion stability and 
cause NPs aggregation. 
In the current study, the ζ-potential of the 20nm sized COO-PS-NPs (Fig. 3.1) 
measured at high temperatures (20
°
 and 37
°
C) was found generally less than that 
measured at low temperature (4
°
) which might indicate that increasing the temperature 
caused a decrease in the total negative charge of the COO-PS-NPs (most clear in the MQ-
dH2O). Furthermore, the ζ-potential of both sized COO-PS-NPs diluted in LHC-9 SFM 
were significantly smaller than the equivalent sized COO-PS-NPs in the SS or in the MQ-
dH2O at all concentrations investigated (Table 2). This decrease in ζ-potential is perhaps 
due to (i) adsorption of protein molecules present in the LHC-9 SFM onto the surfaces of 
COO-PS-NPs [Dos Santos et al (2011)] and/or (ii) effective neutralization of COO-PS-
NPs charge occurred by interactions with divalent cations of salts in the surrounding 
media [Wei and Khun (2014)]. This drop in ζ-potential would consequently decrease the 
electrostatic repulsion between NPs reducing at the end the stability of the COO-PS-NPs 
and increasing their tendency to aggregate [Wei and Khun (2014)]. The data showed that 
the decrease of the value of the negative charge seems to be directly proportional to 
decreasing concentrations of COO-PS-NPs (of the 20nm or 100nm) in the culture media. 
 
 
 
Chapter 3                                                       COO-PS-NPs Physicochemical Characterization 
 
 
 
 
                                    111 
This would suggest that more anions (COO-) with negative charge are present in the high 
concentrations of COO-PS-NPs solutions compared to fewer NPs in low concentrations 
of COO-PS-NPs where cations in the media can neutralize the negative charge and so 
decrease the total negative charge. 
NPs that have a high ζ-potential (above +/- 30 mV) are stable in suspension 
because charges on the particle surface act to enhance the repulsive forces between 
particles minimizing the particles attractions and preventing their aggregation [Mohanraj 
and Chen (2006), Bihari et al (2008), Gowda et al (2009)]. In other words, the higher the 
ζ-potential (in number not in value) is, the higher the repulsion between the NPs, the 
higher the energy barrier and the more stability status (dispersion of these nanoparticles) 
in the solution. According to that, the decrease in the ζ-potential of the COO-PS-NPs 
observed at high temperature (37
°
C) would directly have an impact on dispersion state of 
the NPs as they tend to aggregate due to the loss (or decline) of the inter-particles 
repulsion leading to size augmentation. 
In summary, the electrostatic repulsive forces are dominant and strong enough 
to resist agglomeration by maintaining the equilibrium energy state and preventing the 
COO-PS-NPs from attracting each other through keeping appropriate distance between 
these NPs, according to the classical DLVO theory. Thus, the COO-PS-NPs would be in 
a state of dispersion in a solution. Increasing the temperature increases (e.g. 37C) would 
accelerate the Brownian motion of these COO-PS-NPs (mainly at high concentrations of 
the 20nm COO-PS-NPs) and increase the kinetic energy to overcome the total energy 
barrier allowing the NPs to get close to each other to the extent that Van der Waals forces 
would attract them to each other and get them in contact causing agglomeration. 
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However, the stability of NPs solution is yet a complicated issue and other forces such as 
the acid-base (AB) forces (including the hydrogen-bonding force, hydrophobic 
interaction force and hydration forces) might play a role in administrating the stability of 
NPs and have been suggested therefore to be taken in consideration (by involving them 
into what is known as the extended DLVO theory) to give a more accurate explanation 
for the NPs agglomeration [Petosa et al 2010, Chen et al (2012)]. 
Furthermore, the charge of NPs is important for their stability and salts have 
been proposed to electrostatically obscure this charge causing NPs aggregation [Soenen 
et al (2011)]. Charge neutralizations of the COO-PS-NPs might therefore have taken 
place due to COO-PS-NPs interactions with salts present in culture media leading to a 
drop in the stability of the NPs and cause NPs agglomeration. In addition, it is also 
possible that proteins in the culture media may have higher affinity to bind and coat the 
20nm sized COO-PS-NPs which have larger surface area for interaction compared to the 
100nm COO-PS-NPs although LHC-9 SFM contain low protein compared to normal 
serum-supplemented medium. Low aggregation occurred in the 100nm COO-PS-NPs can 
be attributed to the difficulties for the protein molecules to completely enclose the large 
size (of 100nm) COO-PS-NPs and consequently their size have partially increased to 
some extent but they overall stay more stable (Fig. 3.7). Proteins are known to instantly 
be adsorbed on the surface of NPs forming a coating surface, known as protein corona 
[Cedervall et al
a
 (2007), Lynch and Dawson (2008)]. This protein corona can mediate the 
NPs reactions in biological systems through several mechanisms including modification 
of the characteristics of NPs surfaces, amendment of the active function of protein, 
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protein content reduction in the biological system and increase of tendency of NPs for 
aggregation [Fubini et al (2010), Lynch et al (2013)]. 
The analysis of the Cu, Fe and Zn in the COO-PS-NPs sample in stock 
solution demonstrates that there were only trace amounts of these elements present in the 
COO-PS-NPs (Fig. 3.12). These results showing very low concentrations of elements are 
significant as they would show that the possible toxicological impact of these COO-PS-
NPs (if there are any, see chapter 5) are unlikely be related to metal elements content. 
Moreover, it is worthy to mention that these concentrations were in the stock solution and 
the dilution of the COO-PS-NPs by the media would make the amount of the elements 
even smaller. 
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4.1 Introduction 
The assessment of the cellular uptake of ENPs is of fundamental importance 
as particles must penetrate across the cell membrane and get into the cells before they can 
cause any cell-specific damage and hence understanding internalisation of particles into 
cells is crucial for the risk assessment of the ENPs-containing products in order to predict 
their consequences in the human body [Lovrić et al (2005)]. In addition, it has been 
suggested that ENPs-induced biological effects may be due to ENPs internalisation and 
co-localisation to specific organelles such as mitochondria [Li et al (2003), Oberdörster et 
al
b
 (2005)] or near the nucleus [Bhattacharya et al (2009)] causing oxidative stress, DNA 
damage and cell death following cellular accumulation of ENPs [Oh et al (2010)]. 
Moreover, ENPs intracellular co-localisation and distribution to specific organelles can 
be investigated using various fluorescent markers for staining and distinguishing definite 
cellular compartments. In the current study, co-localisation experiments were conducted 
to image the intracellular fate of COO-PS-NPs and to investigate whether there was any 
specific uptake by specific organelles. Such information may aid in understanding the 
mechanism behind their possible toxicological effect on cells and in monitoring the ENPs 
delivery as drug-carrier systems. 
Several experimental techniques are available for the study of uptake and co-
localisation on ENPs including advanced microscopic techniques such as confocal laser 
scanning microscopy (CLSM) and transmission electron microscopy (TEM) as well as 
spectroscopic techniques such as fluorescent flow cytometry. Each of these approaches 
has advantages and disadvantages for the study of NPs uptake. The advantages of 
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implementation of each of these techniques to study NPs uptake have been discussed 
briefly below. 
TEM is a commonly used method for ENPs detection in biological systems 
and assessment of uptake into sub-cellular components (e.g. mitochondria, Golgi 
apparatus, endoplasmic reticulum) at high spectral resolution [Lee et al (2010)]. 
Nevertheless, it is sometimes difficult to distinguish between the ENPs and the other cell 
components in the 2-dimensional black and white images because some organelles are 
dense and have the potential to cause scattering of high-velocity electrons [Nagashima et 
al (2011)]. This is particularly a problem for PS-NPs which are not electron dense like 
metal NPs and also prone to artifacts during sample preparation. In addition, the cell 
imaging is not easily possible since cultured cells need to undergo various stages of toxic, 
is cost- and time-consuming and complicated sample preparation procedure required for 
imaging following the desired time and dose treatment including fixation, dehydration, 
thin sectioning and staining with heavy-metal dyes [Lee et al (2010), Schrand et al 
(2010), Mühlfeld et al (2007)]. This would also make live imaging not possible. In 
contrast, CLSM allows live cell imaging and can be used to perform time-course studies 
but is complicated and the use of a high-energy laser beam over long time can result in 
bleaching of fluorescent ENPs making it difficult to distinguish the fluorescent ENPs 
within the cell [Frigault et al (2009)]. In addition, the repeated exposure of living cell to 
highly-intensive illumination may cause excitation of fluorescence ENPs and hence 
initiate phototoxicity on account of the oxygen-dependent reaction of free radicals that 
can damage sub-cellular compartments and lyse the cell [Frigault et al (2009)]. Table 4.1 
summarises the advantages and disadvantages of TEM and CLSM.  
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 TEM CLSM 
Adv. 
1. Ideal tool used commonly for monitoring 
and detection of non-fluorescent ENPs in cells. 
2. High resolution so it provides information 
about size and morphological structure. 
3. Evaluation of cellular distribution and 
uptake into sub-cellular components (e.g. 
mitochondria, Golgi apparatus, endoplasmic 
reticulum) at high spectral resolution. 
1. Allows imaging of 
ENPs in live cell. 
2. Allow performing time-
course studies. 
Disadv. 
1. Complicated, time-consuming and costly 
procedures required for optimal sample 
preparation including fixation, dehydration, 
thin sectioning and staining with heavy-metal 
dyes. 
2. Possibility of toxicity of cultured cells 
through various stages of sample preparation. 
3. Artifacts due to sample preparation. 
4. Difficulty in distinguishing the ENPs 
(particularly PS-NPs which are not electron 
dense-like metal NPs) from other cell 
components in 2-D black and white images as 
some organelles are dense and have the 
potential to cause scattering of high-velocity 
electrons resulting in unwanted interfere. 
5. Live imaging is not possible. 
1. Can result in bleaching 
of fluorescent ENPs due to 
the use of a high-energy 
laser beam over long time 
which might make it 
difficult to distinguish the 
fluorescent ENPs within 
the cell.   
2. Repeated exposure of 
living cell to intensive 
illumination may cause 
phototoxicity leading to 
damage of sub-cellular 
organelles and cell lysis 
due to the reaction with 
free radicals. 
Table 4.1 The advantages and disadvantages of TEM and CLSM techniques used for 
imaging of ENPs in cells. 
Quantification of fluorescently labelled ENPs uptake is generally performed by 
flow cytometry, however, real NP uptake evaluation by flow cytometry method presents 
a challenge because of the difficulties in distinction between the internalised ENPs and 
the plasma-adsorbed ENPs upon their interaction with the cell surface following exposure 
[Dausend et al (2008), Vranic et al (2013), Gottstein et al (2013)]. Thus, these different 
approaches (flow cytometry, CLSM and TEM) were applied in this study to overcome 
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their own limitations and validate the results regarding the COO-PS-NPs basic cellular 
uptake and co-localisation. 
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4.2 Results 
4.2.1 Uptake of COO-PS-NPs into BEAS-2B cells 
4.2.1.1 Quantification by flow cytometry 
In summary, after 24h incubation of BEAS-2B cells independently with 
different concentration of COO-PS-NPs, cells were washed three times with PBS (to 
remove the membrane-bound COO-PS-NPs), trypsinised, centrifuged and re-suspended 
in PBS before analysis by flow cytometry (Becton Dickinson FACS Calibur from BD 
Science, San Jose, USA) equipped with a 488nm laser [Zucker et al (2010)] (section. 
2.6). Data acquisition was performed by CellQuest software (Pro-V 5.2.1, BD Science) 
and the results were analysed by Weasel program (V 3.1, WEHI, Melbourne, Australia) 
and reported (Fig. 4.1) as the mean of the cell ﬂuorescence intensity (as uptake 
indication) obtained after analyzing 10,000 events (cells) in the gate. Error bars are the 
standard error of the mean (± SEM) between 4 independent samples (n=4). 
Results of statistical analysis of two-way ANOVA conducted using SPSS 
revealed that there were significant main effects of the size (F(1, 30) = 524.356, p < .001) 
and the concentration (F(4, 30) = 108.255, p < .001) of COO-PS-NPs as well as a 
significant interaction effect of size and concentration (F(4, 30) = 83.875, p < .001) on 
the intensity of the COO-PS-NPs in BEAS-2B cells. This means that both factors (size 
and concentration) affect the uptake output and that the outcome resulted from changes in 
one factor (size for example) depended on the level of the other factor (the concentration) 
indicating a relationship between the size and concentration of the COO-PS-NPs in 
affecting their uptake in BEAS-2B cells. 
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The results (Fig. 4.1) showed that when the 100nm sized COO-PS-NPs were 
used for exposure, the intensity of red fluorescence was concentration dependent and has 
been the highest for cells treated with 300 cm
2
/ml while the lowest was when cells were 
incubated with 25cm
2
/ml. Interestingly, the relative levels of fluorescence in cells treated 
with 20nm COO-PS-NPs was approximately an order of magnitude lower than for cells 
treated with 100nm COO-PS-NPs of the equivalent concentration suggesting that the 
100nm particles were more readily taken up into the cells. Furthermore, in both cases the 
uptake appeared to plateau at concentration of 150cm
2
/ml and above. 
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Fig. 4.1 Intracellular uptake of various concentrations of 20nm COO-EPSNs (blue) and 100nm (red) in BEAS-2B cells. The intensity of 
fluorescence is correlated with the uptake of the COO-PS-NPs into cells. Significant difference in uptake of the 20nm COO-EPSNs and 
100nm COO-EPSNs was observed. Measurements of at least 4 samples (n=4) were recorded using flow cytometry and the error bars on the 
graph represent the standard error of the mean (± SEM). 
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4.2.1.2 Uptake of COO-PS-NPs into BEAS-2B cells by CLSM 
CLSM (A1R-A1, Nikon Instruments, Surrey, UK) was used to monitor the 
internalisation of the red fluorescently labeled 20nm and 100nm sized COO-PS-NPs into 
live BEAS-2B cells. Cells were independently exposed to 25 and 150 cm
2
/ml for several 
time points (45 min, 1h, 5h and 24h) at 37˚C, washed three times with PBS and 
investigated for uptake of these nanoparticles. 
As can be visually seen (Fig. 4.2), the 20nm and 100nm sized red fluorescent-
labelled COO-PS-NPs were internalised into BEAS-2B cells within less than an hour (45 
minutes) of exposure. Moreover, Fig. 4.2 demonstrated that the amount of internalisation 
increased over time and that the uptake of the larger 100nm COO-PS-NPs was greater 
than the 20nm COO-PS-NPs at the same time point in agreement with the flow cytometry 
data. Furthermore, the uptake increased with increasing the concentration used for cell 
treatments for both sizes of the nanoparticles. In addition, no distinct evidence of damage 
to BEAS-2B cell membrane was observed and cells seem able to preserve their 
morphological structure without serious injuries or major modifications even after 
incubation for 24h in agreement with the cytotoxicity data in chapter five. 
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Fig. 4.2 Confocal microscopy images of uptake of 20nm and 100nm red COO-PS-NPs (of 25 or 150 cm
2
/ml) after various time points 
(45min, 1, 5 and 24h) in live BEAS-2B cells. Visually, it can be seen that uptake was a concentration-, size- and time-dependent process. 
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4.2.1.3 Uptake of COO-PS-NPs into BEAS-2B cells by TEM 
TEM is a powerful technique that was used not only in investigating the 
physicochemical characteristics of the COO-PS-NPs regarding their size and shape as 
well as the agglomeration status (section 3.2.2) but also for fluorescent COO-PS-NPs 
detection inside cells and co-localisation within sub-cellular compartments at high spatial 
resolution [Lee et al (2010)]. Since that is pivotal for studying the use of ENPs in several 
applications such as drug carrier system. It was utilized with high pressure in this study to 
examine the uptake of 20nm and 100nm COO-PS-NPs in fixed BEAS-2B cell samples. 
The digital microphotograph images (Fig. 4.3) showed a cellular uptake of the 100nm 
COO-PS-NPs that were found mostly in the cytoplasm and around the nucleus. The 
images also showed the 100nm COO-PS NPs between cells and in attached to the outer 
cell membrane as well as in vesicle-like structures. The TEM images (Fig 4.4) 
demonstrated that it is confusing and difficult to detect the 20nm COO-PS-NPs in BEAS-
2B cells potentially due to their small size and low electron density [Ng et al (2010)]. 
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B 
   
Fig. 4.3 TEM images of cellular uptake of the 100nm COO-PS-NPs (50cm2/ml). Arrows point out to these COO-PS-NPs that can be seen in the 
cytoplasm around the nucleus (1A and 1B), between cells (2A and 2B), attached to the cell membrane (3A) and in a vesicle-like structure (3B). 
NUCLEUS 
CELL 
CELL 
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Fig. 4.4 TEM images of BEAS-2B cells incubated with 20nm COO-PS-NPs (50cm
2
/ml) 
showing (A) the whole cell, (B) section inside the cell and (C) the outer cell membrane. It 
was confusing and difficult to detect and visualize the 20nm COO-PS-NPs in the 
cytoplasm or cell compartments because of their small size and low electron density. 
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4.2.2 Co-localisation of COO-PS-NPs in the nucleus, mitochondria and Golgi 
apparatus of BEAS-2B cells by CLSM 
To study the possible co-localisation of red fluorescent COO-PS-NPs in 
various sub-cellular organelles of BEAS-2B cells, different stains were used to co-stain 
BEAS-2B cells following 24h exposure to 50cm
2
/ml COO-PS-NPs. The mitochondria 
was marked with the green Rhodamine 123 dye in living cells whereas the blue DAPI 
was used for staining the nucleus and green WGA-lectin was used for staining the Golgi 
apparatus in fixed cells. The treated BEAS-2B cells were imaged by LSCM (Nikon A1R-
A1 or Leica) using a 60X oil lens against untreated cells as negative control and images 
were analyzed using ImageJ software. 
The red fluorescent COO-PS-NPs were distributed widely throughout the 
cytoplasm and could be seen as foci of accumulated fluorescence that appears as bright 
red clusters. The 20nm sized COO-PS-NPs were found around the blue DAPI-stained 
nuclei (Fig. 4.5 A). Some of these 20nm COO-PS-NPs seemed to be located inside the 
mitochondria as yellow fluorescence dots were seen as a result of the red particles and the 
green mitochondria overlay (Fig. 4.8 A). Moreover, very few COO-PS-NPs sized 20nm 
were situated in the green lectin-stained Golgi and only after 24h incubation (Fig. 4.9 and 
Fig. 4.10). On the other hand, it seems that the 100nm red COO-PS-NPs colocolise more 
inside the Golgi apparatus mainly after 24h incubation and partially after 6h incubation 
(Fig. 4.11 and Fig. 4.12). Furthermore, it was difficult to clearly observe co-localisation 
of the 100nm COO-PS-NPs inside the mitochondria (B and D). 
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A 
 
 
B 
 
Fig. 4.5 Red fluorescent COO-PS-NPs (20nm, 50cm
2
/ml) were observed as 
clusters in the cytoplasm around the blue DAPI-stained nucleus in fixed BEAS-2B 
cells imaged by CLSM indicating the intracellular uptake (A) in comparison to the 
non-treated cells (B). The scale bar is 10 µm. 
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 Rhodamine 123 COO-PS-NPs Overlay 
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(20nm) 
   
B 
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Fig. 4.6 CLSM images of green rhodamine-stained mitochondria in BEAS-2B cells after 24h incubation with 50 cm
2
/ml COO-PS-NPs 
sized 20nm (A) or 100nm (B) to monitor their co-localisation. Images were presented to show the mitochondria stained with rhodamine 123 
(left column), the red COO-PS-NPs (middle column) and the overlay of red COO-PS-NPs and green-stained mitochondria (right column). 
The scale bar is 10 µm 
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A 
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B 
(100nm) 
  
Fig. 4.7 The graph of quantification of the red COO-PS-NPs showed some colocalisation of the 20nm red COO-PS-NPs in the Rhodamine 123 
green-stained mitochondria (A) as the red and green channels were overlapped. Meanwhile, no clear co-localisation of the 100nm red COO-PS-NPs 
could be seen inside the mitochondria (B) since no clear red and green overlapping was displayed. The scale bar is 10 µm 
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A (20nm) B (100nm) 
  
C (20nm) D (100nm) 
  
Fig. 4.8 BEAS-2B cells were incubated with 50 cm
2
/ml of the 20nm or 100nm red 
fluorescent COO-PS-NPs for 24h followed by mitochondria staining with green 
Rhodamine 123 for 30 minutes. Confocal images of the 20nm red COO-PS-NPs (A and 
C) revealed some co-localisation inside the mitochondria as yellow dots resulted from 
the overlay of the red and green fluorescence. Meanwhile, it was hard to clearly see co-
localisation of the 100nm sized red COO-PS-NPs inside the green rhodamine-stained 
mitochondria (B and D). The scale bar is 10 µm 
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1h 6h 24h 
   
   
Fig. 4.9 CLSM images of red 20nm COO-PS-NPs (50 cm
2
/ml) in green lectin-stained Golgi in BEAS-2B cells after 1h (left columns), 6h 
(middle columns) and 24h (right columns) incubations. Partial co-localisation of 20nm COO-PS-NPs in the Golgi apparatus can be seen 
only after 24h. The blue DAPI was utilized for 1 and 6h studies to stain the nucleus. Scale bar is 10µm. 
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Fig. 4.10 The graph of quantification of the 20nm red COO-PS-NPs showed obvious red and green channels overlapping after 24h incubation 
(right column), partial overlapping after 6h incubation (middle column) but no overlapping after 1h incubation (left column). This overlapping 
indicates colocalisation of the 20nm red COO-PS-NPs in the lectin green-stained Golgi apparatus of BEAS-2B cells. The blue DAPI was utilized 
for staining the nucleus. The scale bar is 10µm. 
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Fig. 4.11 CLSM images of red 100nm COO-PS-NPs (50 cm
2
/ml) in green lectin-stained Golgi in BEAS-2B cells after 1h (left columns), 6h 
(middle columns) and 24h (right columns) incubations. Some co-localisation of the 100nm COO-PS-NPs in the Golgi apparatus can be seen 
mainly after 24h and partly after 6h. Scale bar is 10µm. 
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Fig. 4.12 The graph of quantification of the 100nm red COO-PS-NPs showed obvious red and green channels overlapping after 24h incubation 
(right column) and 6h incubation (middle column) but partial overlapping after 1h incubation (left column). This overlapping indicates 
colocalisation of the 100nm red COO-PS-NPs in the lectin green-stained Golgi apparatus of BEAS-2B cells. The blue DAPI was utilized for 
staining the nucleus. The scale bar is 10µm. 
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4.3 Discussion 
The evaluation of ENPs cellular uptake has been known to be important since 
the biological influences that these ENPs can cause depend on their ability to get across 
the plasma membrane to the interior of cells. Therefore, COO-PS-NPs uptake into 
BEAS-2B cells was assessed in this study using flow cytometry, CLSM and TEM 
techniques. CLSM was utilized to observe the internalisation of two concentrations of the 
fluorescent COO-PS-NPs at several time points while studying the uptake by TEM and 
FACS was performed after 24h. The intracellular co-localisation of these COO-PS-NPs 
was accomplished using various fluorescent markers for staining and labeling specific 
organelle within live or fixed cells following the incubation with the COO-PS-NPs. 
For the internalisation assessment by flow cytometry, BEAS-2B cell samples 
were treated independently with various concentrations (25-300 cm
2
/ml) of 20nm and 
100nm COO-PS-NPs and the relative fluorescence intensity was then measured. The 
measurements were then plotted against the concentration (dose) used for the treatment 
for 24h exposure to find out the COO-PS-NPs uptake status in these cells. The flow 
cytometry results (Fig. 4.1) displayed that the lowest fluorescence intensity was in cells 
exposed to 25cm
2
/ml COO-PS-NPs and then increased with increasing the concentration 
to reach the highest level at 300cm
2
/ml. This was the pattern of both the 20 and the 
100nm COO-PS-NPs and confirms that the internalisation of these particles was 
proportional to the external concentration used in the experiment indicating a 
concentration-dependent process. There was no significant increase further than the 
150cm
2
/ml (as verified statistically) since the curve attained a stable level (plateau) 
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probably as a result of saturation status. This might indicate some kind of active 
internalisation of COO-PS-NPs (before saturation at 150cm
2
/ml) and this is in agreement 
with what has been hypothesized that the cellular uptake of ENPs is active process which 
involves enclosing them by the cell membrane prior to internalisation [Gao et al (2005)]. 
Moreover, it has been proposed the cellular uptake of ENPs is controlled by a 
thermodynamic equilibrium where the internalisation increases with the time and 
concentrations until it reaches a plateau [Chithrani et al (2006), Zhang et al (2009)]. In 
addition, it can be clearly seen that the fluorescence intensity of the 100nm COO-PS-NPs 
(even as low as the 25cm
2
/ml) are much more than the 20nm COO-PS-NPs intensity at 
all concentrations in BEAS-2B cells. This means that more of the larger sized COO-PS-
NPs (of 100nm) were internalised into BEAS-2B cells compared to the small size COO-
PS-NPs (of 20nm) showing an indirect correlation between the size of ENPs and their 
uptake. This is concordant with other studies which reported greater uptake of the larger 
ENPs compared with the smaller ones and argued the 100-200nm to be the optimum size 
for ENPs internalisation [Win et al (2005)]. This can be attributed to the heavy 
aggregation of the 20nm sized COO-PS-NPs observed in the LHC-9 SFM. 
As mentioned above, the cellular uptake of ENPs has been hypothesized to be 
active process in which the cell membrane surrounds the ENPs to engulf them [Gao et al 
(2005)]. The size characterisation of COO-PS-NPs by DLS has revealed significant size 
changes in the 20nm COO-PS-NPs (Fig. 3.9) due to significant aggregation (i.e. 
size/diameter augmentation) at 37˚C in the LHC-9 cell culture media compared with the 
100nm ones that showed less agglomeration. Consequently, the aggregated 20nm COO-
PS-NPs in LHC-9 would yield larger sized COO-PS-NPs (Fig. 3.9 C taken by TEM) that 
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require more time and energy to be enclosed by the membrane and engulfed into the cells 
resulting therefore in lower uptake into BEAS-2B cells compared to 100nm ones. This 
would explain the low amount of the 20nm COO-PS-NPs in comparison to the 100nm 
COO-PS-NPs at equivalent concentration and exposure time. 
For investigating the COO-PS-NPs uptake into BEAS-2B cells using CLSM, 
cells were incubated individually with either 25 or 150 cm
2
/ml of the 20nm and 100nm 
COO-PS-NPs in a time course study. The high concentration of COO-PS-NPs (300 
cm
2
/ml) was not used in cell treatment for imaging in order to avoid the potential of 
saturation during uptake process. The first thing observed was that COO-PS-NPs did not 
cause obvious alterations in the morphology of BEAS-2B cells even after incubation for 
24h (Fig. 4.2) for example: condensed chromatin or membrane blebbing –both features of 
apoptosis. These data are in agreement with the cell viability studies (chapter 5). 
Furthermore, confocal images (incorporated in Fig. 4.2) showed COO-PS-NPs 
accumulation that seems to be mainly inside the BEAS-2B living cells that were washed 
with PBS to remove the membrane-attached (non-internalised) particles before imaging. 
Although, quantification of the nanoparticles by cell section scan was not performed, the 
intracellular uptake of both sizes of COO-PS-NPs could be observed as they appear to 
accumulate inside cells in a proportional way to the concentrations used and to the 
incubation time. It is unlikely that these are plasma membrane-bound COO-PS-NPs 
considering the negative potential of cell membrane and the electrostatic repulsion that 
would occur between the cell and the anionic COO-PS-NPs unless they were neutralized 
after being coated with protein. Moreover, both size of the 20nm and 100nm red 
fluorescent COO-PS-NPs were internalised into BEAS-2B cells at low concentration 
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(25cm
2
/ml) and could be easily identified inside cells as early as 45 minutes after 
incubation (Fig. 4.2). In addition, it is also apparent that the uptake of the 100nm COO-
PS-NPs was more rapid than that observed for the 20nm sized COO-PS-NPs which tend 
to be limitedly internalised possibly due to their heavy aggregation tendency in cell 
culture media (LHC-9) that has been observed and characterised by DLS. This is also 
agrees with the flow cytometry results. It seems that the 100nm COO-PS-NPs 
nevertheless have found a pathway to escape the plasma membrane and get access to the 
interior of the cells probably using a non-endocytotic mechanism since endocytosis is 
limited to the uptake of objects that have dimensions of less than 80nm [Joris et al 
(2013)]. The microscopic images obtained by CLSM technique for live BEAS-2B cells 
(Fig. 4.2) are consistent with the flow cytometry results (Fig. 4.1) even if flow cytometry 
is considered a semi-quantitative analysis that does not discriminate between extracellular 
membrane-bound ENPs and those internalised inside the cell [Oh et al (2010)]. These 
results confirm that the internalisation of COO-PS-NPs was proportional to the 
experimental concentration and incubation time. 
The results obtained by flow cytometry and CLSM were also validated by 
TEM after 24h incubation with 20nm and 100nm COO-PS-NPs (50 cm
2
/ml) at 37
º
C.  
Albeit it is fairly difficult to distinguish between some spherical cellular structures (such 
as vesicles) and the polymer-based ENPs of the same size range since they are electron 
lucent spherical-like nanoparticles [Mühlfeld et al (2007)], the results verified the uptake 
of the COO-PS-NPs of 20nm and 100nm size into the BEAS-2B cells as they were found 
(to appear as bright objects) into the cytoplasm, possibly in vesicles, but not in the 
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nucleus of BEAS-2B cells (Fig. 4.3). These COO-PS-NPs would appear as white dots (or 
small vesicles-like shape) since they are not heavy dense metals [Ng et al (2010)]. 
Furthermore, the COO-PS-NPs co-localisation with some sub-cellular 
components, including the nucleus, the mitochondria and the Golgi apparatus, were 
monitored by CLSM using organelle specific colored-dyes. The CLSM images showed 
that the 20nm sized red fluorescent COO-PS-NPs (of the 20 and COO-PS-NPs) were not 
found inside the nucleus (Fig. 4.5 A) and this would point at the difficulty for COO-PS-
NPs to go through the nuclear membrane. There was some evidence that 20nm red COO-
PS-NPs were located within the mitochondria (A of Fig. 4.6 and Fig. 4.7) and inside the 
Golgi just when incubated for 24h (Fig. 4.9 and Fig. 4.10). In contrast, no clear co-
localisation of the 100nm COO-PS-NPs inside the mitochondria (Fig. 4.8 B and D) but 
these 100nm COO-PS-NPs could be seen contained by the Golgi apparatus mostly after 
24h and somewhat after 6h (Fig. 4.11 and Fig. 4.12). 
It is worthy to mention that it has been hypothesized that the cell (line) type 
[Zauner et al (2001), He et al (2010)], incubation time [Win et al (2005)], ENPs 
concentration [Jiang et al (2011)] as well as several ENPs physicochemical 
characteristics including size [Rejman et al (2004)], shape [Chithrani et al (2006)] and 
functional group [Yamamoto et al (2002), Makino et al (2003), Dausend et al (2008), 
Harush-Frenkel et al (2008), Jiang et al (2011)] are all important parameters that 
influence ENPs-cell binding and interaction and therefore the ENPs cellular uptake. In 
this study, the flow cytometry, CLSM and TEM techniques have been used to investigate 
the uptake behavior and co-localisation of different sizes and concentrations of red 
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fluorescent COO-PS-NPs in BEAS-2B cells upon several exposure time points. The 
results have showed that the uptake of the COO-PS-NPs has increased in general with 
increasing the concentration and time of incubation, however, the internalisation of larger 
size (100nm) COO-PS-NPs is higher than the small sized (20nm) ones at equivalent 
concentration used (in cm
2
/ml) and incubation time point. This indicates that the COO-
PS-NPs were internalised into BEAS-2B cells in a size-, concentration- and time-
dependent mode. In all cases, COO-PS-NPs were found to be distributed in the cytoplasm 
and around the nucleus but not inside it. No clear co-localisation of the 100nm red COO-
PS-NPs was observed in the mitochondria (Fig. 4.8 B and D) while some of the 20nm red 
COO-PS-NPs were colocolised in the mitochondria (A of Fig. 4.6 and Fig. 4.7). 
Regarding the co-localisation inside the Golgi apparatus, the 20nm red COO-PS-NPs 
were found in the Golgi only when after 24h (Fig. 4.9 and Fig. 4.10) whereas the 100nm 
COO-PS-NPs  could be seen in the Golgi apparatus mostly after 24h and to some extent 
after 6h (Fig. 4.11 and Fig. 4.12). 
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5.1 Introduction 
The emerging use of ENPs in various applications due to their distinctive 
properties has focused attention on, and raised the concern of, possible harmful 
interactions with biological systems and their possible toxicological consequences. As 
part of this, it is essential to investigate the mechanisms of toxicity of ENPs using in vitro 
system to enable better risk assessment to be undertaken. This includes an assessment of 
both their long and short term cytotoxicity as well as their potential genotoxicity. In fact, 
several in vivo and in vitro studies have confirmed the toxicity of different ENPs in 
various cell lines including amino-modified polystyrene nanoparticles (NH-PS-NPs) in 
mouse leukaemia monocyte macrophages (RAW 264.7) and normal human bronchial 
epithelial cells (BEAS-2B) cells [Xia et al (2008)], zinc oxide nanoparticles (ZnO-NPs) 
and titanium dioxide (TiO2-NPs) in human skin fibroblast cells [Dechsakulthorn et al 
(2007)], multi-wall carbon nanotubes (MWCNT) in A3 and human lung mesothelioma 
(MSTO-211H) cells [Hu et al (2010)] as well as starch-coated Ag-NPs in U251 cells 
[AshaRani et al (2009)]. Several techniques can be utilized to investigate cell morphology 
and viability at the cellular and molecular levels following exposure to ENPs including 
MTT assay, ROS analysis, cytokine release test in addition to exploring their cellular 
uptake and sub-cellular co-localisation through cell-stain microscopy imaging [Lai et al 
(2013)]. In this study, the cyto-toxicological effects of COO-PS-NPs in human bronchial 
epithelial cells (BEAS-2B) were evaluated by investigating the cell viability by MTT test 
and examining the oxidative stress status of cells (production of ROS and GSH 
depletion), while the genotoxicity was studied using the comet assay to detect the DNA 
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strand breaks. In addition, the possible mechanism(s) of action was investigated to begin 
to understand the cellular pathways of toxicity caused by COO-PS-NPs. 
Reactive oxygen species (ROS) are transient free radicals that are chemically 
highly reactive and contain oxygen [Jefferies et al (2003)]. Examples of ROS include 
superoxide anions (O2
•‾
), hydroxyl radical (OH
•
) and peroxy radical (ROO
•
) in addition to 
the non-radical species hydrogen peroxide (H2O2) that is considered a ROS [Halliwell 
(1999), Waris et al (2006), Genestra et al (2007), Rigas et al (2008)]. Endogenous ROS 
are produced at low concentrations [Zhang and Gutterman (2007)] as natural byproducts 
of several aerobic cellular metabolism processes (e.g. the electron transport chain) 
[Boveris and Chance (1973)]. They can play a role in gene regulation and intracellular 
signal transduction process in the cell by acting as second messengers including 
regulation of apoptosis [Valko et al (2006)]. It has been reported that elevated levels of 
ROS, in response to various chemical stimuli and physical stresses, can activate several 
mitogen-activated protein kinase (MAPK) family that are involved in the regulation of 
cellular survival and adaptation processes including gene expression, proliferation, 
differentiation, protein synthesis and programmed cell death (apoptosis) [Chang and 
Karin (2001), Kyriakis and Avruch (2001)]. 
Under normal circumstances, cells are in equilibrium state where ROS are 
maintained at low levels by cellular defensive antioxidant systems [Mohora et al (2009)]. 
For example, H2O2 is detoxified to H2O and O2 either by the action of glutathione 
peroxidase in mitochondria or catalase in peroxisomes (in cytosol) [Mohora et al (2009)]. 
Excessive uncontrolled ROS overproduction and/or failure to maintain and stabilize the 
balanced level of ROS by defensive anti-oxidant mechanisms can disrupt the reduction-
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oxidation (redox) equilibrium status resulting in abnormal ROS accumulation within the 
cell in a way that exceeds the cellular defensive antioxidant capacity. Abnormal ROS 
accumulation may cause toxic effects that result in cell death owing to damage of wide 
range of biological molecules (such as DNA, protein and lipids) and cellular organelles 
(such as mitochondria, that might suffer mitochondria membrane permeability transition) 
[Magder (2006), Marquis et al (2009)]. 
It has been observed that direct ENPs-mitochondria interaction can damage the 
inner membrane of mitochondria disrupting the electron transport chain (of the oxidative 
phosphorylation) due to deregulation of the redox potential of this mitochondria 
membrane [Soenen et al (2011)]. Mitochondrial membrane damage might induce 
production of ROS and this has been related to cationic PS-NPs concentration-dependent 
cytotoxicity [Xia et al (2006)]. ENPs-induced ROS production has been suggested to 
cause cellular cytotoxicity since these ROS, if excessively produced but not effectively 
buffered, can react with and damage cellular bio-molecules including lipid, DNA and 
protein causing lipid peroxidation, DNA damage and protein oxidation respectively 
[Lewinski et al (2008)]. This study has demonstrated (chapter 4) that COO-PS-NPs were 
at least partially colocalised in the mitochondria and it was essential therefore to 
investigate whether this can cause cellular ROS generation and depletion of intracellular 
GSH in BEAS-2B cells resulting in oxidative stress induction. In addition, ENPs cellular 
internalisation is an important requirement for their biomedical use as drug delivery 
molecules however, they should not cause severe or complicated effects on targeted cells 
[Soenen et al (2011)]. Therefore, the biological impacts related to time of exposure to 
COO-PS-NPs in BEAS-2B cells were investigated in this study in addition to the 
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cytotoxicity effects of their size and concentration as well. Further investigations of other 
cellular parameters to explore possible toxicological effects of COO-PS-NPs were 
conducted and endpoints measured included cell viability assessment by MTT assay, 
ROS generation analysis, depletion of intracellular GSH, DNA damage detection by 
comet assay, caspase-3/7 activation and probable role of calcium in COO-PS-NPs 
induced cell death. Moreover, mechanistic studies in cell free systems were also 
undertaken and we present evidence that COO-PS-NPs are able to directly bind to free 
GSH in solution and that this is the mechanism of cellular depletion of GSH. 
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5.2 Results 
5.2.1 Cytotoxicity assessment 
5.2.1.1 Evaluation of cell viability by MTT assay 
BEAS-2B cell were cultured and incubated with different concentrations of 
COO-PS-NPs for various time points (1, 4, 6, 18 and 24h) before cell viability was 
assessed by the MTT assay [Mosmann (1983)] to investigate possible cytotoxicity of 
COO-PS-NPs. Cell viability was expressed as a percent as compared to the control 
(untreated cells). 
Statistical analysis (multiple regression) was undertaken using SPSS to predict 
cell viability from size, concentration and time. The results revealed that the viability of 
cells is dependent on concentration (p < 0.05) and time (p < 0.05) but independent from 
size (p > 0.05). This means that time of incubation and concentration of COO-PS-NPs 
(but not size of COO-PS-NPs) can affect the cell viability indicating a relationship 
between exposure time and COO-PS-NPs concentration in changing the viability of 
BEAS-2B cells treated with COO-PS-NPs. The multiple regression model with all three 
predictors, i.e. independent variables, predicted the viability of BEAS-2B cells F(3, 428) 
= 4.414, p < 0.05, R
2
 = 0.023. The model to predict the viability of treated cells is: 
Viability = 0.965 + 0.01 size + 0.013 time – 0.024 concentration. 
The results (Fig. 5.1) showed a significant decline in viability of BEAS-2B 
cells (related to mitochondrial activity) when treated with 20nm COO-PS-NPs only at the 
concentration of 300cm
2
/ml in a time-dependent manner. Apart from that, the results 
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clearly show that all other concentrations (25 and 150 cm
2
/ml) of the 20nm sized COO-
PS-NPs and all concentrations (25, 150 and 300 cm
2
/ml) of the 100nm sized COO-PS-
NPs investigated had no effect on cellular viability of BEAS-2B cells over time as 
assessed by the MTT assay. Interestingly, they resulted in a slight increase in 
mitochondrial activities of BEAS-2B cells which might indicate enhanced cell growth. 
 
 
 
 
 
Chapter 5                                                                                               Cell Toxicity and mechanism of action 
 
 
149 
0
20
40
60
80
100
120
140
1 4 6 12 18 24
C
e
ll
 V
ia
b
il
it
y 
(%
)
Time (h)
Treatment with 20nm COO-EPNPs at concentration of 25 cm²/ml Treatment with 20nm COO-EPNPs at concentration of 150 cm²/ml
Treatment with 20nm COO-EPNPs at concentration of 300 cm²/ml Treatment with 100nm COO-EPNPs at concentration of 25 cm²/ml
Treatment with 100nm COO-EPNPs at concentration of 150 cm²/ml Treatment with 100nm COO-EPNPs at concentration of 300 cm²/ml
 
Fig. 5.1 MTT assay were performed at different time points (as specified in materials and method, see section 2.5) to evaluate the viability 
of BEAS-2B cells after exposure to different concentrations of COO-PS-NPs. Data show that the viability of BEAS-2B cells was decreased 
only after 24h treatment with 20nm COO-PS-NPs at 300cm
2
 whereas all the other treatments with different concentrations of this 20nm 
sized and the 100nm sized COO-PS-NPs treatments did not significantly influence the viability of BEAS-2B cells at any time point. 
Investigated measurements of at least 3 samples (n=3) with triplicate were recorded and the error bars represent the standard error of the 
mean (± SEM) although they were small and could not be seen on the graph. 
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5.2.1.2 Investigation of the oxidative stress markers 
5.2.1.2.1 Induction of ROS by COO-PS-NPs 
ROS is a key factor in both cellular toxicity and apoptosis and excess 
generation of ROS can trigger changes in mitochondrial membrane permeability and 
damages the respiratory chain, and thus induces apoptosis [Jezek et al (2005), Valko et al 
(2006)]. In the current study, 2',7'-dichlorodihydrofluorescein diacetate (H2DCF-DA), 
were used to quantify ROS level in BEAS-2B cells after exposure to COO-PS-NPs to 
assess possible ENPs-mediated ROS-production. In the current study, ROS generation 
(assessed by H2DCF-DA oxidation) in BEAS-2B cells was investigated at different 
incubation times (1, 4, 6, 12, 18 and 24h) with a range of concentrations (25, 150 and 
300cm
2
/ml) of 20nm and 100nm sized COO-PS-NPs. 
The results of multiple regression conducted using SPSS demonstrated in the 
model that only time of incubation (p < 0.05) can affect the ROS generation in BEAS-2B 
cells whereas COO-PS-NPs concentration (p > 0.05) and size (p > 0.05) did not influence 
ROS level. The multiple regression model with all three predictors, i.e. independent 
variables, predicted the ROS production in BEAS-2B cells F(3, 144) = 5.286, p < 0.05, 
R
2
 = 0.099. The multiple regression equation of ROS generation upon incubation time, 
concentration and size of COO-PS-NPs is: 
ROS level = 23.162 + 13.08 concentration + 13.614 time – 1.918 size 
However, Microsoft Excel 2010 was used to run the standard t-test (i.e. 
independent sample) and the results showed a significant difference in ROS production 
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level only after 24 hours of cell exposure to 300cm
2
/ml of 20nm- and 100nm-sized COO-
EPSNPs with a two-tailed p value (=0.00015478) <0.05. 
The results of the experiment (Fig. 5.2) revealed that ROS generation did not 
change significantly when cells were exposed to different concentrations of 20nm and 
100nm COO-PS-NPs at any time point except after 24h of incubation where the 
intracellular ROS level increased significantly with increasing concentration of the 20nm 
COO-PS-NPs. The highest generated ROS level in BEAS-2B cells was after incubation 
with 300cm
2
/ml of the 20nm sized COO-PS-NPs for 24h while the 24h treatment of 
BEAS-2B cells with 150cm
2
/ml of the 100nm sized COO-PS-NPs produced more ROS 
compared to other concentrations of the 100nm sized COO-PS-NPs used. Moreover, only 
the 18 and 24h treatment with the 20nm COO-PS-NPs at 150cm
2
/ml and 300cm
2
/ml 
significantly increased the ROS level compared to the non-treated cells whereas the other 
time points of incubation have no significant effect on ROS level. This would indicate 
that short-time exposure (<18h) may have no effect on the ROS production. 
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Fig. 5.2 ROS generation (assessed by H2DCF-DA) did not change significantly overtime in cells exposed to different concentrations of 
20nm and 100nm COO-PS-NPs except after 24h where steady increase in ROS can be seen with increasing the concentration of the 20nm 
COO-PS-NPs. Incubation of BEAS-2B cells with 300cm
2
/ml of the 20nm COO-PS-NPs for 24h caused the highest ROS generation among 
other different treatments. Size of COO-PS-NPs and concentration used for treatment did not cause significant differences in ROS levels 
within one particular time of incubation. Measurements of at least 3 samples (n=3) were recorded and the error bars on the graph represent 
the standard error of the mean (± SEM). 
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5.2.1.2.2 Depletion of intracellular GSH 
GSH is an important cellular antioxidant that plays a significant role in ROS 
detoxification [Green et al (2006)]. Therefore, intracellular GSH levels following 
treatment for 24h with different concentrations of the two sized COO-PS-NPs were 
measured to investigate another parameter related to oxidative stress that might be altered 
in cells. 
Multiple regression analysis was conducted to predict the average of 
intracellular GSH from the concentration and size of COO-PS-NPs. The results showed 
that the GSH depletion in COO-PS-NPs treated cells depends on both of the predictor 
variables, the concentration and size of COO-PS-NPs, as each of them is significant (p < 
0.05). The multiple regression model with both predictor variables, i.e. independent 
variables, predicted the GSH in BEAS-2B cells F(2, 77) = 408.267, p < 0.05, R
2
 = 0.914. 
The model to predict the intracellular GSH is: 
Intracellular GSH = 0.722 + 0.073 size – 0.235 concentration 
The results demonstrated that different concentrations of 20nm and 100nm 
sized COO-PS-NPs (ranging from 25 - 300 cm
2
/ml) caused significant decreases in the 
total levels of GSH after 24h incubation. As can be seen (Fig. 5.3), increasing the 
concentrations of the 20nm and 100nm COO-PS-NPs resulted in a concentration-
dependent reduction in GSH. There was a sharp decline in GSH level when BEAS-2B 
cells were treated with 75cm
2
/ml of the 20nm COO-PS-NPs followed by a more gradual 
decline in GSH levels as the concentration of COO-PS-NPs was increased to the highest 
concentration of 300cm
2
/ml. The GSH depletion caused by treatment with the 20nm 
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COO-PS-NPs was statistically significantly greater than that resulting from the 100nm 
COO-PS-NPs at equivalent concentrations. 
The intracellular GSH levels were plotted against the percentage of ROS 
generation in BEAS-2B cells after 24h treatment with different concentrations (0, 25, 150 
and 300 cm
2
/ml) of 20nm and 100nm COO-PS-NPs (Fig. 5.4). The non-treated cells 
(negative control) have had the highest GSH level with the lowest ROS level and 
increasing the concentration of COO-PS-NPs resulted generally in a gradual increase of 
the ROS level associated with a steady decrease in the GSH level. Nonetheless, a 
significant sharp increase in ROS production was observed when cells were incubated 
with 300cm
2
/ml of the 20nm COO-PS-NPs for 24h. Cells incubated for 24h with 
different concentrations of the100nm COO-PS-NPs behaved similarly however the 
highest ROS level was at 150cm
2
/ml. 
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Fig. 5.3 This graph shows the depletion of intracellular level of GSH in BEAS-2B cells by COO-PS-NPs treatment for 24h. GSH level was 
depleted with increasing the concentrations of 20nm and 100nm of COO-PS-NPs as both caused gradual decline in GSH level with 
increasing the concentration of the treatment doses. Interestingly, there was a sharp drop in the cellular GSH content when cells were 
incubated with the 75 cm
2
/ml of the 20nm COO-PS-NPs before retaining a more gradual decline. Measurements of four samples (n=4) 
were recorded and the error bars on the graph represent the standard error of the mean (± SEM). 
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Fig. 5.4 The intracellular GSH levels plotted against the ROS generation in BEAS-2B cells exposed for 24h to different concentrations (0, 
25, 150 and 300 cm
2
/ml) of 20nm and 100nm COO-PS-NPs. The GSH level was the highest in the untreated cells while ROS level was the 
lowest and in general increasing the concentration of COO-PS-NPs resulted in rise of the ROS level accompanied with decline of the GSH 
level. In cells treated with 20nm for 24h, there were gradual increase in ROS generation and steady decrease in GSH before a sharp 
increase in ROS production occurred when cells were exposed to 300cm
2
/ml. Likewise, cells treated with 100nm COO-PS-NPs for 24h 
followed similar pattern however the highest ROS level was at 150cm
2
/ml. 
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5.2.1.3 Induction of DNA strand breaks 
DNA single strand breaks as assessed by the comet assay were investigated by 
incubating BEAS-2B cells with increasing concentrations (25 and 150cm
2
/ml) of the 
20nm and 100nm COO-PS-NPs as detailed in the General Materials and Methods (see 
section 2.8) and the results were compared to control sample (i.e. untreated cells). 
Furthermore, the comet assay was used to assess the ability of the COO-PS-NPs to cause 
DNA strand breaks in BEAS-2B cell lysate as well as in cell suspension. The cell lysate 
treatments and the assays procedures carried out in this experiment were detailed in the 
General Materials and Methods (section 2.8.2). 
SPSS was used to perform multiple regression analysis to predict the DNA 
damage in COO-Ps-NPs treated cell from size and concentration. The results showed that 
the DNA strand breaks is dependent on both ENPs concentration (p < 0.05) and size (p < 
0.05) which means that both of the independent variables can affect the DNA damage in 
COO-PS-NPs treated cells. The multiple regression model with the two predictors 
produced the DNA strand breaks in BEAS-2B cells F(2, 17) =67.152, p < 0.05, R
2
 = 
0.888. The model to predict the DNA strand breaks is: 
DNA damage = 1.877 + 20.727 concentration – 5.695 size 
The results of the comet assay (Fig. 5.5) show an increase in the number of 
DNA damaged cells after 24h treatment with 20nm and 100nm COO-PS-NPs in 
comparison to untreated controls. Furthermore, the amount of DNA damage was 
concentration-dependent and treatment with 150cm
2
/ml resulted in more DNA damages 
than treatment with 25cm
2
/ml of the same sized COO-PS-NPs. Regarding the DNA 
  
 
Chapter 5                                                                        Cell Toxicity and mechanism of action 
 
 
 
158 
damage measured in cell lysate and cell suspension at corresponding concentration (25 
and 150cm
2
/ml) of the 20nm COO-PS-NPs, the results revealed a lack of DNA strand 
breaks compared to that produced in cultured BEAS-2B cells (Fig. 5.6). Hence, this 
means that the DNA damage observed is real and not a result of the particles interfering 
with the comet assay that has been reported in some types of ENPs. The effect of the 
20nm COO-PS-NPs on cell lysate and cell suspension have been investigated as these 
small sized ENPs caused more significant DNA injury compared with their 100nm 
counterparts at equivalent concentrations. 
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Fig. 5.5 Induction of DNA strand breaks as assessed by comet assay following 24h treatments of BEAS-2B cells with 25 and 150cm
2
/ml of 
the 20nm and 100nm sized COO-PS-NPs.  Results were expressed as tail intensity (percentage of DNA breaks in tail) of damaged BEAS-
2B cells (at least 100 cells were counted in each sample). Significant difference can be seen in the comet tail intensity between different 
treatments of the same sized nanoparticles. Measurements of four samples (n=4) were recorded and the error bars on the graph represent 
the standard error of the mean (± SEM). 
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Fig. 5.6 This graph shows the DNA strand breaks detected by comet assay after various treatments with 25 and 150cm
2
/ml of the 20nm and 
100nm sized COO-PS-NPs expressed as the tail intensity (percentage of DNA breaks in tail) of damaged DNA in BEAS-2B cells, cell 
suspension and cell lysate (at least 100 cells were counted in each sample). There was significant difference in the comet tail intensity 
between the 24h treatment of whole BEAS-2B cells and the other different treatments of the same sized COO-PS-NPs. Nonetheless, no 
considerable variations were observed between the other treatments compared to each other or to the control. Measurements of three 
samples (n=3) have been recorded and the error bars represent the standard error of the mean (±SEM). 
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5.2.2 Possible role of calcium in COO-PS-NPs mediated cytotoxicity 
5.2.2.1 Assessment of COO-PS-NPs influenced cell viability after treatment with 
BAPTA 
Ca
2+
 is an important second messenger that is involved in regulation of several 
cellular processes including cell death since elevation of cytoplasmic calcium level can 
activate and accelerate this mechanism [Nicotera et al (1992)]. In this study, BEAS-2B 
cells were pretreated for 1h with 5µM BAPTA-AM (calcium chelator) before treatment 
with a single concentration of COO-PS-NPs for 24h and cell viability was then assessed 
by the MTT assay. 
Statistical analysis (multiple regression) was carried out using SPSS to predict 
viability of cell pretreated with BAPTA-AM from NPs’ size, concentration and BAPTA 
treatment. Statistical analysis (multiple regression) was carried out using SPSS to predict 
viability of cell pretreated with BAPTA-AM from NPs’ size, concentration and BAPTA 
treatment. The results revealed that the viability of cells is dependent on size (p < 0.05) 
and BAPTA treatment (p < 0.05) but independent from concentration (p > 0.05). This 
means that size of COO-PS-NPs and pretreatment with BAPTA (but not concentration of 
COO-PS-NPs) can affect the cell viability indicating a relationship between BAPTA 
pretreatment and size of COO-PS-NPs used for post-treatment of cells in changing the 
viability of BEAS-2B cells. The multiple regression model with all three predictors, i.e. 
independent variables, predicted the viability of BEAS-2B cells F(3, 216) = 29.29, p < 
0.05, R
2
 = 0.289. The model to predict the viability is: 
Viability = 0.951 + 0.021 size – 0.006 concentration – 0.124 BAPTA pretreatment 
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Likewise, independent sample t-tests performed using Microsoft Excel 2010 
have showed significant differences in the viability of BEAS-2B cells treated with the 
20nm-sized COO-EPSNPs only compared to cells pre-exposed to 5µM BAPTA-AM for 
1h except at the 300cm
2
/ml with two-tailed p values <0.05. In contrast, excluding at the 
300cm
2
/ml, no significant differences were indicated in the viability between cells 
exposed first to BAPTA-AM for 1h at ahead of a treatment with 100nm-sized COO-
EPSNPs and cells presented purely to the 100nm-sized COO-EPSNPs for 24h with two-
tailed p values >0.05. 
This would mean that the 1h 5µM BAPTA-AM pretreatment could 
significantly affect the viability of BEAS-2B cells when treated with the 20nm-sized 
COO-PS-NPs (Fig. 5.7) since this caused a considerable decrease in the MTT reduction 
of BEAS-2B cell in comparison to cells exposed only to 20nm COO-PS-NPs.  On the 
other hand, this 1h pre-exposure to 5µM BAPTA-AM could not significantly affect the 
cell viability treated with the 100nm-sized COO-EPSNPs (Fig. 5.8). 
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Fig. 5.7 The MTT assay showed that the 1h pretreatment with BAPTA-AM (5µM) followed by 24h exposure to 20nm sized COO-
PS-NPs (ranged 50 -300 cm2/ml) caused a reduction in the viability of BEAS-2B cells in comparison with the 24h exposure to COO-
PS-NPs at their own. Measurements of five samples (n=5) were recorded and the error bars on the graph represent the standard error 
of the mean (± SEM). 
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Fig. 5.8 The MTT assay results revealed that the viability of BEAS-2B cells pre-exposed to BAPTA-AM (5µM) for 1h followed by 24h 
treatment with 100nm sized COO-PS-NPs (ranged 50 -300 cm
2
/ml) was significantly decreased compared the 24h treatment solely with 
equivalent concentrations of COO-PS-NPs. Measurements of five samples (n=5) were recorded and the error bars on the graph represent 
the standard error of the mean (± SEM). 
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5.2.2.2 Measurement of COO-PS-NPs induced ROS level after treatment with 
BAPTA 
The same treatments used for investigating the role of Ca
2+
 on the cell viability 
(as assessed by the MTT assay) were also used to evaluate the possible effect of Ca
2+
 on 
ROS production in BEAS-2B cells following individual exposure to two different 
concentrations (75 and 150cm
2
/ml) of 20nm and 100nm COO-PS-NPs for 24h preceded 
by 1h treatment with BAPTA-AM (5µM). The results (Fig. 5.9) demonstrated significant 
differences in the ROS generation caused in cells treated only with COO-PS-NPs for 24h 
and that caused in cells pretreated with BAPTA-AM (5µM) for 1h before 24h treatment 
with COO-PS-NPs (of 20nm and 100nm) at equivalent concentration (of 75 and 
150cm
2
/ml). It showed that 1h pretreatment with BAPTA-AM statistically and 
significantly increased the ROS generation before treatment with COO-PS-NPs 24h 
compared to the 24h treatment with COO-PS-NPs only. 
Three independent variables (that are BAPTA, size and concentration of COO-
PS-NPs) were involved in multiple regression analysis using SPSS to predict ROS 
generation in BEAS-2B cells. The results revealed that the viability of cells is dependent 
on size of COO-PS-NPs (p < 0.05) and BAPTA (p < 0.05) but independent from 
concentration (p > 0.05). The multiple regression model with all three independent 
variables predicted the level of ROS in BEAS-2B cells F(3, 36) = 10.028, p < 0.05, R
2
 = 
0.455. The model to predict the ROS is: 
ROS = 43.598 + 3.695 BAPTA + 0.003 concentration – 0.111 size 
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Fig. 5.9 The results showed that ROS generated in cells pretreated with BAPTA-AM for 1h before being exposed to COO-PS-NPs for 24h is 
significantly increased in comparison to ROS generated in cells exposed for 24h only to same sized COO-PS-NPs (at corresponding concentration). 
ROS generation seems to be stimulated by the BAPTA-AM pretreatment. Measurements of four samples (n=4) were recorded and the error bars on the 
graph represent the standard error of the mean (± SEM). 
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5.2.3 Induction of caspase-3/7 activity by COO-PS-NPs 
Activation of caspases-3 and -7 is an important event in apoptosis that results 
in irreversible commitment to cell death [Cullen and Martin (2009)]. Thus, measurement 
of the activity of the caspases-3/7 was conducted to investigate whether COO-PS-NPs 
induced cell death involves activation of caspases or not. The results (Fig. 5.10) revealed 
that only the 24h treatment with the 20nm sized COO-PS-NPs resulted in significant 
caspases-3/7 activation. 
Multiple regression was performed as a statistical analysis by SPSS to predict 
the caspases-3/7 activity using size and concentration of COO-PS-NPs. The results 
showed that the caspases-3/7 activation in BEAS-2B cells is significantly dependent on 
the size of COO-PS-NPs (p < 0.05) but not on their concentration (p > 0.05). This means 
that only the size of COO-PS-NPs influences the activation of caspases-3/7 in BEAS-2B 
cells treated with COO-PS-NPs. The multiple regression model with the two independent 
variables predicted the caspases-3/7 activity in BEAS-2B cells F(2, 162) = 5.922, p < 
0.05, R
2
 = 0.068. The model to predict the activation of caspases-3/7 is: 
Caspases-3/7 activity = 3287.278 + 33.268 concentration - 337.447 size. 
A 
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Fig. 5.10 BEAS-2B cells were incubated for 1hr with the caspase reagent following treatment with different concentrations (25-300cm
2
/ml) 
of 20nm and 100nm COO-PS-NPs for 24h or with Etoposide (as +Ve control) for 2h before measuring the luminescence. Compared to the 
negative control sample, the results showed that only the 20nm sized COO-PS-NPs significantly activated caspases-3/7 in BEAS-2B cells 
in a concentration-dependent manner (to some extent) while the 24h treatment with the 100nm COO-PS-NPs did not cause caspases-3/7 
activation. Measurements of at least five samples were recorded and the error bars represent the standard error of the mean (± SEM). 
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5.2.4 Depletion of the GSH by COO-PS-NPs in cell-free systems 
ENPs are known to adsorb and bind proteins and other bio-molecules in 
biological fluids forming a corona [Lundqvist et al (2008), Cedervall et al
b
 (2007)]. 
Results of a previous experiment in this chapter of current study have shown a depletion 
of the intracellular GSH content after 24h incubation of BEAS-2B cells. Consequently, it 
was of interest to investigate whether the mechanism of GSH depletion was due to 
detoxification of the COO-PS-NPs generated ROS or due to a direct physical interaction 
between COO-PS-NPs and GSH molecules. This was performed in cell-free systems 
where GSH compound (final concentration of 3.25µM) were left alone in one tube or 
mixed well with single concentration (25 or 150 cm
2
/ml) of the 20nm or 100nm sized 
COO-PS-NPs in another tube before all being incubated on ice for 1hr. The GSH level 
was then measured in these solutions as detailed in the General Materials and Methods 
(section 2.12.1). 
Statistical multiple regression analysis was conducted using SPSS to predict 
cell GSH level from size and concentration of COO-PS-NPs. The results demonstrated 
that the GSH level in cell-free solutions is significantly dependent on the concentration of 
COO-PS-NPs (p < 0.05) but not on their size (p > 0.05). This means that only the 
concentration of COO-PS-NPs has an impact on the GSH level measured in cell-free 
system. The multiple regression model with the two independent variables predicted the 
GSH level F(2, 57) = 6.718, p < 0.05, R
2
 = 0.191. The model to predict the GSH level is: 
GSH level = 1.042 + 0.009 size – 0.154 concentration. 
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The results (Fig. 5.11) demonstrated that incubation of COO-PS-NPs with 
GSH in cell free solutions resulted in significant COO-PS-NPs concentration-dependent 
decreases in the concentrations of detectable GSH. The GSH content was at high 
concentration (of approximately 1.5µg/ml) in GSH solution but dropped in solutions 
containing GSH mixed with the 20nm sized COO-PS-NPs (at concentrations of 25 and 
150cm
2
/ml to 1.21 and 0.74µg/ml respectively) and in solutions containing GSH mixed 
with the 100nm sized COO-PS-NPs (at concentrations of 25 and 150cm
2
/ml to 1.28 and 
0.83µg/ml respectively). The decline was found to be slightly more in the 20nm COO-
PS-NPs containing solutions than those with 100nm COO-PS-NPs. However, the GSH 
level was higher in these cell-free systems in comparison to the GSH level measured in 
the BEAS-2B cells following 24h treatments with various concentrations (25 and 
150cm
2
/ml) of the 20nm and 100nm COO-PS-NPs.  
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Fig. 5.11 The GSH level was measured (µg) in different cell-free solutions that were composed of GSH compound mixed with individual 
concentration of COO-PS-NPs (20nm or 100nm) at different concentrations (25 and 150cm
2
/ml while the zero concentration represents 
GSH compound only without COO-PS-NPs molecules). The results showed that the GSH level declined in a dose-dependent manner in 
COO-PS-NPs containing cell-free solutions and that the 20nm sized COO-PS-NPs caused more decrease compared to the 100nm at the 
same concentrations. Measurements of four samples (n=4) have been recorded and error bars represent the standard error of the mean 
(±SEM). 
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5.2.5 Evaluation of the GSH level in COO-PS-NPs treated cell lysate 
Because incubation of GSH solutions with COO-PS-NPs in cell-free system 
could decrease the concentration of measurable GSH, it was important to investigate 
whether a similar effect could be observed when COO-PS-NPs were incubated with GSH 
containing cell extracts prepared from BEAS-2B cells. Therefore, BEAS-2B cells were 
cultured for 24h before extracting the lysate that was then exposed to COO-PS-NPs for 
1h and the GSH level was measured in this cell lysate. 
The results illustrated that incubation of cells extracts with both of 20nm and 
100nm sized COO-PS-NPs caused significant decreases in detectable GSH levels in cell 
lysates compare to the non-treated lysate (Fig. 5.12). However, no significant differences 
in GSH level were observed neither between the 20nm and the 100nm COO-PS-NPs used 
for treatment at equivalent concentrations nor between different concentrations of the 
same sized COO-PS-NPs. 
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Fig. 5.12 The GSH level measured in cell lysates treated with 20nm and 100nm COO-PS-NPs at various concentrations (of 25 and 
300cm
2
/ml) for 1h showed significant decreases compared with non-treated lysate. The GSH level decline was not significantly in 
concentration- or size-dependent manner. Measurements of six samples (n=6) have been recorded and the error bars represent the standard 
error of the mean (±SEM). 
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5.3 Discussion 
This study used a range of concentrations (25-300cm
2
/ml) of two different 
sized COO-PS-NPs (20nm and 100nm) to treat BEAS-2B cells for different time points 
(1-24h) before investigating different biological markers related to toxicity. The results of 
MTT assay showed that the 100nm sized COO-PS-NPs were not toxic as assessed by this 
assay at any of the concentrations investigated over the time course. Likewise, the cell 
viability as assessed by MTT assay in BEAS-2B cells treated with low concentrations (≤ 
150cm
2
/ml) of the 20nm sized COO-PS-NPs was not significantly altered following up to 
24h treatment. In contrast, treatment with the 20nm sized COO-PS-NPs at high 
concentration (300cm
2
/ml) caused significant cell death in a time-dependent manner but 
mainly after 24h incubation (Fig. 5.1). Previous literatures that studied the toxicity of a 
variety of nanoparticles on several cell lines have proposed that the toxicological effect of 
nanoparticles depends on the NPs’ composition [Sohaebuddin et al (2010)], NPs’ size 
[(Fröhlich et al
b
 (2012)], NPs’ concentration [Çiftçi et al (2013)] and time of incubation 
[Bottini et al (2006)]. In agreement, the cell viability results of this study indicate that the 
COO-PS-NPs toxicity is particle’s size-, concentration- and time-dependant. This 
concentration-dependent decrease in BEAS-2B cell viability was associated with a 
concentration-dependent elevation of the intracellular ROS level (Fig. 5.2) induced by the 
20nm COO-PS-NPs. In contrast, there was little evidence of ROS formation in cells 
treated with 100nm COO-PS-NPs at any of the concentration investigated. Consequently, 
the cell viability decrease might be attributed to the oxidative stress stimulated by 20nm 
COO-PS-NPs and several previous studies have reported that increased ROS levels is a 
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possible mechanism of toxicity for COO-PS-NPs including induction of programmed cell 
death [(Fröhlich et al
a
 (2012)]. Moreover, the three factors (i.e. incubation time, COO-
PS-NPs’ size and concentration) seem to work altogether to affect the ROS production 
since the ROS level did not change significantly over incubation time in COO-PS-NPs 
treated cells in comparison with the non-treated ones except when incubated with the 
20nm COO-PS-NPs at high concentrations (≥150cm2/ml) for long period of time (≥18h). 
A number of concerns have challenged using this dye for evaluating the intracellular 
redox status change. It has been reported, for instance, that DCF (the oxidized fluorescent 
product) might leach out of cells which lead to underestimation of the oxidative stress 
[Jakubowski and Bartosz (1997)]. Additionally, cytochrome c release from the 
mitochondria during apoptosis has been reported to be a strong oxidative catalyst for 
H2DCF-DA and can result in overestimation of the oxidative stress [Lawrence et al 
(2003)]. Therefore, H2DCF-DA should be carefully used for oxidative stress 
measurements when apoptosis occurs as a result of ENPs exposure. Moreover, this 
possible mitochondrial release of cytochrome c might explain the big ROS resulted at 
high concentration of the 20nm COO-PS-NPs. 
It is well known that GSH has an essential role as a cellular anti-oxidant 
[Jefferies et al (2003)] and that elevated levels of ROS can deplete the intracellular GSH. 
In the current study, cell treatment with both of the 20nm and 100nm sized COO-PS-NPs 
caused GSH status of cells to be reduced in a concentration-dependent manner (as can be 
seen in Fig. 5.3). GSH level was severely dropped at 75cm
2
/ml of the 20nm COO-PS-
NPs after which the GSH level retains the gradual decrease trend down to the high dose 
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concentration of 300 cm
2
/ml. Taken together, our experimental results would suggest that 
the cell toxicity observed is caused by ROS elevated levels in BEAS-2B cells treated with 
high concentrations (300cm
2
/ml) of 20nm COO-PS-NPs accompanied with a decline in 
the intracellular GSH content level as it becomes oxidised in response to NP-induced 
oxidative stress. Continuous ROS generation at high concentration of the 20nm sized 
COO-PS-NPs results in excessive ROS accumulation that would exhaust GSH (and other 
protective factors) and exceed the cellular defensive mechanism leading to the reduced 
cell viability observed. In contrast, cells exposure to the 100nm COO-PS-NPs or to low 
concentrations (≤150cm2/ml) of the 20nm COO-PS-NPs did not significantly reduce cell 
viability because although cells were stressed other sufficient cellular non-enzymatic 
antioxidants (such as vitamin C) might remain in the cell and can hence still counteract 
the damaging effects of ROS and maintain cell viability. Furthermore, DNA damage is 
known to be caused by several stimuli including cellular ROS [Hoeijmakers (2001)] and 
the current study showed that COO-PS-NPs induced ROS generation in BEAS-2B cells 
(as assessed by H2DCF-DA) in a ENPs’ size-dependent manner at a particular time point. 
Taken together, this mean that the 20nm COO-PS-NPs produced higher ROS level than 
the 100nm COO-PS-NPs and this would be the reason that make the 20nm sized COO-
PS-NPs to be more toxic leading to more DNA damages in BEAS-2B cells after 24h 
compared to the 100nm sized COO-PS NPs at the same concentration (of 25 and 
150cm
2
/ml) investigated. Moreover, no significant DNA strand breaks have been 
observed when COO-PS-NPs were individually introduced directly to cell lysate and cell 
suspension (Fig. 5.6) indicating that the DNA damage was not due to direct interaction 
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between COO-PS-NPs and the DNA since both (the DNA and COO-PS-NPs) are 
negatively charged molecules. 
Ca
2+
 has many key roles in cellular functions and it is involved, for example, in 
regulating apoptosis by inducing caspases-3 activation in response to various stimuli 
[Hajnoczky et al (2003), Orrenius et al (2003), Tantral et al (2004)]. Disrupting the 
intracellular Ca
2+
 has been suggested to be a possible mechanism of toxicity of ENPs 
[Xia et al (2008)]. BAPTA (Ca
2+
 chelator) was used therefore to control the cytosolic 
Ca
2+
 activity in BEAS-2B cells and subsequently enable investigating the possible role of 
Ca
2+
 in COO-PS-NPs toxicity. The results of cell viability (as assessed by MTT assay) 
showed that the cell pretreatment with BAPTA-AM did not prevent cell death by the 
20nm COO-PS-NPs after 24h exposure. This would suggest that although Ca
2+
 is 
important in multi cellular functions, but this divalent cation might not fundamentally 
contribute in the COO-PS-NPs-induced cell death mechanism in BEAS-2B cells and that 
other Ca
2+
-independent pathway might be involved in mediating the cytotoxicity, for 
instance via rupture of the mitochondrial transmembrane due to COO-PS-NPs co-
localisation and release of the mitochondrial components such as cytochrome c into the 
cytosol which would hence lead to cell death. It has been stated that increasing the 
intracellular Ca
2+ 
is not crucial for apoptotic mechanism [Kluck et al (1994)] and the 
cellular Ca
2+
 homeostasis disruption has been suggested to be a downstream event that 
takes place at late phase while GSH depletion occurs at earlier stage in oxidant-induced 
cell death [Macho et al (1997)]. In contrast, the exposure of BEAS-2B cells to COO-PS-
NPs (at 20nm) following pretreatment with BAPTA-AM has surprisingly reduced the cell 
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viability even at low (non-toxic) concentrations that did not considerably show any effect 
by their own (Fig. 5.7 and 5.8). BAPTA-AM has been stated to induce apoptosis causing 
death of cultured cells [Kluck et al (1994)]. Moreover, the ROS generation (as assessed 
by the H2DCF-DA assay) was significantly increased by COO-PS-NPs in BAPTA 
pretreated BEAS-2B cells in the current study (Fig. 5.9) and these data would suggest 
that the ROS generation induced by COO-PS-NPs is not triggered by Ca
2+
 but it may 
have some role. 
Caspase-3 and -7 are executioner (effector) caspases and considered major 
mediators for the execution of apoptosis since their activation by initiator caspases (in an 
upstream cascade) is a crucial event to cleave other substrates in a downstream 
proteolytic process that can lead to apoptosis (programmed cell self-destruction) [Cullen 
and Martin (2009)]. Therefore, activation of caspases-3and -7 was assessed in BEAS-2B 
cells following treatment with COO-PS-NPs to investigate their role in decreasing cell 
viability. The results (Fig. 5.10) showed that COO-PS-NPs caused caspases-3/7 
activation in BEAS-2B cells only when treated with 20nm COO-PS-NPs mainly at high 
concentration of 300cm
2
/ml where cell viability was significantly decreased as assessed 
by the MTT assay. This would suggest that the toxicity of the 20nm sized COO-PS-NPs 
in BEAS-2B cells is mediated through the activation of caspases-3/7. This caspases-3/7 
activation caused by the 20nm sized COO-PS-NPs can be attributed to their capability to 
colocalise into the mitochondria as observed by confocal microscopy (see previous 
chapter) and this ability seems to be the reason that makes the 20nm sized COO-PS-NPs 
more toxic than the 100nm counterparts. Such mechanism of caspases-3/7 activation 
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dependent toxicity (that cause cell death) has been observed in different cells when 
treated with small sized ENPs such as amine-modified polystyrene nanoparticles (NH-
PS-NPs) introduced to human brain astrocytoma cells [Bexiga et al (2011)] and to 
macrophages (RAW 264.7) at size of 60nm [Xia et al (2008)] as well as in bronchial 
epithelial (16HBE14o) cells exposed individually to carbon nanoparticles (CB-NPs) at 
size of 13nm and to titanium dioxide (TiO2 NPs) at size of 15nm [Hussain et al (2010)]. 
The levels of GSH in cell-free solutions incubated with COO-PS-NPs (20nm or 
100nm) were measured to investigate whether GSH depletion observed in the COO-PS-
NPs treated BEAS-2B cells was related to detoxification of the COO-PS-NPs induced 
ROS or due to direct interaction between GSH and COO-PS-NPs. The results (Fig. 5.11) 
have shown significant decreases of the GSH levels compared to the solution of GSH 
only (that was in a NPs-free system) and this would reveal possible binding between 
GSH and COO-PS-NPs under certain conditions. It is well-known that GSH is a stable 
tri-peptide molecule with net negative electrical charge on the C-end of the Gly residue 
under physiological pH conditions, however it has a zwitterion (i.e. hybrid ions) on the 
N-end of the Glu residue of its structure [Yan et al (2007)]. This means that the GSH 
would be able to react with acids and bases and thus these GSH molecules might have 
interacted with (and bound to) the negatively charged COO-PS-NPs through the 
zwitterionic surface on the N-terminus forming nanoparticle induced GSH aggregation 
and causing a drop in the GSH level observed in free-cell systems. The GSH level in the 
cell-free systems was inversely correlated with the concentration of the COO-PS-NPs 
used in these solutions (Fig. 5.11). Moreover, the GSH levels in these cell-free systems 
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were generally higher than that in the COO-PS-NPs treated BEAS-2B cells at equivalent 
concentrations since the ROS molecules in the biological system (beside the COO-PS-
NPs) would take part in depleting the GSH level. In addition, there would be some free 
GSH molecules (i.e. COO-PS-NPs boundless GSH molecules) in the cell-free system that 
came from the added GSH compound. Furthermore, there was a drop in the GSH level in 
cell lysate and cell suspension exposed to the 20nm and 100nm COO-PS-NPs (Fig. 5.12) 
which support the findings about the capability of the COO-PS-NPs to bind GSH. 
In conclusion, these experiments show that 24h treatment of BEAS-2B cells 
with the 20nm COO-PS-NPs at high concentrations (300cm
2
/ml) can cause Ca
2+
-
independent generation of ROS, GSH depletion, ROS-mediated oxidative stress and 
DNA damage leading consequently to cell death (mainly apoptosis) that involves 
caspase-3/7 activation. Results would suggest that raising the cytosolic Ca
2+
 do not have 
a direct role in the COO-PS-NPs-induced cell death mechanism in BEAS-2B cells and 
that other cytosolic Ca
2+
-independent pathway seems to be involved in the cytotoxicity of 
the COO-PS-NPs, via mitochondrial damage for example since mitochondria are vital 
organelles for cellular energy production. This can happen as consequence of the COO-
PS-NPs co-localisation into the mitochondria which would have a toxic effect in the cell. 
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6.1 General discussion 
NPs are materials with at least one external nano-scaled dimension (≤100nm) 
and they have increasingly been synthesized and used widely for various applications 
because of their unique physicochemical characteristics. However, they might also cause 
a risk of harmful effects on health and environment as several researches have reported 
that their use can cause cell death through ROS generation and oxidative stress which 
have been suggested to result in NPs-induced apoptosis [Nel et al (2006), De Stefano et al 
(2012)]. Moreover, many global researches are ongoing for further investigations of the 
physicochemical characteristics of ENPs that might help in making it possible to use 
them for other applications. This widespread use of ENPs makes exposure to them 
inevitable and inhalation is the primary potential exposure route of the body making the 
lung a major target for NP-mediated toxicities [Mühlfeld et al (2007)]. The toxicological 
effects of ENPs need consequently to be individually investigated to identify possible risk 
on environment and human health before employing them in medical and other industrial 
applications. 
COO-PS-NPs have potential applications as vehicles for drug delivery, for 
example anti-tuberculosis drug in addition to take part in other wide range of 
applications. It has therefore been recommended that special attention should be paid to 
ENPs designed for drug delivery or for food components and systematic investigations 
[Hoet et al (2004)]. Accordingly, it is of great importance to assess the potential risks of 
COO-PS-NPs to lungs at the cellular level and understand how they would cause their 
biological and toxicological effect. Furthermore, monitoring the uptake and co-
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localisation of these COO-PS-NPs into different organelles would be helpful in 
elucidating the possible role of the physicochemical properties of COO-PS-NPs. This 
study was conducted in vitro (BEAS-2B lung epithelial cells) with a range of 
concentrations (25-300cm
2
/ml) of two different sized fluorescently labelled COO-PS-NPs 
(20nm and 100nm in diameter) to investigate the role of size and concentration on uptake 
and to observe their co-localisation within different cellular compartments with the 
ultimate aim of studying their biological effects. 
MTT assay is widely used technique and considered as an easy, fast and 
powerful colorimetric method to assess the cell viability by evaluating the mitochondrial 
activity of cells [Horie et al (2012)] using the yellow 3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyl-tetrazolium bromide and simple optical density reader machine to yield 
reproducible results. The MTT results in this study showed significant decrease in 
viability of BEAS-2B cells when treated with the 20nm sized COO-PS-NPs only at 
300cm
2
/ml but not after treatment with 100nm sized COO-PS-NPs at any concentration. 
Furthermore, cells appeared morphologically normal by microscopy suggesting that the 
MTT assay was an appropriate measure and indication in this system. However, it has 
been argued that media additives including serum (which might alter the media pH) may 
result in deceptive outcomes about cell viability while the cell number is steady 
[Laaksonen et al (2007)] and that ENPs may interfere with cell viability assays such as 
the MTT assay [Kroll et al (2012)] making it complicated to connect the metabolically 
reduced tetrazolium salts measurement to cellular viability [Marquis et al (2009)]. It 
would have been useful to have another endpoint of cell viability if time would allow 
doing so. 
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PS-NPs have been reported to have high affinity for proteins and have been 
observed to form large aggregates in protein-containing systems [Fröhlich et al
a
 (2012)]. 
The characterisation results of this study have revealed that the 20nm COO-PS-NPs 
(especially at high concentration) tend to aggregate heavily in the cell culture LHC-9 
SFM while their 100nm counterparts were more stable with less agglomeration. Although 
no serum is added to the LHC-9 media, it seems that other protein molecules are present 
in the LHC-9 SFM in addition to proteins produced by the cells in biological systems and 
these proteins caused the COO-PS-NPs (especially the 20nm) to undergo aggregation. 
This yielded COO-PS-NPs with larger size that represents the aggregates more than the 
individual NP and would change their physicochemical characteristics. The lowest 
cellular uptake of COO-PS-NPs was seen after exposure to 25cm
2
/ml and the uptake then 
increased in a concentration-dependent manner (in both of the 20 and the 100nm sized 
COO-PS-NPs) towards the concentration of 150cm
2
/ml as assessed by flow cytometry 
and CLSM (Fig. 4.1 and Fig. 4.2 respectively). This increase attained a plateau at the 
300cm
2
/ml possibly due to saturation status since thermodynamic equilibrium has been 
suggested to control the cellular internalisation of ENPs over time and concentrations 
[Chithrani et al (2006), Zhang et al (2009)]. Images of live BEAS-2B cells by CLSM 
demonstrated rapid COO-PS-NPs uptake into BEAS-2B cells as fluorescent COO-PS-
NPs were easily identified in cells after only 45min incubation. This is consistent with 
findings of a recent study that observed fast cellular uptake of fluorescent COO-PS-NPs 
into the cytoplasm of HEp-2 cells [Hemmerich and Mikecz (2013)]. Nevertheless, BEAS-
2B cells internalised more 100nm COO-PS-NPs than the 20nm ones possibly due to 
aggregation observed in LHC-9 SFM that increased their size. The cellular endocytosis of 
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ENPs has been reported to be an active process that involves surrounding them by the cell 
membrane before internalisation [Gao et al (2005)]. Consequently, the aggregated 20nm 
COO-PS-NPs in LHC-9 would require more time and energy to be enclosed by the 
membrane and engulfed into the cells resulting therefore in lower uptake into BEAS-2B 
cells compared to the 100nm COO-PS-NPs. This would explain the low uptake of the 
20nm COO-PS-NPs in comparison to the 100nm COO-PS-NPs at equivalent 
concentration and exposure time. These data are consistent with findings by Win and 
colleagues who have argued that 100-200nm ENPs are an optimum size for 
internalisation as greater concentration-dependent uptake of the 100 and 200nm sized PS-
NPs by Caco-2 cells was observed compared to small sized (50nm) and large sized (500-
1000nm) ones investigated [Win et al (2005)]. 
Although there was less uptake of the 20nm COO-PS-NPs compared to the 
100nm ones in this study, only these 20nm sized ENPs caused significant death of BEAS-
2B cells after 24h treatment at high concentration (300cm
2
/ml). The images of CLSM 
experiments indicated the presence of small fractions of the 20nm COO-PS-NPs within 
the mitochondria after 24h incubation (Fig. 4.8 A and C) but no evidence of 
mitochondrial co-localisation of the 100nm COO-PS-NPs was clearly observed (Fig. 4.8 
B and D). It is known that mitochondrial changes (at the structure and function levels) 
play an important role in a wide variety of cellular processes including apoptosis [Green 
and Reed (1998)]. These results would therefore suggest that the toxicity of the 20nm 
sized COO-PS-NPs (at 300cm
2
/ml) may be mediated by their partial co-localisation in the 
mitochondria. This co-localisation into the mitochondria might cause the opening of the 
permeability transition pore (PTP) which may consequently result in inﬂux of water and 
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solutes from the cytosol which lead in turn to alteration of mitochondrial 
Ca
2+
 homeostasis, swelling of the mitochondrial matrix and then to the rupture of the 
mitochondrial trans-membrane [Bernardi and Rasola (2007)]. This would be 
accompanied with release of cytochrome c and apoptosis-inducing factor (AIF) from the 
mitochondrial inter-membrane space into the cytosol [Giacomello et al (2007), Pizzo and 
Pozzan (2007)]. Cytochrome c has been suggested to be involved in activating the 
caspase cascade (including caspases-3/7) whereas AIF that translocates in the nucleus can 
contribute in chromatin condensation and DNA fragmentation leading at the end to cell 
death [Zhivotovsky and Orrenius (2011)]. In agreement with this, our results showed that 
the 300cm
2
/ml of the 20nm COO-PS-NPs caused activation of caspases-3/7 in BEAS-2B 
cells (Fig. 5.10) and this would indicate that ROS-mediated caspases activation induced 
in response to the treatment with the 300cm
2
/ml of the 20nm COO-PS-NPs is involved in 
cell death mechanism. 
In addition to the cellular response discussed above, there was a decline in the 
GSH content in cell-free systems following incubation with both 20nm and 100nm COO-
PS-NPs and this would suggest that these negatively charged COO-PS-NPs might be able 
to bind to GSH through the zwitterionic surface on the N-terminus of the Glu residue 
hence reducing their levels in solutions. Similarly, intracellular GSH levels were 
decreased in BEAS-2B cells after incubation with the 20nm and 100nm COO-PS-NPs 
(Fig. 5.3). However, only treatment with the 20nm sized COO-PS-NPs (at high 
concentrations ≥150cm2/ml for long incubation time ≥18h) caused significant increase in 
the intracellular ROS generation (Fig. 5.2). This would propose that the produced ROS 
were not efficiently detoxified by the anti-oxidant system (including GSH and vitamins) 
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and hence excessively accumulated in the cell leading to toxic oxidative stress. The 20nm 
sized COO-PS-NPs seem to be capable of causing DNA damage in BEAS-2B cells 
indirectly by generating ROS but not by direct interaction between DNA and COO-PS-
NPs due to two reasons. Firstly, they could not get direct access to DNA as they were too 
large (due to aggregation in media) to enter the nucleus via nuclear pores and so no 
nuclear co-localisation of COO-PS-NPs were observed although Hemmerich and 
colleagues have reported co-localisation of fluorescent COO-PS-NPs (of 50nm in 
diameter) in the nucleus of Hep-2 cells [Hemmerich and Mikecz (2013)]. Secondly, there 
was lack of DNA strand breaks when COO-PS-NPs were introduced to cell lysate and 
cell suspension (Fig. 5.6) potentially because both the DNA and COO-PS-NPs are 
negatively charged molecules. This toxicity is unlikely be related to metal element 
content since the analysis of major metals such as Cu, Fe and Zn in the COO-PS-NPs 
stock solution sample significantly demonstrated very low concentrations of these 
elements (Fig. 3.12). Moreover, the COO-PS-NPs would undergo dilution by the cell 
culture media and this would make the elements concentrations even smaller compared 
with the stock solution. 
In summary, genotoxic and cytotoxic methodologies were employed to 
investigate the activity of COO-PS-NPs in this study which revealed that the toxicity of 
COO-PS-NPs is size-dependent as the 20nm sized COO-PS-NPs (at 300cm
2
/ml) showed 
more toxic effect than their 100nm sized counterparts in BEAS-2B cells and this was 
consistent with results of other studies used similar COO-PS-NPs [Fröhlich et al
a
 (2012)]. 
The results indicated that the toxicity of the 20nm sized COO-PS-NPs (at 300cm
2
/ml)  in 
BEAS-2B cells after 24h treatment is mediated through mitochondrial co-localisation 
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which caused generation of ROS and GSH depletion leading to oxidative stress, DNA 
damage and consequently to Ca
2+
-independent cell death (mainly apoptosis) that involves 
caspase-3/7 activation. Ca
2+
 is important for multi cellular functions however this study 
indicated that it does not fundamentally participate in the COO-PS-NPs-induced cell 
death mechanism in BEAS-2B cells. In contrast, in vitro exposure to the 100nm COO-
PS-NPs (at all the concentrations investigated) or to low concentrations (≤150cm2/ml) of 
the 20nm COO-PS-NPs did not significantly reduce cell viability. This is because 
although they were taken up by cells and caused oxidative stress however other sufficient 
cellular non-enzymatic antioxidants (such as vitamin C) might remain in the cell and 
could counteract the damaging effects of ROS and hence maintain cell viability. In 
conclusion, 100-200nm has been suggested earlier to be the optimum size for ENPs 
internalisation [Win et al (2005)] and Polymer-based NPs (including PS-NPs) have been 
reported as good drug carrier systems to lungs [Sung et al (2007)]. The results of the 
current study have revealed that the 100nm sized COO-PS-NPs are not toxic to BEAS-2B 
cells at any concentration investigated since they did not cause reduction of viability of 
BEAS-2B cells with higher cellular uptake compared to the 20nm sized ones. This would 
provide a versatile platform that the 100nm COO-PS-NPs can therefore be suitable for 
use as carrier system for drug delivery (e.g. anti-tuberculosis). However, further studies 
should be carried out to attain deeper understanding of the toxicity of COO-PS-NPs after 
the drugs are mounted (conjugated) to them as this conjugation might alter their 
physicochemical properties. 
Since the results and observations of literatures showed differences (and 
sometimes contradictions) in the possible cellular uptake of NPs and the proposed 
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mechanism of toxicity, it seems that several parameters such as cell line, NPs’ size, NPs’ 
concentration, NPs’ type (chemical nature) and incubation time are important factors that 
affect both of the cellular uptake [Davda and Labhasetwar (2002)], the toxicity [Fröhlich 
et al
b
 (2012)] and the cell death mechanism of ENPs [De Stefano et al (2012)]. Some 
studies, for example, have proposed that generation of cellular ROS, GSH depletion and 
toxic oxidative stress are the mechanism of toxicity of various NPs that would involve 
mitochondrial co-localisation and damage [Xia et al (2006), Bhattacharjee et al (2010)]. 
Another study has suggested that the NPs co-localisation in endosomes and lysosomes 
(but not in the mitochondria) is the reason for ROS generation-independent cellular 
damage and death [Fröhlich et al (2009)]. This diversity in the NPs intracellular 
localisation between different cells can be attributed to different endocytotic capabilities 
of these cell lines [Mailänder and Landfester (2009)]. Other factors including ENPs 
administration procedures, dispersion method and processing technique can also 
contribute in affecting the results of ENPs uptake, cytotoxicity and cell death mechanism 
[Lai et al (2013)]. 
Omics are fast growing disciplines that are used to give comprehensive 
information about the biochemical and functional status of a biological system, 
expression of the whole gene as well as the changes caused by chemical compounds 
[Ramirez et al (2013)]. Thus, the use of different omics techniques (including 
transcriptomic and metabolomic endpoints and modern proteomic approaches such as 
two-dimensional electrophoresis, mass spectrometry and protein microarrays) can be 
useful tools in suggested future work to investigate the genotoxicity (by evaluating the 
changes in exposure biomarkers), understand the possible mechanism(s) of action and 
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detect the potential targets of these COO-PS-NPs in BEAS-2B cells. In addition, 
experiments can be designed and conducted to investigate the required time for a cell to 
recover following removal of the COO-PS-NPs by cell washing and incubating in fresh 
media. Different techniques, methods and assays are recommended to be used in parallel 
for COO-PS-NPs characterisation and for investigating the biomarkers following 
treatment with COO-PS-NPs. This is to overcome the restrictions of a technique (such as 
the amount of sample required) and the bias that might result from the accuracy of one 
instrument and/or the operator although this would boost up the cost and time and may 
produce dissimilar (or even conflict) results. The outcomes from different machines can 
be compared to each other to get additional information and the results of investigating 
various biomarkers using different techniques (that tell different information) can be 
combined to provide more information from one sample. Moreover, further 
characterisation of the COO-PS-NPs to study the changes of their physicochemical 
properties (such as morphology and size) and behaviour in physiological systems that 
might affect the cell exposure to them, their uptake, cellular fate and interpretation of 
results. Techniques of scanning electron microscopy (SEM) and atomic force microscopy 
(AFM) can be used for such characterisation while nanoparticle tracking analysis (NTA) 
can be used to visualise the size, distribution and real time events (such as 
aggregation/dissolution) of NPs with high resolution video in addition to calculate the ζ-
potential and concentration in liquid solutions. Different batches of the same 
fluorescently labelled COO-PS-NPs might display slightly different physicochemical 
properties but result in varied outcomes of one experimental analysis in cells and a 
significant challenge was therefore getting reproducible outcomes which required 
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consequently several repetition albeit limitations of time and cost. Thus, finding a way to 
avoid the polydispersity of nanoparticles batches might be needed. 
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